December 300000202058false2022Q19100002020582022-01-012022-04-0100002020582022-04-22xbrli:sharesiso4217:USD00002020582021-01-022021-04-02iso4217:USDxbrli:shares00002020582022-04-0100002020582021-12-3100002020582021-01-0100002020582021-04-020000202058us-gaap:CommonStockMember2021-12-310000202058us-gaap:OtherAdditionalCapitalMember2021-12-310000202058us-gaap:RetainedEarningsMember2021-12-310000202058us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000202058us-gaap:NoncontrollingInterestMember2021-12-310000202058us-gaap:RetainedEarningsMember2022-01-012022-04-010000202058us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-04-010000202058us-gaap:OtherAdditionalCapitalMember2022-01-012022-04-010000202058us-gaap:CommonStockMember2022-01-012022-04-010000202058us-gaap:NoncontrollingInterestMember2022-01-012022-04-010000202058us-gaap:CommonStockMember2022-04-010000202058us-gaap:OtherAdditionalCapitalMember2022-04-010000202058us-gaap:RetainedEarningsMember2022-04-010000202058us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-010000202058us-gaap:NoncontrollingInterestMember2022-04-010000202058us-gaap:CommonStockMember2021-01-010000202058us-gaap:OtherAdditionalCapitalMember2021-01-010000202058us-gaap:RetainedEarningsMember2021-01-010000202058us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-010000202058us-gaap:NoncontrollingInterestMember2021-01-010000202058us-gaap:RetainedEarningsMember2021-01-022021-04-020000202058us-gaap:NoncontrollingInterestMember2021-01-022021-04-020000202058us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-022021-04-020000202058us-gaap:OtherAdditionalCapitalMember2021-01-022021-04-020000202058us-gaap:CommonStockMember2021-01-022021-04-020000202058us-gaap:CommonStockMember2021-04-020000202058us-gaap:OtherAdditionalCapitalMember2021-04-020000202058us-gaap:RetainedEarningsMember2021-04-020000202058us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-020000202058us-gaap:NoncontrollingInterestMember2021-04-0200002020582021-01-022021-12-31hrs:segmenthrs:plan0000202058hrs:L3HarrisShareholderapprovedEmployeeStockIncentivePlansMember2022-01-012022-04-010000202058hrs:L3HarrisShareholderapprovedEmployeeStockIncentivePlansMember2021-01-022021-04-020000202058hrs:PerformanceStockUnitsMemberhrs:L3HarrisShareholderapprovedEmployeeStockIncentivePlansMember2022-01-012022-04-010000202058us-gaap:RestrictedStockUnitsRSUMemberhrs:L3HarrisShareholderapprovedEmployeeStockIncentivePlansMember2022-01-012022-04-010000202058us-gaap:EmployeeStockOptionMemberhrs:L3HarrisShareholderapprovedEmployeeStockIncentivePlansMember2022-01-012022-04-01xbrli:pure0000202058us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000202058us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310000202058us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000202058us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-04-010000202058us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-04-010000202058us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-04-010000202058us-gaap:AccumulatedTranslationAdjustmentMember2022-04-010000202058us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-010000202058us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-010000202058us-gaap:AccumulatedTranslationAdjustmentMember2021-01-010000202058us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-010000202058us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-010000202058us-gaap:AccumulatedTranslationAdjustmentMember2021-01-022021-04-020000202058us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-022021-04-020000202058us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-022021-04-020000202058us-gaap:AccumulatedTranslationAdjustmentMember2021-04-020000202058us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-04-020000202058us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-04-020000202058hrs:ReceivableSaleAgreementMember2022-04-01hrs:receivableSaleAgreement0000202058hrs:ReceivableSaleAgreementOneMember2022-04-010000202058hrs:ReceivableSaleAgreementTwoMember2022-04-010000202058hrs:ReceivableSaleAgreementMember2021-12-310000202058hrs:IntegratedMissionSystemsMembersrt:ScenarioPreviouslyReportedMember2021-12-310000202058hrs:SpaceandAirborneSystemsMembersrt:ScenarioPreviouslyReportedMember2021-12-310000202058hrs:CommunicationSystemsMembersrt:ScenarioPreviouslyReportedMember2021-12-310000202058hrs:AviationSystemsMembersrt:ScenarioPreviouslyReportedMember2021-12-310000202058srt:ScenarioPreviouslyReportedMember2021-12-310000202058hrs:IntegratedMissionSystemsMembersrt:RestatementAdjustmentMember2021-12-310000202058srt:RestatementAdjustmentMemberhrs:SpaceandAirborneSystemsMember2021-12-310000202058hrs:CommunicationSystemsMembersrt:RestatementAdjustmentMember2021-12-310000202058hrs:AviationSystemsMembersrt:RestatementAdjustmentMember2021-12-310000202058srt:RestatementAdjustmentMember2021-12-310000202058hrs:IntegratedMissionSystemsMember2021-12-310000202058hrs:SpaceandAirborneSystemsMember2021-12-310000202058hrs:CommunicationSystemsMember2021-12-310000202058hrs:AviationSystemsMember2021-12-310000202058hrs:IntegratedMissionSystemsMember2022-01-012022-04-010000202058hrs:SpaceandAirborneSystemsMember2022-01-012022-04-010000202058hrs:CommunicationSystemsMember2022-01-012022-04-010000202058hrs:AviationSystemsMember2022-01-012022-04-010000202058hrs:IntegratedMissionSystemsMember2022-04-010000202058hrs:SpaceandAirborneSystemsMember2022-04-010000202058hrs:CommunicationSystemsMember2022-04-010000202058hrs:AviationSystemsMember2022-04-010000202058us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberhrs:AviationSystemsMemberhrs:CombatPropulsionSystemsMember2021-04-020000202058us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberhrs:AviationSystemsMemberhrs:CombatPropulsionSystemsMember2021-01-022021-04-020000202058us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-04-010000202058us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-04-010000202058us-gaap:PensionPlansDefinedBenefitMember2021-01-022021-04-020000202058us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-022021-04-020000202058us-gaap:EquitySecuritiesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-04-010000202058us-gaap:EquitySecuritiesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2022-04-010000202058us-gaap:EquitySecuritiesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000202058us-gaap:EquitySecuritiesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2021-12-310000202058us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberhrs:CorporateownedlifeinsuranceMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-04-010000202058us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberhrs:CorporateownedlifeinsuranceMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000202058us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-04-010000202058us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000202058us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MutualFundMember2022-04-010000202058us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MutualFundMember2022-04-010000202058us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MutualFundMember2021-12-310000202058us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MutualFundMember2021-12-310000202058us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberhrs:CommonCollectiveTrustsandGuaranteedInvestmentProgramMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-04-010000202058us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberhrs:CommonCollectiveTrustsandGuaranteedInvestmentProgramMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000202058us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-04-010000202058us-gaap:FairValueInputsLevel2Memberus-gaap:MarketApproachValuationTechniqueMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-04-010000202058us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000202058us-gaap:FairValueInputsLevel2Memberus-gaap:MarketApproachValuationTechniqueMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000202058us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2022-04-010000202058us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2021-12-310000202058us-gaap:OtherCurrentAssetsMember2022-04-010000202058us-gaap:OtherCurrentAssetsMember2021-12-310000202058us-gaap:OtherNoncurrentAssetsMember2022-04-010000202058us-gaap:OtherNoncurrentAssetsMember2021-12-310000202058us-gaap:OtherCurrentLiabilitiesMember2022-04-010000202058us-gaap:OtherCurrentLiabilitiesMember2021-12-310000202058us-gaap:ContractsAccountedForUnderPercentageOfCompletionMember2022-01-012022-04-010000202058us-gaap:ContractsAccountedForUnderPercentageOfCompletionMember2021-01-022021-04-0200002020582022-04-022022-04-0100002020582024-01-012022-04-010000202058hrs:IntegratedMissionSystemsMemberus-gaap:OperatingSegmentsMember2022-01-012022-04-010000202058hrs:IntegratedMissionSystemsMemberus-gaap:OperatingSegmentsMember2021-01-022021-04-020000202058us-gaap:OperatingSegmentsMemberhrs:SpaceandAirborneSystemsMember2022-01-012022-04-010000202058us-gaap:OperatingSegmentsMemberhrs:SpaceandAirborneSystemsMember2021-01-022021-04-020000202058hrs:CommunicationSystemsMemberus-gaap:OperatingSegmentsMember2022-01-012022-04-010000202058hrs:CommunicationSystemsMemberus-gaap:OperatingSegmentsMember2021-01-022021-04-020000202058us-gaap:MaterialReconcilingItemsMember2022-01-012022-04-010000202058us-gaap:MaterialReconcilingItemsMember2021-01-022021-04-020000202058us-gaap:CorporateNonSegmentMember2022-01-012022-04-010000202058us-gaap:CorporateNonSegmentMember2021-01-022021-04-020000202058us-gaap:OperatingSegmentsMember2022-01-012022-04-010000202058us-gaap:OperatingSegmentsMember2021-01-022021-04-0200002020582020-01-042021-01-010000202058us-gaap:SalesChannelDirectlyToConsumerMemberhrs:IntegratedMissionSystemsMemberus-gaap:TransferredOverTimeMember2022-01-012022-04-010000202058us-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2022-01-012022-04-010000202058hrs:CommunicationSystemsMemberus-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:TransferredAtPointInTimeMember2022-01-012022-04-010000202058us-gaap:SalesChannelDirectlyToConsumerMemberhrs:IntegratedMissionSystemsMemberus-gaap:TransferredOverTimeMember2021-01-022021-04-020000202058us-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2021-01-022021-04-020000202058hrs:CommunicationSystemsMemberus-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:TransferredAtPointInTimeMember2021-01-022021-04-020000202058hrs:IntegratedMissionSystemsMemberus-gaap:TransferredOverTimeMemberus-gaap:SalesChannelThroughIntermediaryMember2022-01-012022-04-010000202058us-gaap:TransferredOverTimeMemberus-gaap:SalesChannelThroughIntermediaryMemberhrs:SpaceandAirborneSystemsMember2022-01-012022-04-010000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:SalesChannelThroughIntermediaryMember2022-01-012022-04-010000202058hrs:IntegratedMissionSystemsMemberus-gaap:TransferredOverTimeMemberus-gaap:SalesChannelThroughIntermediaryMember2021-01-022021-04-020000202058us-gaap:TransferredOverTimeMemberus-gaap:SalesChannelThroughIntermediaryMemberhrs:SpaceandAirborneSystemsMember2021-01-022021-04-020000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:SalesChannelThroughIntermediaryMember2021-01-022021-04-020000202058hrs:IntegratedMissionSystemsMemberus-gaap:TransferredOverTimeMemberus-gaap:IntersegmentEliminationMember2022-01-012022-04-010000202058us-gaap:TransferredOverTimeMemberus-gaap:IntersegmentEliminationMemberhrs:SpaceandAirborneSystemsMember2022-01-012022-04-010000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:IntersegmentEliminationMember2022-01-012022-04-010000202058hrs:IntegratedMissionSystemsMemberus-gaap:TransferredOverTimeMemberus-gaap:IntersegmentEliminationMember2021-01-022021-04-020000202058us-gaap:TransferredOverTimeMemberus-gaap:IntersegmentEliminationMemberhrs:SpaceandAirborneSystemsMember2021-01-022021-04-020000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:IntersegmentEliminationMember2021-01-022021-04-020000202058hrs:IntegratedMissionSystemsMemberus-gaap:TransferredOverTimeMember2022-01-012022-04-010000202058us-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2022-01-012022-04-010000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMember2022-01-012022-04-010000202058hrs:IntegratedMissionSystemsMemberus-gaap:TransferredOverTimeMember2021-01-022021-04-020000202058us-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2021-01-022021-04-020000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMember2021-01-022021-04-020000202058hrs:IntegratedMissionSystemsMemberus-gaap:FixedPriceContractMemberus-gaap:TransferredOverTimeMember2022-01-012022-04-010000202058us-gaap:FixedPriceContractMemberus-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2022-01-012022-04-010000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:FixedPriceContractMember2022-01-012022-04-010000202058hrs:IntegratedMissionSystemsMemberus-gaap:FixedPriceContractMemberus-gaap:TransferredOverTimeMember2021-01-022021-04-020000202058us-gaap:FixedPriceContractMemberus-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2021-01-022021-04-020000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:FixedPriceContractMember2021-01-022021-04-020000202058hrs:IntegratedMissionSystemsMemberhrs:CostreimbursableMemberus-gaap:TransferredOverTimeMember2022-01-012022-04-010000202058hrs:CostreimbursableMemberus-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2022-01-012022-04-010000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMemberhrs:CostreimbursableMember2022-01-012022-04-010000202058hrs:IntegratedMissionSystemsMemberhrs:CostreimbursableMemberus-gaap:TransferredOverTimeMember2021-01-022021-04-020000202058hrs:CostreimbursableMemberus-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2021-01-022021-04-020000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMemberhrs:CostreimbursableMember2021-01-022021-04-020000202058hrs:IntegratedMissionSystemsMembercountry:USus-gaap:TransferredOverTimeMember2022-01-012022-04-010000202058country:USus-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2022-01-012022-04-010000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMembercountry:US2022-01-012022-04-010000202058hrs:IntegratedMissionSystemsMembercountry:USus-gaap:TransferredOverTimeMember2021-01-022021-04-020000202058country:USus-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2021-01-022021-04-020000202058hrs:CommunicationSystemsMemberus-gaap:TransferredAtPointInTimeMembercountry:US2021-01-022021-04-020000202058us-gaap:NonUsMemberhrs:IntegratedMissionSystemsMemberus-gaap:TransferredOverTimeMember2022-01-012022-04-010000202058us-gaap:NonUsMemberus-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2022-01-012022-04-010000202058hrs:CommunicationSystemsMemberus-gaap:NonUsMemberus-gaap:TransferredAtPointInTimeMember2022-01-012022-04-010000202058us-gaap:NonUsMemberhrs:IntegratedMissionSystemsMemberus-gaap:TransferredOverTimeMember2021-01-022021-04-020000202058us-gaap:NonUsMemberus-gaap:TransferredOverTimeMemberhrs:SpaceandAirborneSystemsMember2021-01-022021-04-020000202058hrs:CommunicationSystemsMemberus-gaap:NonUsMemberus-gaap:TransferredAtPointInTimeMember2021-01-022021-04-020000202058hrs:IntegratedMissionSystemsMemberus-gaap:OperatingSegmentsMember2022-04-010000202058hrs:IntegratedMissionSystemsMemberus-gaap:OperatingSegmentsMember2021-12-310000202058us-gaap:OperatingSegmentsMemberhrs:SpaceandAirborneSystemsMember2022-04-010000202058us-gaap:OperatingSegmentsMemberhrs:SpaceandAirborneSystemsMember2021-12-310000202058hrs:CommunicationSystemsMemberus-gaap:OperatingSegmentsMember2022-04-010000202058hrs:CommunicationSystemsMemberus-gaap:OperatingSegmentsMember2021-12-310000202058us-gaap:MaterialReconcilingItemsMember2022-04-010000202058us-gaap:MaterialReconcilingItemsMember2021-12-310000202058us-gaap:CorporateNonSegmentMember2022-04-010000202058us-gaap:CorporateNonSegmentMember2021-12-310000202058hrs:PassaicRiverAlaskaMemberhrs:ExelisMember2016-03-012016-03-31hrs:responsible_party0000202058hrs:PassaicRiverAlaskaMemberhrs:ExelisMember2022-01-012022-04-010000202058hrs:PassaicRiverAlaskaMemberhrs:ExelisMember2021-10-022021-12-31




hrs-20220401_g1.jpg
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended April 1, 2022
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______________ to ______________
Commission File Number 1-3863
L3HARRIS TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Delaware 34-0276860
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
1025 West NASA Boulevard
Melbourne,Florida 32919
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (321) 727-9100
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $1.00 per shareLHXNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.              þ   Yes   o  No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).          þ   Yes   o  No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer þ  Accelerated filer 
Non-accelerated filer 
¨  
  Smaller reporting company 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).      ☐  Yes   þ  No  
The number of shares outstanding of the registrant’s common stock as of April 22, 2022 was 192,874,623.





L3HARRIS TECHNOLOGIES, INC.
FORM 10-Q
For the Quarter Ended April 1, 2022
TABLE OF CONTENTS
  Page No.
Part I. Financial Information:
Condensed Consolidated Statement of Income for the Quarter Ended April 1, 2022 and April 2, 2021
Condensed Consolidated Statement of Comprehensive Income for the Quarter Ended April 1, 2022 and April 2, 2021
Condensed Consolidated Balance Sheet at April 1, 2022 and December 31, 2021
Condensed Consolidated Statement of Cash Flows for the Quarter Ended April 1, 2022 and April 2, 2021
Condensed Consolidated Statement of Equity for the Quarter Ended April 1, 2022 and April 2, 2021
Part II. Other Information:
ITEM 6.      Exhibits
Signatures
This Report contains trademarks, service marks and registered marks of L3Harris Technologies, Inc. and its subsidiaries. All other trademarks are the property of their respective owners.




PART I. FINANCIAL INFORMATION
 ITEM 1.FINANCIAL STATEMENTS (Unaudited).
L3HARRIS TECHNOLOGIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF INCOME
(Unaudited)
 Quarter Ended
(In millions, except per share amounts)April 1, 2022April 2, 2021
 
Revenue from product sales and services$4,103 $4,567 
Cost of product sales and services(2,892)(3,213)
Engineering, selling and administrative expenses(713)(801)
Business divestiture-related losses— (15)
Impairment of goodwill and other assets— (62)
Non-operating income106 117 
Interest expense, net(68)(66)
Income from continuing operations before income taxes536 527 
Income taxes(61)(60)
Income from continuing operations475 467 
Discontinued operations, net of income taxes— (1)
Net income475 466 
Noncontrolling interests, net of income taxes— 
Net income attributable to L3Harris Technologies, Inc.$475 $468 
Amount attributable to L3Harris Technologies, Inc. common shareholders
Income from continuing operations$475 $469 
Discontinued operations, net of income taxes— (1)
Net income$475 $468 
Net income per common share attributable to L3Harris Technologies, Inc. common shareholders
Basic
Continuing operations$2.46 $2.27 
Discontinued operations— (0.01)
$2.46 $2.26 
Diluted
Continuing operations$2.44 $2.25 
Discontinued operations— — 
$2.44 $2.25 
Basic weighted average common shares outstanding193.2 206.7 
Diluted weighted average common shares outstanding195.1 208.5 
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).
1


L3HARRIS TECHNOLOGIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(Unaudited) 
 Quarter Ended
(In millions)April 1, 2022April 2, 2021
 
Net income$475 $466 
Other comprehensive income (loss):
Foreign currency translation loss, net of income taxes(3)(18)
Net unrealized gain on hedging derivatives, net of income taxes
Other comprehensive income (loss), recognized during the period(13)
Reclassification adjustments for gains included in net income(6)(2)
Other comprehensive loss, net of income taxes(4)(15)
Total comprehensive income471 451 
Comprehensive loss attributable to noncontrolling interests— 
Total comprehensive income attributable to L3Harris Technologies, Inc.$471 $453 
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).
2


L3HARRIS TECHNOLOGIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET
(Unaudited)
(In millions, except shares)April 1, 2022December 31, 2021
Assets
Current Assets
Cash and cash equivalents$402 $941 
Receivables, net1,283 1,045 
Contract assets3,113 3,021 
Inventories1,090 982 
Inventory prepayments58 48 
Income taxes receivable54 98 
Other current assets249 224 
Total current assets6,249 6,359 
Non-current Assets
Property, plant and equipment, net2,078 2,101 
Operating lease right-of-use assets775 769 
Goodwill18,194 18,189 
Other intangible assets, net6,486 6,640 
Deferred income taxes91 85 
Other non-current assets571 566 
Total non-current assets28,195 28,350 
$34,444 $34,709 
Liabilities and Equity
Current Liabilities
Short-term debt$$
Accounts payable1,723 1,767 
Contract liabilities1,275 1,297 
Compensation and benefits290 444 
Other accrued items997 1,002 
Income taxes payable187 28 
Current portion of long-term debt, net262 11 
Total current liabilities4,737 4,551 
Non-current Liabilities
Defined benefit plans524 614 
Operating lease liabilities777 768 
Long-term debt, net6,795 7,048 
Deferred income taxes1,189 1,344 
Other long-term liabilities1,056 1,065 
Total non-current liabilities10,341 10,839 
Equity
Shareholders’ Equity:
Preferred stock, without par value; 1,000,000 shares authorized; none issued
— — 
Common stock, $1.00 par value; 500,000,000 shares authorized; issued and outstanding 192,805,539 and 193,511,401 shares at April 1, 2022 and December 31, 2021, respectively
193 194 
Other capital16,089 16,248 
Retained earnings3,128 2,917 
Accumulated other comprehensive loss(150)(146)
Total shareholders’ equity19,260 19,213 
Noncontrolling interests106 106 
Total equity19,366 19,319 
$34,444 $34,709 
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).
3


L3HARRIS TECHNOLOGIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Unaudited)
 Quarter Ended
(In millions)April 1, 2022April 2, 2021
Operating Activities
Net income$475 $466 
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of acquisition-related intangibles152 164 
Depreciation and other amortization80 87 
Share-based compensation28 33 
Share-based matching contributions under defined contribution plans55 57 
Qualified pension plan contributions(2)(2)
Pension and other postretirement benefit plan income(99)(92)
Impairment of goodwill and other assets— 62 
Business divestiture-related losses— 15 
Deferred income taxes(162)(22)
(Increase) decrease in:
Receivables, net(239)213 
Contract assets(93)(272)
Inventories(108)61 
Prepaid expenses and other current assets(25)(85)
Increase (decrease) in:
Accounts payable(43)15 
Contract liabilities(16)
Compensation and benefits(154)(161)
Other accrued items(12)71 
Income taxes203 72 
Other(1)(30)
Net cash provided by operating activities39 661 
Investing Activities
Additions to property, plant and equipment(55)(67)
Proceeds from sale of property, plant and equipment, net— 
Other investing activities(9)
Net cash used in investing activities(64)(61)
Financing Activities
Net proceeds from borrowings
Repayments of borrowings(5)(1)
Proceeds from exercises of employee stock options30 10 
Repurchases of common stock(308)(700)
Cash dividends(218)(209)
Tax withholding payments associated with vested share-based awards(12)(1)
Other financing activities(1)— 
Net cash used in financing activities(513)(900)
Effect of exchange rate changes on cash and cash equivalents(1)— 
Net decrease in cash and cash equivalents(539)(300)
Cash and cash equivalents, beginning of period941 1,276 
Cash and cash equivalents, end of period$402 $976 
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).
4


L3HARRIS TECHNOLOGIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF EQUITY
(Unaudited)
(In millions, except per share amounts)Common
Stock
Other
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Non-controlling
Interests
Total
Equity
Balance at December 31, 2021$194 $16,248 $2,917 $(146)$106 $19,319 
Net income — — 475 — — 475 
Other comprehensive loss, net of income taxes— — — (4)— (4)
Shares issued under stock incentive plans— 30 — — — 30 
Shares issued under defined contribution plans— 55 — — — 55 
Share-based compensation expense— 28 — — — 28 
Tax withholding payments on share-based awards— (12)— — — (12)
Repurchases and retirement of common stock(1)(260)(47)— — (308)
Cash dividends ($1.12 per share)
— — (218)— — (218)
Distributions to noncontrolling interests— — — — (1)(1)
Other— — — 
Balance at April 1, 2022$193 $16,089 $3,128 $(150)$106 $19,366 
Balance at January 1, 2021$208 $19,008 $2,347 $(839)$117 $20,841 
Net income— — 468 — (2)466 
Other comprehensive loss, net of income taxes— — — (15)— (15)
Shares issued under stock incentive plans— 10 — — — 10 
Shares issued under defined contribution plans— 57 — — — 57 
Share-based compensation expense— 33 — — — 33 
Repurchases and retirement of common stock(3)(620)(77)— — (700)
Cash dividends ($1.02 per share)
— — (209)— — (209)
Other— (1)— — — (1)
Balance at April 2, 2021$205 $18,487 $2,529 $(854)$115 $20,482 
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).
5


NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE A — SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING STANDARDS
Basis of Presentation
The accompanying Condensed Consolidated Financial Statements (Unaudited) include the accounts of L3Harris Technologies, Inc. and its consolidated subsidiaries. As used in these Notes to Condensed Consolidated Financial Statements (Unaudited) (these “Notes”), the terms “L3Harris,” “Company,” “we,” “our” and “us” refer to L3Harris Technologies, Inc. and its consolidated subsidiaries. Intracompany transactions and accounts have been eliminated in consolidation. The accompanying Condensed Consolidated Financial Statements (Unaudited) have been prepared by L3Harris in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, such interim financial statements do not include all information and footnotes necessary for a complete presentation of financial condition, results of operations, cash flows and equity in conformity with GAAP for annual financial statements. In the opinion of management, such interim financial statements reflect all adjustments (including normal recurring adjustments) considered necessary for a fair presentation of our financial condition, results of operations, cash flows and equity for the periods presented therein. The results for the quarter ended April 1, 2022 are not necessarily indicative of the results that may be expected for the full fiscal year or any subsequent period. The balance sheet at December 31, 2021 has been derived from our audited financial statements, but does not include all of the information and footnotes required by GAAP for annual financial statements. We provide complete, audited financial statements in our Annual Report on Form 10-K, which includes information and footnotes required by the rules and regulations of the SEC. The information included in this Quarterly Report on Form 10-Q (this “Report”) should be read in conjunction with the Management’s Discussion and Analysis of Financial Condition and Results of Operations and the Consolidated Financial Statements and accompanying Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (our “Fiscal 2021 Form 10-K”).
Segment reorganization: We implemented a new organizational structure effective January 1, 2022, resulting in changes to our operating segments, which are also our reportable segments and are referred to as our business segments. The new structure streamlined our business segments from four business segments to three business segments. Our former Aviation Systems segment was eliminated as a business segment.
We updated our business segment reporting and accounting policies for pension and other postretirement benefits plan (“OPEB”) income or expense to better align our presentation of business segment information with our industry peers. Our business segment operating results include pension and OPEB cost under U.S. Government Cost Accounting Standards (“CAS”), as CAS pension and OPEB cost is allocable to and allowable under contracts with the U.S. Government. We no longer assign or allocate Financial Accounting Standards (“FAS”) pension and OPEB income or expense to our business segments. U.S. GAAP requires pension and OPEB income or expense to be recognized on a FAS basis. Therefore, we present a “FAS/CAS pension adjustment” outside of business segment results, representing the difference between the service cost component of FAS pension and OPEB income or expense and total CAS pension and OPEB cost or expense. Non-service cost components of FAS pension and OPEB income or expense is included as a component of non-operating income or expense.
The historical results, discussion and presentation of our business segments as set forth in the accompanying Condensed Consolidated Financial Statements (Unaudited) and these Notes reflect the impact of these changes for all periods presented in order to present segment information on a comparable basis. There is no impact on our previously reported consolidated statements of income, balance sheets, statements of cash flows or statements of equity resulting from these changes. See Note Q — Business Segment Information in these Notes for further information regarding our new segment structure and pension presentation effective in fiscal 2022.
Supplemental Cash Flow Information
Non-cash investing and financing activities during the quarter ended April 2, 2021 included a $120 million right-of-use asset we obtained in exchange for a corresponding financing lease liability. These non-cash investing and financing activities are excluded from the “Additions to property, plant and equipment” and “Net proceeds from borrowings” line items in our Condensed Consolidated Statement of Cash Flows (Unaudited). Right-of-use assets for finance leases are included in the “Property, plant and equipment, net” line item and the corresponding finance lease liabilities are included in the “Current portion of long-term debt, net” and “Long-term debt, net” line items in our Condensed Consolidated Balance Sheet (Unaudited).
Use of Estimates
The preparation of financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported in the accompanying Condensed Consolidated Financial Statements (Unaudited) and these Notes and related disclosures. These estimates and assumptions are based on experience and other information available prior to issuance of the accompanying Condensed Consolidated Financial Statements (Unaudited) and these Notes. Materially different results can occur as circumstances change and additional information becomes known.
6


Significant Accounting Policies Update
There have been no material changes to our significant accounting policies described in our Fiscal 2021 Form 10-K.
NOTE B — STOCK OPTIONS AND OTHER SHARE-BASED COMPENSATION
At April 1, 2022, we had options or other share-based compensation outstanding under two Harris shareholder-approved employee stock incentive plans (“SIPs”), the Harris Corporation 2005 Equity Incentive Plan (As Amended and Restated Effective August 27, 2010) and the L3Harris Technologies, Inc. 2015 Equity Incentive Plan (As Amended and Restated Effective August 28, 2020) (the “2015 EIP”), as well as under employee stock incentive plans of L3 Technologies, Inc. assumed by L3Harris (collectively, “L3Harris SIPs”). We believe that share-based awards more closely align the interests of participants with those of shareholders.
The compensation cost related to our share-based awards that was charged against income was $28 million and $33 million for the quarters ended April 1, 2022 and April 2, 2021, respectively. The aggregate number of shares of our common stock issued under L3Harris SIPs, net of shares withheld for tax purposes, was 0.4 million and 0.1 million for the quarters ended April 1, 2022 and April 2, 2021, respectively.
Awards granted to participants under L3Harris SIPs during the quarter ended April 1, 2022 consisted of 0.4 million stock options, 0.2 million performance stock units and 0.2 million restricted stock units. The majority of the options and units were granted on February 25, 2022. The fair value as of the grant date of each stock option award was determined using the Black-Scholes-Merton option-pricing model and the following assumptions: expected dividend yield of 1.92%; expected volatility of 29.11%; risk-free interest rates averaging 1.86%; and expected term of 5.02 years. The fair value as of the grant date of each restricted stock unit award was based on the closing price of our common stock on the grant date. The fair value as of the grant date of each performance stock unit award was determined based on the fair value from a multifactor Monte Carlo valuation model that simulates our stock price and total shareholder return (“TSR”) relative to other companies in the S&P 500, less a discount to reflect the delay in payments of cash dividend-equivalents that are made only upon vesting. The fair value of these awards is amortized to compensation expense over the performance period if achievement of the performance measures is considered probable.
NOTE C — ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (“AOCI”)
The components of AOCI are summarized below:
(In millions)Foreign currency translationNet unrealized losses on hedging derivativesUnrecognized postretirement obligationsTotal AOCI
Balance at December 31, 2021$(118)$(89)$61 $(146)
Other comprehensive (loss) income before reclassifications to earnings, net of income taxes(3)— 
Gains reclassified to earnings, net of income taxes— (1)(5)(6)
Other comprehensive (loss) income, net of income taxes(3)(5)(4)
Balance at April 1, 2022$(121)$(85)$56 $(150)
Balance at January 1, 2021$(58)$(80)$(701)$(839)
Other comprehensive (loss) income before reclassifications to earnings, net of income taxes(18)— (13)
(Gains) losses reclassified to earnings, net of income taxes— (3)(2)
Other comprehensive (loss) income, net of income taxes(18)(15)
Balance at April 2, 2021$(76)$(78)$(700)$(854)
_______________
(1)(Gains) losses reclassified to earnings are included in the “Revenue from product sales and services,” “Business divestiture-related losses,” “Interest expense” and “Non-operating income line items in our Condensed Consolidated Statement of Income (Unaudited).
7


NOTE D — RECEIVABLES, NET
Receivables, net are summarized below:
(In millions)April 1, 2022December 31, 2021
Accounts receivable$1,324 $1,088 
Less: allowances for collection losses(41)(43)
Receivables, net$1,283 $1,045 
We have two receivables sale agreements (“RSAs”) with two separate third-party financial institutions that permit us to sell, on a non-recourse basis, up to $100 million each of outstanding receivables at any given time. From time to time, we have sold certain customer receivables under the RSAs, which we continue to service and collect on behalf of the third-party financial institutions and which we account for as sales of receivables with sale proceeds included in net cash from operating activities. Outstanding accounts receivable sold pursuant to the RSAs was $99 million at April 1, 2022 and $100 million at December 31, 2021, with net cash proceeds of $98 million and $100 million, respectively.
NOTE E — CONTRACT ASSETS AND CONTRACT LIABILITIES
Contract assets include unbilled amounts typically resulting from revenue recognized exceeding amounts billed to customers for contracts utilizing the percentage of completion (“POC”) cost-to-cost revenue recognition method. We bill customers as work progresses in accordance with agreed-upon contractual terms, either at periodic intervals, upon achievement of contractual milestones or upon deliveries and, in certain arrangements, the customer may withhold payment of a small portion of the contract price until contract completion. Contract liabilities include advance payments and billings in excess of revenue recognized, including deferred revenue associated with extended product warranties. Contract assets and liabilities are reported on a contract-by-contract basis at the end of each reporting period.
Contract assets and liabilities in the quarter ended April 1, 2022 were impacted primarily by the timing of contractual billing milestones.
Contract assets and contract liabilities are summarized below:
(In millions)April 1, 2022December 31, 2021
Contract assets$3,113 $3,021 
Contract liabilities, current(1,275)(1,297)
Contract liabilities, non-current(1)
(114)(107)
Net contract assets$1,724 $1,617 
_______________
(1)The non-current portion of contract liabilities is included as a component of the “Other long-term liabilities” line item in our Condensed Consolidated Balance Sheet (Unaudited).
The components of contract assets are summarized below:
(In millions)April 1, 2022December 31, 2021
Unbilled contract receivables, gross$4,530 $4,825 
Unliquidated progress payments and advances(1,417)(1,804)
Contract assets$3,113 $3,021 
Impairment losses related to our contract assets were not material for the quarters ended April 1, 2022 and April 2, 2021. During the quarters ended April 1, 2022 and April 2, 2021, we recognized $517 million and $508 million, respectively, of revenue related to contract liabilities that were outstanding at the end of the respective prior fiscal year.
8


NOTE F — INVENTORIES
Inventories are summarized below:
(In millions)April 1, 2022December 31, 2021
Finished products$159 $141 
Work in process326 335 
Raw materials and supplies605 506 
Inventories$1,090 $982 
NOTE G — PROPERTY, PLANT AND EQUIPMENT, NET
Property, plant and equipment, net are summarized below:
(In millions)April 1, 2022December 31, 2021
Land$80 $79 
Software capitalized for internal use584 576 
Buildings1,250 1,236 
Machinery and equipment2,191 2,177 
4,105 4,068 
Less: accumulated depreciation and amortization(2,027)(1,967)
Property, plant and equipment, net$2,078 $2,101 
Depreciation and amortization expense related to property, plant and equipment was $83 million and $84 million for the quarters ended April 1, 2022 and April 2, 2021, respectively.
NOTE H — GOODWILL
The assignment of goodwill by business segment, and changes in the carrying amount of goodwill by business segment, were as follows:
(In millions)Integrated Mission SystemsSpace & Airborne SystemsCommunication Systems
Aviation Systems(1)
Total
Balance at December 31, 2021 - As Reported$6,485 $5,202 $4,153 $2,349 $18,189 
Transfer of goodwill in segment reorganization(1)
1,702 647 — (2,349)— 
Balance at December 31, 2021 - After Reallocation8,187 5,849 4,153  18,189 
Currency translation adjustments(2)— 
Balance at April 1, 2022$8,193 $5,847 $4,154 $ $18,194 
_______________
(1)As a result of our new organizational structure, effective January 1, 2022, streamlining our operations from four business segments to three business segments, we transferred goodwill previously held by our eliminated Aviation Systems segment to our remaining business segments as of January 1, 2021, the earliest period presented in these Notes. See additional information below and “Segment Reorganization” in. Note A — Significant Accounting Policies and Recent Accounting Standards in these Notes.
Fair Value of Businesses
Segment reorganization: We implemented a new organizational structure effective January 1, 2022, resulting in changes to our operating segments, which are also our reportable segments and are referred to as our business segments. The new structure streamlined our business segments from four business segments to three business segments. As a result of the segment reorganization, we realigned our reporting units from 11 to 9 reporting units, which are our business segments or one level below the business segment. For our realigned reporting units, immediately before and after our goodwill assignments, we completed an assessment of any potential goodwill impairment under our former and new reporting unit structure and determined that no impairment existed.
Combat Propulsion Systems and related businesses (“CPS business”) impairment. During the quarter ended April 2, 2021, we determined the criteria to be classified as held for sale were met with respect to the CPS business within our other non-reportable business segment and assigned $174 million of goodwill to the disposal group on a relative fair value basis. In
9


connection with the preparation of our financial statements for the quarter ended April 2, 2021, we concluded that goodwill related to the CPS business was impaired and we recorded a non-cash impairment charge of $62 million, which is included in the “Impairment of goodwill and other assets” line item in our Condensed Consolidated Statement of Income (Unaudited).
See Note 1: “Significant Accounting Policies” and Note 3: “Business Divestitures and Asset Sales” in the Notes to Consolidated Financial Statement in our Fiscal 2021 Form 10-K for additional information regarding the fair value hierarchy and our business divestitures, respectively.
NOTE I — ACCRUED WARRANTIES
Our liability for standard product warranties is included as a component of the “Other accrued items” and “Other long-term liabilities” line items in our Condensed Consolidated Balance Sheet (Unaudited). Changes in our liability for standard product warranties during the quarter ended April 1, 2022 were as follows:
(In millions)
Balance at December 31, 2021$117 
Accruals for product warranties issued during the period17 
Settlements made during the period(30)
Other, including foreign currency translation adjustments(2)
Balance at April 1, 2022$102 
NOTE J — POSTRETIREMENT BENEFIT PLANS
The following tables provide the components of our net periodic benefit income for our defined benefit plans, including defined benefit pension plans and other postretirement defined benefit plans:
Quarter Ended April 1, 2022Quarter Ended April 2, 2021
(In millions)PensionOther BenefitsPensionOther Benefits
Net periodic benefit income
Operating
Service cost$10 $$18 $
Non-operating
Interest cost55 46 
Expected return on plan assets(156)(5)(155)(5)
Amortization of net actuarial loss (gain)(2)— 
Amortization of prior service credit(6)— (7)— 
Non-service cost periodic benefit income(105)(5)(107)(4)
Net periodic benefit income$(95)$(4)$(89)$(3)
The service cost component of net periodic benefit income is included in the “Cost of product sales and services” and “Engineering, selling and administrative expenses” line items in our Condensed Consolidated Statement of Income (Unaudited). The non-service cost components of net periodic benefit income are included in the “Non-operating income” line item in our Condensed Consolidated Statement of Income (Unaudited).
We made no material contributions to our U.S. qualified defined benefit pension plans during the quarters ended April 1, 2022 and April 2, 2021. As a result of prior voluntary contributions, we are not required to make any contributions to these plans during fiscal 2022 and for several years thereafter.
NOTE K — EARNINGS PER SHARE
Income from continuing operations per common share attributable to L3Harris common shareholders (“EPS”) is computed using the two-class method, which is an earnings allocation formula that determines EPS for common stock and any participating securities according to dividends paid and participation rights in undistributed earnings. Under the two-class method, EPS is computed by dividing the sum of earnings distributed to L3Harris common shareholders and undistributed earnings allocated to L3Harris common shareholders by the weighted-average number of common shares outstanding for the period. Income from continuing operations per diluted common share attributable to L3Harris common shareholders (“diluted EPS”) is computed using
10


the more dilutive of the two-class method or the treasury stock method. Under the treasury stock method, diluted EPS is computed by dividing net income attributable to L3Harris common shareholders by the weighted-average number of common shares outstanding for the period. In applying the two-class method, undistributed earnings are allocated to both common shares and participating securities based on the weighted-average shares outstanding during the period.
The weighted average number of shares outstanding used to compute EPS and diluted EPS are as follows:
Quarter Ended
(In millions)April 1, 2022April 2, 2021
Basic weighted average common shares outstanding193.2 206.7 
Impact of dilutive share-based awards1.9 1.8 
Diluted weighted average common shares outstanding195.1 208.5 
Potential dilutive common shares primarily consist of employee stock options and restricted and performance unit awards. Diluted EPS excludes the antidilutive impact of 0.2 million and 1.6 million weighted average share-based awards outstanding for the quarters ended April 1, 2022 and April 2, 2021, respectively.
NOTE L — INCOME TAXES
Our effective tax rate (income taxes as a percentage of income from continuing operations before income taxes) was 11.3% for the quarter ended April 1, 2022 compared with 11.4% for the quarter ended April 2, 2021. For the quarter ended April 1, 2022, our effective tax rate benefited from the favorable impact of Research and Development (“R&D”) credits, the reduction in deferred tax liabilities on the outside basis of certain foreign subsidiaries due to an internal restructuring, incremental foreign-derived intangible income (“FDII”) benefit resulting from the requirement to capitalize and amortize R&D expenses beginning in fiscal 2022, the resolution of specific audit uncertainties, and excess tax benefits related to equity-based compensation. For the quarter ended April 2, 2021, our effective tax rate benefited from the favorable impact of R&D credits, the resolution of specific audit uncertainties and the recognition of deferred tax assets on the outside basis of entities held-for-sale.
NOTE M — FAIR VALUE MEASUREMENTS
Fair value is defined as the price that would be received for an asset or the price that would be paid to transfer a liability in the principal market or most advantageous market in an orderly transaction between market participants at the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs in measuring fair value, and to utilize a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows:
Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs other than quoted prices included within Level 1, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs other than quoted prices that are observable or are derived principally from, or corroborated by, observable market data by correlation or other means.
Level 3 — Unobservable inputs that are supported by little or no market activity, are significant to the fair value of the assets or liabilities, and reflect our own assumptions about the assumptions market participants would use in pricing the asset or liability developed using the best information available in the circumstances.
In certain instances, fair value is estimated using quoted market prices obtained from external pricing services. In obtaining such data from the external pricing services, we have evaluated the methodologies used to develop the estimate of fair value in order to assess whether such valuations are representative of fair value, including net asset value (“NAV”). Additionally, in certain circumstances, the NAV reported by an asset manager may be adjusted when sufficient evidence indicates NAV is not representative of fair value.
11


The following table presents assets and liabilities measured at fair value on a recurring basis (at least annually) at April 1, 2022 and December 31, 2021:
April 1, 2022December 31, 2021
(In millions)TotalLevel 1TotalLevel 1
Assets
Deferred compensation plan assets(1)
Equity and fixed income securities$72 $72 $77 $77 
Investments measured at NAV:
Corporate-owned life insurance35 35 
Total fair value of deferred compensation plan assets$107 $112 
Liabilities
Deferred compensation plan liabilities(2)
Equity securities and mutual funds$$$$
Investments measured at NAV:
Common/collective trusts and guaranteed investment contracts170 177 
Total fair value of deferred compensation plan liabilities$177 $183 
_______________
(1)Represents diversified assets held in a rabbi trust associated with our non-qualified deferred compensation plans, which we include in the “Other current
assets” and “Other non-current assets” line items in our Condensed Consolidated Balance Sheet (Unaudited), and which are measured at fair value.
(2)Primarily represents obligations to pay benefits under certain non-qualified deferred compensation plans, which we include in the “Compensation and
benefits” and “Other long-term liabilities” line items in our Condensed Consolidated Balance Sheet (Unaudited). Under these plans, participants designate
investment options (including stock and fixed-income funds), which serve as the basis for measurement of the notional value of their accounts.
The following table presents the carrying amounts and estimated fair values of our significant financial instruments that were not measured at fair value (carrying amounts of other financial instruments not listed in the table below approximate fair value due to the short-term nature of those items):
 April 1, 2022December 31, 2021
(In millions)Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Long-term debt (including current portion)(1)
$7,057 $7,174 $7,059 $7,701 
_______________
(1)The fair value was estimated using a market approach based on quoted market prices for our debt traded in the secondary market. If our long-term debt in our balance sheet was measured at fair value, it would be categorized in Level 2 of the fair value hierarchy.
See Note H — Goodwill in these Notes and Note 3: “Business Divestitures and Asset Sales” in the Notes to Consolidated Financial Statement in our Fiscal 2021 Form 10-K for additional information regarding fair value measurements associated with goodwill.
NOTE N — DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
In the normal course of business, we are exposed to global market risks, including the effect of changes in foreign currency exchange rates. We use derivative instruments to manage our exposure to such risks and formally document all relationships between hedging instruments and hedged items, as well as the risk-management objective and strategy for undertaking hedge transactions. We also may enter into derivative instruments that are not designated as hedges and do not qualify for hedge accounting. We recognize all derivatives in our Condensed Consolidated Balance Sheet (Unaudited) at fair value. We do not hold or issue derivatives for speculative trading purposes.
Exchange Rate Risk — Cash Flow Hedges
To manage our exposure to currency risk and market fluctuation risk associated with anticipated cash flows that are probable of occurring in the future, we implement cash flow hedges. More specifically, we use foreign currency forward contracts and options to hedge off-balance sheet future foreign currency commitments, including purchase commitments to suppliers, future committed sales to customers and intersegment transactions. These derivatives are used to hedge currency exposures from cash flows anticipated across our business segments. We also hedge U.S. Dollar payments to suppliers to maintain our anticipated profit margins in our international operations. These derivatives have only nominal intrinsic value at the time of purchase and
12


have a high degree of correlation to the anticipated cash flows they are designated to hedge. Hedge effectiveness is determined by the correlation of the anticipated cash flows from the hedging instruments and the anticipated cash flows from the future foreign currency commitments through the maturity dates of the derivatives used to hedge these cash flows. These financial instruments are marked-to-market using forward prices and fair value quotes with the offset to other comprehensive income (loss). Gains and losses in AOCI are reclassified to earnings when the related hedged item is recognized in earnings. The cash flow impact of our derivatives is included in the same category in our Condensed Consolidated Statement of Cash Flows (Unaudited) as the cash flows of the related hedged items. Notional amounts are used to measure the volume of foreign currency forward contracts and do not represent exposure to foreign currency losses. At April 1, 2022, we had open foreign currency forward contracts with an aggregate notional amount of $298 million, hedging certain forecasted transactions denominated in U.S. Dollars, Canadian Dollars, Euros, British Pounds and Australian Dollars. At December 31, 2021, we had open foreign currency forward contracts with an aggregate notional amount of $328 million, hedging certain forecasted transactions denominated in U.S. Dollars, Canadian Dollars, British Pounds, Euros and Australian Dollars.
At April 1, 2022, our foreign currency forward contracts had maturities through 2025.
The following table presents the fair values of our derivatives designated as foreign currency hedging instruments in our Condensed Consolidated Balance Sheet (Unaudited) at April 1, 2022 and December 31, 2021:
(In millions)April 1, 2022December 31, 2021
Foreign currency forward contracts(1)
Other current assets$$
Other non-current assets
Other accrued items
_______________
(1)See Note M — Fair Value Measurements in these Notes for a description of the fair value hierarchy related to our foreign currency forward contracts.
The impact of any derivative related activities on our income statement was not material for the quarters ended April 1, 2022 and April 2, 2021.
Gains and losses from foreign currency derivatives designated as cash flow hedges are included in the line item in our Condensed Consolidated Statement of Income (Unaudited) associated with the hedged transaction, with the exception of the losses resulting from discontinued cash flow hedges, which are included in the “Engineering, selling and administrative expenses” line item in our Condensed Consolidated Statement of Income (Unaudited).
NOTE O — CHANGES IN ESTIMATES
Under the POC cost-to-cost method of revenue recognition, a single estimated profit margin is used to recognize profit for each performance obligation over its period of performance. Recognition of profit on a contract requires estimates of the total cost at completion and transaction price and the measurement of progress towards completion. Due to the long-term nature of many of our contracts, developing the estimated total cost at completion and total transaction price often requires judgment. Factors that must be considered in estimating the cost of the work to be completed include the nature and complexity of the work to be performed, subcontractor performance and the risk and impact of delayed performance. Factors that must be considered in estimating the total transaction price include contractual cost or performance incentives (such as incentive fees, award fees and penalties) and other forms of variable consideration as well as our historical experience and our expectation for performance on the contract. These variable amounts generally are awarded upon achievement of certain negotiated performance metrics, program milestones or cost targets and can be based upon customer discretion. We include such estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved.
At the outset of each contract, we gauge its complexity and perceived risks and establish an estimated total cost at completion in line with these expectations. After establishing the estimated total cost at completion, we follow a standard Estimate at Completion (“EAC”) process in which we review the progress and performance on our ongoing contracts at least quarterly and, in many cases, more frequently. If we successfully retire risks associated with the technical, schedule and cost aspects of a contract, we may lower our estimated total cost at completion commensurate with the retirement of these risks. Conversely, if we are not successful in retiring these risks, we may increase our estimated total cost at completion. Additionally, as the contract progresses, our estimates of total transaction price may increase or decrease if, for example, we receive award fees that are higher or lower than expected. When adjustments in estimated total costs at completion or in estimated total transaction price are determined, the related impact on operating income is recognized using the cumulative catch-up method, which recognizes in the current period the cumulative effect of such adjustments for all prior periods. Any anticipated losses on these contracts are fully recognized in the period in which the losses become evident.
13


Net EAC adjustments had the following impact to earnings for the periods presented:
Quarter Ended
(In millions, except per share amounts)April 1, 2022April 2, 2021
Net EAC adjustments, before income taxes$46 $82 
Net EAC adjustments, net of income taxes35 62 
Net EAC adjustments, net of income taxes, per diluted share
0.18 0.30 
Revenue recognized from performance obligations satisfied in prior periods was $58 million and $108 million for the quarters ended April 1, 2022 and April 2, 2021, respectively.
NOTE P — BACKLOG
Backlog, which is the equivalent of our remaining performance obligations, represents the future revenue we expect to recognize as we perform on our current contracts. Backlog comprises both funded backlog (i.e., firm orders for which funding is authorized and appropriated) and unfunded backlog. Backlog excludes unexercised contract options and potential orders under ordering-type contracts, such as indefinite delivery, indefinite quantity contracts.
At April 1, 2022, our ending backlog was $21.1 billion. We expect to recognize approximately 51% of the revenue associated with this backlog by the end of 2022 and approximately 75% by the end of 2023, with the remainder to be recognized thereafter. At December 31, 2021, our ending backlog was $21.1 billion.
NOTE Q — BUSINESS SEGMENT INFORMATION
Effective for fiscal 2022, which began January 1, 2022, we report our financial results in the following three reportable segments:
Integrated Mission Systems, including multi-mission surveillance and reconnaissance (“ISR”) systems; integrated electrical and electronic systems for maritime platforms; advanced electro-optical and infrared (“EO/IR”) solutions; fuzing and ordnance systems; commercial aviation products; and commercial pilot training operations;
Space & Airborne Systems, including space payloads, sensors and full-mission solutions; classified intelligence and cyber; avionics; electronic warfare; and mission networks for air traffic management operations; and
Communication Systems, including tactical communications with global communications solutions; broadband communications; integrated vision solutions; and public safety radios, system applications and equipment.
We structure our operations primarily around the products, systems and services we sell and the markets we serve. Effective January 1, 2022, we have streamlined our business segments from four business segments to three business segments. As a result of the segment reorganization, the Aviation Systems segment was eliminated as a business segment. As part of our new business segment structure, the ongoing operations that had been part of our former Aviation Systems segment were integrated into the remaining segments. Defense aviation, commercial aviation products and commercial pilot training operations were moved into our Integrated Mission Systems segment; and mission networks for air traffic management operations was moved into our Space & Airborne Systems segment.
See Note 3: “Business Divestitures and Asset Sales” in the Notes to Consolidated Financial Statement in our Fiscal 2021 Form 10-K for additional information relating to businesses divested in fiscal 2021.
The accounting policies of our business segments are the same as those described in Note 1: “Significant Accounting Policies” in the Notes to Consolidated Financial Statements in our Fiscal 2021 Form 10-K. We evaluate each business segment’s performance based on its operating income or loss, which we define as profit or loss from operations before income taxes, including CAS pension cost and excluding interest income and expense, royalties and related intellectual property expenses, equity method investment income or loss and gains or losses from securities and other investments. Intersegment sales are generally transferred at cost to the buying segment, and the sourcing segment recognizes a profit that is eliminated. The “Corporate eliminations” line item in the table below represents the elimination of intersegment sales. Corporate expenses are primarily allocated to our business segments using an allocation methodology prescribed by U.S. Government regulations for government contractors. The unallocated items in the table below represent the portion of corporate expenses not allocated to our business segments and elimination of intersegment profits.
In accordance with CAS, we allocate a portion of pension and other postretirement benefit plan costs to our U.S. Government contracts. However, our consolidated financial statements require pension and other postretirement benefit plan income or expense be calculated in accordance with FAS requirements under GAAP. The “FAS/CAS pension adjustment” line item in the table below represents the difference between the service cost component of FAS pension and OPEB expense and total CAS
14


pension and OPEB cost. The net non-service cost components of FAS pension and OPEB income are included as an income component in the “Non-operating income” line item in our Condensed Consolidated Statement of Income (Unaudited). See Note J — Postretirement Benefit Plans for more information on the composition of non-service components of FAS pension and OPEB income and expense.
Segment revenue, segment operating income and a reconciliation of segment operating income to total income from continuing operations before income taxes are as follows:
Quarter Ended
(In millions)April 1, 2022April 2, 2021
Revenue
Integrated Mission Systems$1,721 $1,751 
Space & Airborne Systems1,450 1,460 
Communication Systems963 1,112 
Other non-reportable businesses— 284 
Corporate eliminations(31)(40)
Total revenue$4,103 $4,567 
Income from Continuing Operations before Income Taxes
Segment Operating Income:
Integrated Mission Systems$255 $234 
Space & Airborne Systems172 192 
Communication Systems229 270 
Other non-reportable businesses— 52 
656 748 
Unallocated Items:
Unallocated corporate department expense, net(1)
(7)(33)
L3Harris Merger-related transaction, integration and other expenses and losses
(20)(21)
Amortization of acquisition-related intangibles(2)
(152)(164)
Business divestiture-related losses— (15)
Impairment of goodwill and other assets— (62)
Other items (1)(7)
FAS/CAS pension adjustment(3)
22 30 
(158)(272)
Non-operating income106 117 
Net interest expense(68)(66)
Income from continuing operations before income taxes$536 $527 
_______________
(1)For the quarter ended April 2, 2021, includes a $15 million accrual for a value added tax obligation.
(2)Includes amortization of identifiable intangible assets acquired as a result of the all-stock merger between Harris Corporation and L3 Technologies, Inc. (the “L3Harris Merger”) and the acquisition of Exelis Inc. (“Exelis”). Because the L3Harris Merger and the acquisition of Exelis benefited the entire Company as opposed to any individual segment, the amortization of identifiable intangible assets acquired was not allocated to any segment.
(3)Represents the difference between the service cost component of FAS pension and OPEB income and total CAS pension and OPEB cost and replaces the “Pension adjustment” line item previously presented, which included the non-service components of FAS pension and OPEB income. See Net FAS/CAS pension adjustment table below.

15


The table below is a reconciliation of the FAS/CAS pension adjustment:
Quarter Ended
(In millions)April 1, 2022April 2, 2021
FAS pension service cost$(11)$(18)
Less: CAS pension cost(33)(48)
FAS/CAS pension adjustment22 30 
Non-service FAS pension income110 111 
Net FAS/CAS pension adjustment(1)
$132 $141 
_______________
(1)Net FAS/CAS pension adjustment excludes net settlement and curtailment losses recognized in fiscal 2021.
Disaggregation of Revenue
We disaggregate revenue for all three business segments by customer relationship, contract type and geographical region. We believe these categories best depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.
Quarter Ended
(In millions)April 1, 2022April 2, 2021
Integrated Mission SystemsSpace & Airborne SystemsCommunication SystemsIntegrated Mission SystemsSpace & Airborne SystemsCommunication Systems
Revenue By Customer Relationship
Prime contractor$1,131 $931 $656 $1,189 $876 $728 
Subcontractor574 513 296 550 581 373 
Intersegment16 11 12 11 
$1,721 $1,450 $963 $1,751 $1,460 $1,112 
Revenue By Contract Type
Fixed-price(1)
$1,277 $863 $797 $1,294 $914 $940 
Cost-reimbursable428 581 155 445 543 161 
Intersegment16 11 12 11 
$1,721 $1,450 $963 $1,751 $1,460 $1,112 
Revenue By Geographical Region
United States$1,244 $1,279 $625 $1,275 $1,274 $832 
International461 165 327 464 183 269 
Intersegment16 11 12 11 
$1,721 $1,450 $963 $1,751 $1,460 $1,112 
_______________
(1)Includes revenue derived from time-and-materials contracts.
Total assets by business segment are as follows:
(In millions)April 1, 2022December 31, 2021
Total Assets
Integrated Mission Systems$11,811 $11,830 
Space & Airborne Systems8,573 8,151 
Communication Systems6,083 6,035 
Other non-reportable businesses— 
Corporate(1)
7,977 8,690 
$34,444 $34,709 
_______________
(1)Identifiable intangible assets acquired in connection with the L3Harris Merger in the two quarters ended January 3, 2020 and our acquisition of Exelis in fiscal 2015 were recorded as Corporate assets because they benefited the entire Company as opposed to any individual segment. Identifiable intangible asset balances recorded as Corporate assets were $6.5 billion and $6.6 billion at April 1, 2022 and December 31, 2021, respectively. Corporate assets also
16


consisted of cash, income taxes receivable, deferred income taxes, deferred compensation plan investments, buildings and equipment, as well as any assets of discontinued operations and divestitures.
NOTE R — LEGAL PROCEEDINGS AND CONTINGENCIES
From time to time, as a normal incident of the nature and kind of businesses in which we are or were engaged, various claims or charges are asserted and litigation or arbitration is commenced by or against us arising from or related to matters, including, but not limited to: product liability; personal injury; patents, trademarks, trade secrets or other intellectual property; labor and employee disputes; commercial or contractual disputes; strategic acquisitions or divestitures; the prior sale or use of former products allegedly containing asbestos or other restricted materials; breach of warranty; or environmental matters. Claimed amounts against us may be substantial, but may not bear any reasonable relationship to the merits of the claim or the extent of any real risk of court or arbitral awards. We record accruals for losses related to those matters against us that we consider to be probable and that can be reasonably estimated. Gain contingencies, if any, are recognized when they are realized and legal costs generally are expensed when incurred. At April 1, 2022, our accrual for the potential resolution of lawsuits, claims or proceedings that we consider probable of being decided unfavorably to us was not material. Although it is not feasible to predict the outcome of these matters with certainty, it is reasonably possible that some lawsuits, claims or proceedings may be disposed of or decided unfavorably to us and in excess of the amounts currently accrued. Based on available information, in the opinion of management, settlements, arbitration awards and final judgments, if any, that are considered probable of being rendered against us in litigation or arbitration in existence at April 1, 2022 are reserved against or would not have a material adverse effect on our financial condition, results of operations, cash flows or equity.
Environmental Matters
We are subject to numerous U.S. Federal, state, local and international environmental laws and regulatory requirements and are involved from time to time in investigations or litigation of various potential environmental issues. We or companies we have acquired are responsible, or alleged to be responsible, for environmental investigation and/or remediation of multiple sites. These sites are in various stages of investigation and/or remediation and in some cases our liability is considered de minimis. Notices from the U.S. Environmental Protection Agency (“EPA”) or equivalent state or international environmental agencies allege that several sites formerly or currently owned and/or operated by us or companies we have acquired, and other properties or water supplies that may be or have been impacted from those operations, contain disposed or recycled materials or wastes and require environmental investigation and/or remediation. These sites include instances of being identified as a potentially responsible party under the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as the “Superfund Act”) and/or equivalent state and international laws. For example, in June 2014, the U.S. Department of Justice, Environment and Natural Resources Division, notified several potentially responsible parties, including Exelis, which we acquired in 2015, of potential responsibility for contribution to the environmental investigation and remediation of multiple locations in Alaska. In addition, in March 2016, the EPA notified over 100 potentially responsible parties, including Exelis, of potential liability for the cost of remediation for the 8.3-mile stretch of the Lower Passaic River in New Jersey, estimated by the EPA to be $1.38 billion. During the fourth quarter of fiscal 2021, the EPA further announced an interim plan to remediate sediment in the upper nine miles of the of the Lower Passaic River with an estimated cost of $441 million. The potential responsible parties’ respective allocations for the Lower Passaic River remediation have not been determined. Although it is not feasible to predict the outcome of these environmental claims made against us, based on available information, in the opinion of our management, any payments we may be required to make as a result of environmental claims made against us in existence at April 1, 2022 are reserved against, covered by insurance or would not have a material adverse effect on our financial condition, results of operations, cash flows or equity.
17


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and the Board of Directors of L3Harris Technologies, Inc.

Results of Review of Interim Financial Statements
We have reviewed the accompanying consolidated balance sheet of L3Harris Technologies, Inc. (“the Company”) as of April 1, 2022, the related condensed consolidated statements of income, comprehensive income, cash flows and equity for the quarters ended April 1, 2022 and April 2, 2021, and the related notes (collectively referred to as the “condensed consolidated financial statements”). Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated interim financial statements for them to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the consolidated balance sheet of the Company as of December 31, 2021, the related consolidated statements of income, comprehensive income, cash flows and equity for the year then ended, and the related notes (not presented herein); and in our report dated February 25, 2022, we expressed an unqualified audit opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2021, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

Basis for Review Results
These financial statements are the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the U.S. Securities and Exchange Commission and the PCAOB. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial statements consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.


/s/ Ernst & Young LLP

Orlando, Florida
April 29, 2022



18


ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
OVERVIEW
The following Management’s Discussion and Analysis (“MD&A”) is intended to assist in an understanding of our financial condition and results of operations. This MD&A is provided as a supplement to, should be read in conjunction with, and is qualified in its entirety by reference to, our Condensed Consolidated Financial Statements (Unaudited) and accompanying Notes appearing elsewhere in this Report (the “Notes”). In addition, reference should be made to our audited Consolidated Financial Statements and accompanying Notes to Consolidated Financial Statements and Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Fiscal 2021 Form 10-K. Except for the historical information contained herein, the discussions in this MD&A contain forward-looking statements that involve risks and uncertainties. Our future results could differ materially from those discussed herein. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below in this MD&A under “Forward-Looking Statements and Factors that May Affect Future Results.”
KEY DEVELOPMENTS
The following is a list of the remaining sections of this MD&A, together with our perspective on their contents, which we hope will assist in reading these pages:
Results of Operations — an analysis of our consolidated results of operations and the results in each of our business segments, to the extent the segment operating results are helpful to an understanding of our business as a whole, for the periods presented in our Condensed Consolidated Statement of Income (Unaudited).
Liquidity, Capital Resources and Financial Strategies — an analysis of cash flows, funding of pension plans, common stock repurchases, dividends, capital structure and resources, material cash requirements and commercial commitments.
Critical Accounting Policies and Estimates — a discussion of accounting policies and estimates that require the most judgment and a discussion of accounting pronouncements that have been issued but not yet implemented by us and their potential impact on our financial condition, results of operations, cash flows and equity.
Forward-Looking Statements and Factors that May Affect Future Results — cautionary information about forward-looking statements and a description of certain risks and uncertainties that could cause our actual results to differ materially from our historical results or our current expectations or projections.
Effective January 1, 2022, we streamlined our business segments from four business segments to three business segments. As a result of the segment reorganization, the Aviation Systems segment was eliminated as a business segment. Effective for fiscal 2022, which began January 1, 2022, we reported our financial results in the following three reportable segments:
Integrated Mission Systems, including multi-mission ISR systems; integrated electrical and electronic systems for maritime platforms; advanced EO/IR solutions; fuzing and ordnance systems; commercial aviation products; and commercial pilot training operations;
Space & Airborne Systems, including space payloads, sensors and full-mission solutions; classified intelligence and cyber; avionics; electronic warfare; and mission networks for air traffic management operations; and
Communication Systems, including tactical communications with global communications solutions; broadband communications; integrated vision solutions; and public safety radios, system applications and equipment.
The following businesses were divested or classified as held for sale at April 1, 2022 and April 2, 2021:
Space and Navigation business, definitive agreement entered into on February 14, 2022 for a selling price of $5 million and classified as held for sale during the quarter ended April 1, 2022, expected to be completed in the second quarter of fiscal 2022, the results of which are reported as part of our Space & Airborne Systems segment;
CPS business, definitive agreement entered into on March 1, 2021 and classified as held for sale during the quarter ended April 2, 2021 and divested on July 2, 2021, the results of which are reported as part of other non-reportable businesses through the date of divestiture;
Military training business, definitive agreement entered into on February 27, 2021 and classified as held for sale during the quarter ended April 2, 2021 and divested on July 2, 2021, the results of which are reported as part of other non-reportable businesses through the date of divestiture; and
Voice Switch Enterprise disposal group (“VSE disposal group”), definitive agreement entered into on February 23, 2021 and classified as held for sale during the quarter ended April 2, 2021 and partially divested on July 2, 2021, with the remainder divested on July 30, 2021, the results of which are reported as part of other non-reportable businesses through the date of divestiture.
19


See Note 3: “Business Divestitures and Asset Sales” in the Notes to Consolidated Financial Statement in our Fiscal 2021 Form 10-K for additional information regarding businesses divested in fiscal 2021.
RESULTS OF OPERATIONS
Consolidated Results of Operations
 Quarter Ended
(Dollars in millions, except per share amounts)April 1, 2022April 2, 2021% Inc/(Dec)
 
Revenue
Integrated Mission Systems$1,721 $1,751 (2)%
Space & Airborne Systems1,450 1,460 (1)%
Communication Systems963 1,112 (13)%
Other non-reportable businesses— 284 *
Corporate eliminations(31)(40)(23)%
Total revenue4,103 4,567 (10)%
Total cost of product sales and services(2,892)(3,213)(10)%
% of total revenue70 %70 %
Gross margin1,211 1,354 (11)%
% of total revenue30 %30 %
Engineering, selling and administrative expenses(713)(801)(11)%
% of total revenue17 %18 %
Business divestiture-related losses— (15)*
Impairment of goodwill and other assets— (62)*
Non-operating income 106 117 (9)%
Net interest expense(68)(66)%
Income from continuing operations before income taxes536 527 %
Income taxes(61)(60)%
Effective tax rate11 %11 %
Income from continuing operations475 467 %
Noncontrolling interests, net of income taxes— *
Income from continuing operations attributable to L3Harris common shareholders
$475 $469 %
% of total revenue12 %10 %
Income from continuing operations per diluted common share attributable to L3Harris common shareholders
$2.44 $2.25 %
_________________
*Not meaningful
Revenue and Gross Margin
Revenue declined 10% in the first quarter of fiscal 2022 compared to the first quarter of fiscal 2021 from the impact of prior year divestitures that totaled $268 million, continued supply chain disruptions including impacts arising from electronic component shortages within Communication Systems, award timing and airborne program transitions. Gross margin decreased in the first quarter of fiscal 2022 compared to the first quarter of fiscal 2021 from volume effects across our business segments and supply chain disruptions. Gross margin as a percentage of revenue (“gross margin percentage”) was comparable.
See the “Discussion of Business Segment Results of Operations” discussion below in this MD&A for further information.
Engineering, Selling and Administrative Expenses
The decrease in engineering, selling and administrative (“ESA”) expenses and ESA expense as a percentage of revenue (“ESA percentage”) in the first quarter of fiscal 2022 compared with the first quarter of 2021 was primarily due to $10 million of lower amortization of identifiable intangible assets acquired as a result of the L3Harris Merger, $8 million decrease in “FAS/CAS pension adjustment” and $6 million of lower divestiture-related expenses as well as the absence of a $15 million charge related to a value added tax obligation and $29 million of costs related to divested businesses in the first quarter of 2021.
20


See the “Discussion of Business Segment Results of Operations” discussion below in this MD&A for further information.
Business Divestiture-Related Losses
There were no business divestiture-related gains or losses recorded in the first quarter of fiscal 2022. Business divestiture-related losses in the first quarter of fiscal 2021 reflected a $7 million non-cash remeasurement loss on the then-pending divestiture of the CPS business and an $8 million non-cash remeasurement loss on the then-pending divestiture of the VSE disposal group.
See Note 3: “Business Divestitures and Asset Sales” in the Notes to Consolidated Financial Statements in our Fiscal 2021 Form 10-K for further information.
Impairment of Goodwill and Other Assets
No impairment charges were recorded in the first quarter of fiscal 2022. Impairment of goodwill and other assets in the first quarter of fiscal 2021 reflected $62 million of non-cash charges for the impairment of goodwill and other assets associated with the divestiture of the CPS business.
See Note 3: “Business Divestitures and Asset Sales” in the Notes to Consolidated Financial Statements in our Fiscal 2021 Form 10-K and Note H — Goodwill in the Notes for further information.
Non-Operating Income
The decrease in non-operating income in the first quarter of fiscal 2022 compared with the first quarter of fiscal 2021 was primarily due to losses related to investments in the first quarter of fiscal 2022 compared with gains related to investments in the first quarter of fiscal 2021.
Net Interest Expense
Our net interest expense increased in the first quarter of fiscal 2022 compared with the first quarter of fiscal 2021 primarily due to lower interest income in the first quarter of fiscal 2022.
See Note 13: “Debt” in the Notes to Consolidated Financial Statements in our Fiscal 2021 Form 10-K for further information.
Income Taxes
Our effective tax rate (income taxes as a percentage of income from continuing operations before income taxes) was 11.3% for the first quarter of fiscal 2022 compared with 11.4% for the first quarter of fiscal 2021. For the first quarter of fiscal 2022, we benefited from the favorable impact of R&D credits, the reduction in deferred tax liabilities on the outside basis of certain foreign subsidiaries due to an internal restructuring, incremental FDII benefit resulting from the requirement to capitalize and amortize R&D expenses beginning in fiscal 2022, the resolution of specific audit uncertainties, and excess tax benefits related to equity-based compensation. For the first quarter of fiscal 2021, our effective tax rate benefited from the favorable impact of R&D credits, the resolution of specific audit uncertainties and the recognition of deferred tax assets on the outside basis of entities held-for-sale.
Income From Continuing Operations
The increase in income from continuing operations in the first quarter of fiscal 2022 compared with the first quarter of fiscal 2021 was primarily due to the combined effects of the reasons noted in the sections above regarding fiscal 2022 and 2021.
Diluted EPS
Diluted EPS attributable to L3Harris common shareholders in the first quarter of fiscal 2022 increased compared with the first quarter of fiscal 2021 primarily due to to higher net income and fewer diluted weighted average common shares outstanding, reflecting the repurchases of shares of our common stock under our repurchase program in the first quarter of fiscal 2022.
See the “Common Stock Repurchases” discussion below in this MD&A for further information.

21


Discussion of Business Segment Results of Operations
Integrated Mission Systems Segment (“IMS”)
 Quarter Ended
(Dollars in millions)April 1, 2022April 2, 2021% Inc/(Dec)
Revenue$1,721 $1,751 (2 %)
Operating income255 234 %
Operating income as a percentage of revenue (“operating margin”)
14.8 %13.4 %
IMS revenue decreased 2%, driven primarily by declines of $35 million in ISR, reflecting lower aircraft procurement and delivery volume that outweighed higher production and modification activity on an aircraft missionization program and $47 million in fuzing and ordnance systems and other related programs, reflecting lower volume. The declines were partially offset by an increase in revenue of $24 million in Electro Optical, reflecting higher WESCAM volumes, $22 million in Maritime primarily due to higher revenue on Virginia-class and classified programs and $10 million in Commercial Aviation Solutions, from a continued aerospace market recovery.
IMS operating margin expanded 140 basis points to 14.8% from favorable program and product mix.
Space & Airborne Systems Segment (“SAS”)
 Quarter Ended
(Dollars in millions)April 1, 2022April 2, 2021% Inc/(Dec)
Revenue$1,450 $1,460 (1 %)
Operating income172 192 (10 %)
Operating margin11.9 %13.2 %
SAS revenue decreased 1%, driven primarily by declines in our airborne businesses, due to production transitions and lower development on the F-35 program, $16 million decline in Intel & Cyber due to award timing and $8 million in Mission Networks due to updates on certain Federal Aviation Administration (“FAA”) programs. The decrease was partially offset by a $60 million increase in revenue in Space, reflecting growth in responsive satellite programs.
SAS operating margin contracted 130 basis points to 11.9% from strong program performance in the prior year and unfavorable program mix.
Communication Systems Segment (“CS”)
 Quarter Ended
(Dollars in millions)April 1, 2022April 2, 2021% Inc/(Dec)
Revenue$963 $1,112 (13 %)
Operating income229 270 (15 %)
Operating margin23.8 %24.3 %
CS revenue decreased 13%. Tactical Communications declined $59 million primarily due to supply chain impacts arising from electronic component shortages, which also affected Integrated Vision Solutions and Public Safety, and $72 million in Broadband Communications due to lower volume on legacy platforms.
CS operating margin contracted 50 basis points to 23.8% primarily due to volume and supply chain impacts at the segment, as noted in the discussion above regarding CS revenue.
22


Unallocated Corporate Expenses
Quarter Ended
(Dollars in millions)April 1, 2022April 2, 2021% Inc/(Dec)
Unallocated corporate department expense, net(1)
$(7)$(33)(79 %)
L3Harris Merger-related transaction, integration and other expenses and losses(20)(21)(5 %)
Amortization of acquisition-related intangibles(152)(164)(7 %)
Business divestiture-related losses— (15)*
Impairment of goodwill and other assets— (62)*
Other items(1)(7)*
______________
(1)For the quarter ended April 2, 2021, includes a $15 million accrual for a value added tax obligation.
*Not meaningful
LIQUIDITY, CAPITAL RESOURCES AND FINANCIAL STRATEGIES
Cash Flows
 Quarter Ended
(In millions)April 1, 2022April 2, 2021
Net cash provided by operating activities$39 $661 
Net cash used in investing activities(64)(61)
Net cash used in financing activities(513)(900)
Effect of exchange rate changes on cash and cash equivalents
(1)— 
Net decrease in cash and cash equivalents(539)(300)
Cash and cash equivalents, beginning of period941 1,276 
Cash and cash equivalents, end of period$402 $976 
Cash and cash equivalents: At April 1, 2022 we had cash and cash equivalents of $402 million and we have a senior unsecured $2 billion revolving credit facility that expires in June 2024 (all of which was available to us as of April 1, 2022). Additionally, we had $7.1 billion of net long-term debt outstanding at April 1, 2022, the majority of which we incurred in connection with the L3Harris Merger during the two quarters ended January 3, 2020 and the acquisition of Exelis in the fourth quarter of fiscal 2015. Our $402 million of cash and cash equivalents at April 1, 2022 included $211 million held by our foreign subsidiaries, a significant portion of which we believe can be repatriated to the U.S. with minimal tax cost.
Given our current cash position, outlook for funds generated from operations, credit ratings, available credit facility, cash needs and debt structure, we have not experienced to date, and do not expect to experience, any material issues with liquidity, although, we can give no assurances concerning our future liquidity, particularly in light of our overall level of debt, U.S. Government budget uncertainties and the state of global commerce and general political and financial uncertainty. We cannot predict the on-going impact that COVID, among other potential risks and uncertainties, will have on our cash from operating activities. Additionally, the provisions in the Tax Cuts and Jobs Act of 2017 require that, beginning in fiscal 2022, research and experimental expenditures be capitalized and amortized over five years, which we estimate will have an approximately $600 million to $700 million impact to cash from operating activities in fiscal 2022 based on the provisions currently in effect, however, there was no impact to cash from operating activities during the first quarter of 2022. See Item 1A. “Risk Factors” of our Fiscal 2021 Form 10-K and Part II, Item 1A. “Risk Factors” in this Report.
Based on our current business plan and revenue prospects, we believe that our existing cash, funds generated from operations, our credit facility and access to the public and private debt and equity markets will be sufficient to provide for our anticipated working capital requirements, capital expenditures, dividend payments, repurchases under our share repurchase program and repayments of our debt securities at maturity for the next twelve months and reasonably foreseeable future thereafter. Our total capital expenditures for fiscal 2022 are expected to be approximately $330 million. We anticipate tax payments in fiscal 2022 to be approximately equal to or marginally less than our tax expense for the same period, absent R&D capitalization and subject to adjustment for timing differences. Other than those cash outlays noted in “Material Cash Requirements” in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Fiscal 2021 Form 10-K and in the “Material Cash Requirements and Commercial Commitments” section below in this MD&A, capital expenditures, dividend payments and repurchases under our share repurchase program, we do not anticipate any significant cash outlays during the remainder of fiscal 2022.
23


There can be no assurance that our business will continue to generate cash flows at current levels or that the cost or availability of future borrowings, if any, under our commercial paper program, or our credit facility or in the debt markets will not be impacted by any potential future credit or capital markets disruptions. If we are unable to maintain cash balances, generate cash flow from operations or borrow under our commercial paper program or our credit facility sufficient to service our obligations, we may be required to reduce capital expenditures, reduce or eliminate strategic acquisitions, reduce or terminate our share repurchases, reduce or eliminate dividends, refinance all or a portion of our existing debt, obtain additional financing, or sell assets. Our ability to make principal payments or pay interest on or refinance our indebtedness depends on our future performance and financial results, which, to a certain extent, are subject to general conditions affecting the defense, government and other markets we serve and to general economic, political, financial, competitive, legislative and regulatory factors beyond our control.
Net cash provided by operating activities: The $622 million decrease in net cash provided by operating activities in the first quarter of fiscal 2022 compared with the first quarter of fiscal 2021 was primarily due to a $525 million increase in cash used to fund working capital (i.e., accounts receivable, contract assets, inventories, accounts payable and contract liabilities) and the impact of $87 million of lower income (excluding the impact of non-cash items such as depreciation and amortization, impairment of goodwill and other assets and gains related to business divestitures).
Net cash used in investing activities: The $3 million increase in net cash used in investing activities in the first quarter of fiscal 2022 compared with the first quarter of fiscal 2021 was primarily due to a $12 million increase in cash used in other investing activities which primarily relate to a strategic investment, partially offset by a $9 million decrease of net cash used for additions of property, plant and equipment in fiscal 2022.
Net cash used in financing activities: The $387 million decrease in net cash used in financing activities in the first quarter of fiscal 2022 compared with the first quarter of fiscal 2021 was primarily due to a $392 million decrease in cash used to repurchase our common stock under our share repurchase program and a $20 million increase in proceeds from exercises of employee stock options, partially offset by a $11 million increase in cash used for tax withholding payments associated with vested share-based awards, a $9 million increase in cash used to pay dividends and a $4 million increase in cash used for repayments of borrowings.
Funding of Pension Plans
Funding requirements under applicable laws and regulations are a major consideration in making contributions to our U.S. pension plans. Although we have significant discretion in making voluntary contributions, the Employee Retirement Income Security Act of 1974, as amended by the Pension Protection Act of 2006 and further amended by the Worker, Retiree, and Employer Recovery Act of 2008, the Moving Ahead for Progress in the 21st Century Act (“MAP-21”), and applicable Internal Revenue Code regulations, mandate minimum funding thresholds. The Highway and Transportation Funding Act of 2014, the Bipartisan Budget Act of 2015, the American Rescue Plan Act of 2021 and the Infrastructure Investment and Jobs Act further extended the interest rate stabilization provision of MAP-21. Failure to satisfy the minimum funding thresholds could result in restrictions on our ability to amend the plans or make benefit payments. With respect to our U.S. qualified defined benefit pension plans, we intend to contribute annually no less than the required minimum funding thresholds. As a result of prior voluntary contributions and plan performance, we are not required to make any contributions to our U.S. qualified defined benefit pension plans in fiscal 2022 and for several years thereafter.
Future required contributions primarily will depend on the actual annual return on assets and the discount rate used to measure the benefit obligation at the end of each year. Depending on these factors, and the resulting funded status of our pension plans, the level of future statutory required minimum contributions could be material. We had net unfunded defined benefit plan obligations of $524 million as of April 1, 2022. See Note 14: “Pension and Other Postretirement Benefits” in the Notes to Consolidated Financial Statements in our Fiscal 2021 Form 10-K and Note J — Postretirement Benefit Plans in the Notes for further information regarding our pension plans.
Common Stock Repurchases
During the first quarter of fiscal 2022, we used $308 million to repurchase 1.3 million shares of our common stock under our share repurchase program at an average price per share of $231.39, including commissions of $0.02 per share. During the first quarter of fiscal 2021, we used $700 million to repurchase 3.8 million shares of our common stock under our share repurchase program at an average price per share of $184.54, including commissions of $0.02 per share. During the first quarter of fiscal 2022 and 2021, $12 million and $1 million, respectively, in shares of our common stock were delivered to us or withheld by us to satisfy withholding taxes on employee share-based awards. Shares repurchased by us are cancelled and retired.
On January 28, 2021, we announced that our Board of Directors approved a new $6 billion share repurchase authorization under our repurchase program that was in addition to the remaining unused authorization of $210 million at January 1, 2021, under our prior repurchase program, for a total unused authorization of $6.2 billion. Our repurchase program does not have a stated expiration. At April 1, 2022, we had a remaining unused authorization under our repurchase program of $2.2 billion under our share repurchase program. Repurchases under our share repurchase program may be made through open-market transactions, private transactions, transactions structured through investment banking institutions or any combination thereof. The level of our
24


repurchases depends on a number of factors, including our financial condition, capital requirements, cash flows, results of operations, future business prospects and other factors our Board and management may deem relevant. The timing, volume and nature of repurchases are subject to market conditions, applicable securities laws and other factors and are at our discretion and may be suspended or discontinued at any time. Additional information regarding our current repurchase program is set forth in this Report under Part II, Item 2. “Unregistered Sales of Equity Securities and Use of Proceeds.”
Dividends
On February 25, 2022, our Board of Directors increased the quarterly per share cash dividend rate on our common stock from $1.02 to $1.12, commencing with the dividend declared by our Board of Directors for the first quarter of fiscal 2022, for an annualized per share cash dividend rate of $4.48, which was our twenty-first consecutive annual increase in our quarterly cash dividend rate. Quarterly cash dividends are typically paid in March, June, September and December. We paid $218 million in cash dividends during March 2022. We currently expect that cash dividends will continue to be paid in the near future, but we can give no assurances concerning payment of future dividends or future dividend increases. The declaration of dividends and the amount thereof will depend on a number of factors, including our financial condition, capital requirements, cash flows, results of operations, future business prospects and other factors our Board of Directors may deem relevant.
Capital Structure and Resources
2019 Credit Agreement: We have a $2 billion, 5-year senior unsecured revolving credit facility (the “2019 Credit Facility”) under a Revolving Credit Agreement (as amended, the “2019 Credit Agreement”) entered into on June 28, 2019 with a syndicate of lenders. For a description of the 2019 Credit Facility and the 2019 Credit Agreement, see Note 12: “Credit Arrangements” in the Notes to Consolidated Financial Statements in our Fiscal 2021 Form 10-K.
We were in compliance with the covenants in the 2019 Credit Agreement at April 1, 2022, including the covenant requiring that we not permit our ratio of consolidated total indebtedness to total capital, each as defined in the 2019 Credit Agreement, to be greater than 0.65 to 1.00. At April 1, 2022, we had no borrowings outstanding under the 2019 Credit Agreement.
Long-Term Debt: For a description of our long-term variable-rate and fixed-rate debt, see Note 13: “Debt” in the Notes to Consolidated Financial Statements in our Fiscal 2021 Form 10-K.
Short-Term Debt: Our short-term debt was $3 million at April 1, 2022 and $2 million December 31, 2021, consisting of local borrowing by international subsidiaries for working capital needs.
Other Agreements: We have two RSAs with two separate third-party financial institutions that permit us to sell, on a non-recourse basis, up to an aggregate of $100 million of outstanding receivables at any given time. From time to time, we have sold certain customer receivables under the RSAs, which we continue to service and collect on behalf of the third-party financial institution and we account for as sales of receivables with sale proceeds included in net cash from operating activities. Outstanding accounts receivable sold pursuant to the RSAs was $99 million at April 1, 2022 and $100 million at December 31, 2021, with net cash proceeds of $98 million and $100 million, respectively.
Material Cash Requirements and Commercial Commitments
The amounts disclosed in our Fiscal 2021 Form 10-K include our material cash requirements and commercial commitments. There were no material changes during the first quarter of fiscal 2022 in our material cash requirements from contractual cash obligations to repay debt, to purchase goods and services, to make payments under operating leases or our commercial commitments, or in our contingent liabilities on outstanding surety bonds, standby letters of credit or other arrangements as disclosed in our Fiscal 2021 Form 10-K.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Our Condensed Consolidated Financial Statements (Unaudited) and accompanying Notes are prepared in accordance with GAAP. Preparing financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and backlog as well as disclosures of contingent assets and liabilities. Actual results may differ from our estimates. These estimates and assumptions are affected by the application of our accounting policies. Critical accounting policies and estimates are those that require application of management’s most difficult, subjective or complex judgments, often as a result of matters that are inherently uncertain and may change in subsequent periods. Critical accounting policies and estimates for us include: (i) revenue recognition on contracts and contract estimates; (ii) postretirement benefit plans; (iii) impairment testing of goodwill; (iv) accounting for business combinations; and (v) income taxes and tax valuation allowances. For additional discussion of our critical accounting policies and estimates, see “Critical Accounting Policies and Estimates” in Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Fiscal 2021 Form 10-K.
25


Revenue Recognition
A significant portion of our business is derived from development and production contracts. Revenue and profit related to development and production contracts are generally recognized over time, typically using the POC cost-to-cost method of revenue recognition, whereby we measure our progress towards completion of the performance obligation based on the ratio of costs incurred to date to estimated costs at completion under the contract. Because costs incurred represent work performed, we believe this method best depicts the transfer of control of the asset to the customer. Under the POC cost-to-cost method of revenue recognition, a single estimated profit margin is used to recognize profit for each performance obligation over its period of performance. Recognition of profit on a contract requires estimates of the total cost at completion and transaction price and the measurement of progress towards completion. Due to the long-term nature of many of our contracts, developing the estimated total cost at completion and total transaction price often requires judgment. Factors that must be considered in estimating the cost of the work to be completed include: the nature and complexity of the work to be performed, subcontractor performance and the risk and impact of delayed performance. Factors that must be considered in estimating the total transaction price include contractual cost or performance incentives (such as incentive fees, award fees and penalties) and other forms of variable consideration as well as our historical experience and our expectation for performance on the contract. These variable amounts generally are awarded upon achievement of certain negotiated performance metrics, program milestones or cost targets and can be based upon customer discretion. We include such estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved.
At the outset of each contract, we gauge its complexity and perceived risks and establish an estimated total cost at completion in line with these expectations. After establishing the estimated total cost at completion, we follow a standard EAC process in which we review the progress and performance on our ongoing contracts at least quarterly and, in many cases, more frequently. If we successfully retire risks associated with the technical, schedule and cost aspects of a contract, we may lower our estimated total cost at completion commensurate with the retirement of these risks. Conversely, if we are not successful in retiring these risks, we may increase our estimated total cost at completion. Additionally, as the contract progresses, our estimates of total transaction price may increase or decrease if, for example, we receive award fees that are higher or lower than expected. When adjustments in estimated total costs at completion or in estimated total transaction price are determined, the related impact on operating income is recognized using the cumulative catch-up method, which recognizes in the current period the cumulative effect of such adjustments for all prior periods. Any anticipated losses on these contracts are fully recognized in the period in which the losses become evident.
EAC adjustments had the following impacts to operating income for the periods presented:
Quarter Ended
(In millions)April 1, 2022April 2, 2021
Favorable adjustments$135 $162 
Unfavorable adjustments(89)(80)
Net operating income adjustments$46 $82 
The net favorable impact to operating income from EAC adjustments in the first quarter ended April 1, 2022 reflected benefits of operational performance on programs, including additional retirement of risks and material and labor cost savings. There were no individual impacts to operating income due to EAC adjustments in the first quarter of 2022 or 2021 that were material to our results of operations on a consolidated or segment basis for such periods.
We recognize revenue from numerous contracts with multiple performance obligations. For these contracts, we allocate the transaction price to each performance obligation based on the relative standalone selling price of the good or service underlying each performance obligation. The standalone selling price represents the amount for which we would sell the good or service to a customer on a standalone basis (i.e., not sold as bundled sale with any other products or services). The allocation of transaction price among separate performance obligations may impact the timing of revenue recognition but will not change the total revenue recognized on the contract.
A substantial majority of our revenue is derived from contracts with the U.S. Government, including foreign military sales contracts. These contracts are subject to the Federal Acquisition Regulation (“FAR”) and the prices of our contract deliverables are typically based on our estimated or actual costs plus a reasonable profit margin. As a result, the standalone selling prices of the goods and services in these contracts are typically equal to the selling prices stated in the contract, thereby eliminating the need to allocate (or reallocate) the transaction price to the multiple performance obligations. In our non-U.S. Government contracts, when standalone selling prices are not directly observable, we also generally use the expected cost plus margin approach to determine standalone selling price. In determining the appropriate margin under the cost plus margin approach, we consider historical margins on similar products sold to similar customers or within similar geographies where objective evidence is available. We may also consider our cost structure and profit objectives, the nature of the proposal, the effects of customization of pricing, our
26


practices used to establish pricing of bundled products, the expected technological life of the product, margins earned on similar contracts with different customers and other factors to determine the appropriate margin.
FORWARD-LOOKING STATEMENTS AND FACTORS THAT MAY AFFECT FUTURE RESULTS
This Report contains forward-looking statements that involve risks and uncertainties, as well as assumptions that may not materialize or prove to be correct, which could cause our results to differ materially from those expressed in or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including, but not limited to, statements concerning: our plans, strategies and objectives for future operations; new products, systems, technologies, services or developments; future economic conditions, performance or outlook; future political conditions; the outcome of contingencies; the potential level of share repurchases, dividends or pension contributions; potential acquisitions or divestitures; the value of contract awards and programs; expected cash flows or capital expenditures; our beliefs or expectations; activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future, including expected COVID-related impacts to our businesses; and assumptions underlying any of the foregoing. Forward-looking statements may be identified by their use of forward-looking terminology, such as “believes,” “expects,” “may,” “should,” “would,” “will,” “intends,” “plans,” “estimates,” “anticipates,” “projects” and similar words or expressions. You should not place undue reliance on these forward-looking statements, which reflect our management’s opinions only as of the date of filing of this Report and are not guarantees of future performance or actual results. Forward-looking statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The following are some of the factors we believe could cause our actual results to differ materially from our historical results or our current expectations or projections:
The effects of COVID could have a material adverse effect on our business operations, financial condition, results of operations, cash flows and equity.
We depend on U.S. Government customers for a significant portion of our revenue, and the loss of these relationships, a reduction in U.S. Government funding or a change in U.S. Government spending priorities could have an adverse impact on our business, financial condition, results of operations, cash flows and equity.
We depend significantly on U.S. Government contracts, which often are only partially funded, subject to immediate termination, and heavily regulated and audited. The termination or failure to fund, or negative audit findings for, one or more of these contracts could have an adverse impact on our business, financial condition, results of operations, cash flows and equity.
The U.S. Government’s budget deficit and the national debt, as well as any inability of the U.S. Government to complete its budget process for any government fiscal year and consequently having to shut down or operate on funding levels equivalent to its prior fiscal year pursuant to a “continuing resolution,” could have an adverse impact on our business, financial condition, results of operations, cash flows and equity.
Our results of operations and cash flows are substantially affected by our mix of fixed-price, cost-plus and time-and-material type contracts. In particular, our fixed-price contracts could subject us to losses in the event of cost overruns or a significant increase in inflation.
Our commercial aviation products, systems and services businesses are affected by global demand and economic factors that could negatively impact our financial results.
We participate in markets that are often subject to uncertain economic conditions, which makes it difficult to estimate growth in our markets and, as a result, future income and expenditures.
We cannot predict the consequences of future geo-political events, but they may adversely affect the markets in which we operate, our ability to insure against risks, our operations or our profitability.
We derive a significant portion of our revenue from international operations and are subject to the risks of doing business internationally, including fluctuations in currency exchange rates.
We are subject to government investigations, which could have a material adverse effect on our business, financial condition, results of operations, cash flows and equity.
We could be negatively impacted by a security breach, through cyber attack, cyber intrusion, insider threats or otherwise, or other significant disruption of our IT networks and related systems or of those we operate for certain of our customers.
Our future success will depend on our ability to develop new products, systems, services and technologies that achieve market acceptance in our current and future markets.
We must attract and retain key employees, and any failure to do so could seriously harm us.
To the extent some of our workforce is or becomes represented by labor unions, a prolonged work stoppage could harm our business.
Disputes with our subcontractors or key suppliers, or their inability to perform or timely deliver our components, parts or services, could cause our products, systems or services to be produced or delivered in an untimely or unsatisfactory manner.
27


We have significant operations in locations that could be materially and adversely impacted in the event of a natural disaster or other significant disruption.
Changes in estimates we use in accounting for many of our programs could adversely affect our future financial results.
Our level of indebtedness and our ability to make payments on or service our indebtedness and our unfunded defined benefit plans liability may materially adversely affect our financial and operating activities or our ability to incur additional debt.
A downgrade in our credit ratings could materially adversely affect our business.
The level of returns on defined benefit plan assets, changes in interest rates and other factors could materially adversely affect our financial condition, results of operations, cash flows and equity in future periods.
Changes in our effective tax rate may have an adverse effect on our results of operations.
We may not be successful in obtaining the necessary export licenses to conduct certain operations abroad, and Congress may prevent proposed sales to certain foreign governments.
Our reputation and ability to do business may be impacted by the improper conduct of our employees, agents or business partners.
The outcome of litigation or arbitration in which we are involved from time to time is unpredictable, and an adverse decision in any such matter could have a material adverse effect on our financial condition, results of operations, cash flows and equity.
Third parties have claimed in the past and may claim in the future that we are infringing directly or indirectly upon their intellectual property rights, and third parties may infringe upon our intellectual property rights.
We face certain significant risk exposures and potential liabilities that may not be covered adequately by insurance or indemnity.
Unforeseen environmental issues, including regulations related to greenhouse gas emissions or change in customer sentiment related to environmental sustainability, could have a material adverse effect on our business, financial condition, results of operations, cash flows and equity.
Strategic transactions, including mergers, acquisitions and divestitures, involve significant risks and uncertainties that could adversely affect our business, financial condition, results of operations, cash flows and equity.
Changes in future business or other market conditions could cause business investments and/or recorded goodwill or other long-term assets to become impaired, resulting in substantial losses and write-downs that would materially adversely affect our results of operations and financial condition.
Additional details and discussions concerning some of the factors that could affect our forward-looking statements or future results are set forth in our Fiscal 2021 Form 10-K under Item 1A. “Risk Factors” and in Part II, Item 1A. “Risk Factors” in this Report. The foregoing list of factors and the factors set forth in Item 1A. “Risk Factors” included in our Fiscal 2021 Form 10-K and in Part II, Item 1A. “Risk Factors” in this Report are not exhaustive. Additional risks and uncertainties not known to us or that we currently believe not to be material also may adversely impact our business, financial condition, results of operations, cash flows and equity. Should any risks or uncertainties develop into actual events, these developments could have a material adverse effect on our business, financial condition, results of operations, cash flows and equity. The forward-looking statements contained in this Report are made as of the date of filing of this Report, and we disclaim any intention or obligation, other than imposed by law, to update or revise any forward-looking statements or to update the reasons actual results could differ materially from those projected in the forward-looking statements, whether as a result of new information, future events or developments or otherwise.
ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
In the normal course of business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates. We employ established policies and procedures governing the use of financial instruments to manage our exposure to such risks. There were no material changes during the quarter ended April 1, 2022 with respect to the information appearing in Part II, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk” of our Fiscal 2021 Form 10-K.
ITEM 4.CONTROLS AND PROCEDURES.
(a) Evaluation of Disclosure Controls and Procedures: We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms. Our disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and
28


procedures can provide only reasonable assurance of achieving their control objectives, and management necessarily is required to use its judgment in evaluating the cost-benefit relationship of possible controls and procedures. As required by Rule 13a-15 under the Exchange Act, as of April 1, 2022, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. This evaluation was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer. Based on this work and other evaluation procedures, our management, including our Chief Executive Officer and our Chief Financial Officer, has concluded that as of April 1, 2022 our disclosure controls and procedures were effective at the reasonable assurance level.
(b) Changes in Internal Control: We periodically review our internal control over financial reporting as part of our efforts to ensure compliance with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002. In addition, we routinely review our system of internal control over financial reporting to identify potential changes to our processes and systems that may improve controls and increase efficiency, while ensuring that we maintain an effective internal control environment. Changes may include such activities as implementing new, more efficient systems, consolidating the activities of business units, migrating certain processes to our shared services organizations, formalizing policies and procedures, improving segregation of duties and increasing monitoring controls. In addition, when we acquire new businesses, we incorporate our controls and procedures into the acquired business as part of our integration activities. There have been no changes in our internal control over financial reporting that occurred during the quarter ended April 1, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

29


PART II. OTHER INFORMATION
ITEM 1.LEGAL PROCEEDINGS.
See Note R — Legal Proceedings and Contingencies in the Notes for discussion regarding material legal proceedings and contingencies. Except as set forth in such discussion, there have been no material developments in legal proceedings as reported in Item 3. “Legal Proceedings” of our Fiscal 2021 Form 10-K.
ITEM 1A.RISK FACTORS.
Investors should carefully review and consider the information regarding certain factors that could materially affect our business, results of operations, financial condition, cash flows and equity as set forth in Item 1A. “Risk Factors” of our Fiscal 2021 Form 10-K. There have been no material changes to the risk factors disclosed in our Fiscal 2021 Form 10-K. We may disclose changes to our risk factors or disclose additional risk factors from time to time in our future filings with the SEC. Additional risks and uncertainties not presently known to us or that we currently believe not to be material also may adversely impact our business, financial condition, results of operations, cash flows and equity.
ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
Issuer Purchases of Equity Securities
During the quarter ended April 1, 2022, we repurchased 1.3 million shares of our common stock under our share repurchase program for $308 million at an average share price of $231.37, excluding commissions of $0.02 per share. The level and timing of our repurchases depends on a number of factors, including our financial condition, capital requirements, cash flows, results of operations, future business prospects and other factors our Board of Directors and management may deem relevant. We have announced that we currently expect to repurchase up to $1.5 billion in shares under our repurchase program in fiscal 2022, but we can give no assurances regarding the level and timing of share repurchases. The timing, volume and nature of repurchases are subject to market conditions, applicable securities laws and other factors and are at our discretion and may be suspended or discontinued at any time. Shares repurchased by us are cancelled and retired.
The following table sets forth information with respect to repurchases by us of our common stock during the quarter ended April 1, 2022:
Period*Total number of
shares purchased
Average price
paid per share
Total number of
shares purchased as part of publicly
announced plans or programs(1)
Maximum approximate dollar value of shares that may
yet be purchased under the plans or programs(1)
($ in millions)
Month No. 1    
(January 1, 2022-January 28, 2022)
Repurchase program(1)
273,155 $218.71 273,155 $2,476 
Employee transactions(2)
106,690 $217.54 — — 
Month No. 2
(January 29, 2022-February 25, 2022)
Repurchase program(1)
506,083 $214.76 506,083 $2,367 
Employee transactions(2)
46,142 $222.47 — — 
Month No. 3
(February 26, 2022-April 1, 2022)
Repurchase program(1)
551,348 $252.88 551,348 $2,228 
Employee transactions(2)
120,224 $263.87 — — 
Total1,603,642 1,330,586 $2,228 
_______________
* Periods represent our fiscal months.
(1) On January 28, 2021, we announced that our Board of Directors approved a $6 billion share repurchase authorization under our share repurchase program that was in addition to the remaining unused authorization of $210 million as of January 1, 2021. We repurchase shares of our common stock through open-market purchases, private transactions, transactions structured through investment banking institutions or any combination thereof. As of April 1, 2022, $2.2 billion (as reflected in the table above) was the approximate dollar amount of our common stock that can still be purchased under our share repurchase program, which does not have a stated expiration date.
(2) Represents a combination of (a) shares of our common stock delivered to us in satisfaction of the tax withholding obligation of holders of performance units, restricted units or restricted shares that vested during the quarter and (b) performance units, restricted units or restricted shares returned to us upon retirement
30


or employment termination of employees. Our equity incentive plans provide that the value of shares delivered to us to pay the exercise price of options or to cover tax withholding obligations shall be the closing price of our common stock on the date the relevant transaction occurs.
Sales of Unregistered Equity Securities
During the first quarter of fiscal 2022, we did not issue or sell any unregistered equity securities.
ITEM 3.DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4.MINE SAFETY DISCLOSURES.
Not applicable.
ITEM 5.OTHER INFORMATION.
None.

ITEM 6.EXHIBITS.
The following exhibits are filed herewith or are incorporated herein by reference to exhibits previously filed with the SEC:
(3)(a) Restated Certificate of Incorporation of L3Harris Technologies, Inc. (1995), as amended.
(3)(b) Amended and Restated By-Laws of L3Harris Technologies, Inc., as amended.
*(10.1) Conditional Waiver, Separation Agreement and Release of All Claims, dated January 21, 2022, between L3Harris Technologies, Inc. and Jesus Malave.
*(10.2) Offer Letter Agreement dated January 24, 2022, between L3Harris Technologies, Inc. and Michelle L. Turner.
*(10.3) Amendment Ten to the L3Harris Retirement Savings Plan (Amended and Restated Effective January 1, 2021) dated March 28, 2022.
(15)    Letter Regarding Unaudited Interim Financial Information.
(31.1)    Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.
(31.2)    Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.
(32.1)    Section 1350 Certification of Chief Executive Officer.
(32.2)    Section 1350 Certification of Chief Financial Officer.
(101) The financial information from L3Harris Technologies, Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended April 1, 2022 formatted in Inline XBRL (Extensible Business Reporting Language) includes: (i) the Condensed Consolidated Statement of Income, (ii) the Condensed Consolidated Statement of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheet, (iv) the Condensed Consolidated Statement of Cash Flows, (v) the Condensed Consolidated Statement of Equity, and (vi) the Notes to Condensed Consolidated Financial Statements.
(104) Cover Page Interactive Data File formatted in Inline XBRL and contained in Exhibit 101.
_______________
*    Management contract or compensatory plan or arrangement.

31


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
  L3HARRIS TECHNOLOGIES, INC.
 (Registrant)
Date: April 29, 2022 By: 
/s/    MICHELLE L. TURNER
  Michelle L. Turner
  Senior Vice President and Chief Financial Officer
(Principal Financial Officer)

32
Exhibit 3(a)


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 
l3harrislogopra33.jpg Exhibit 3(b)







BY-LAWS OF

L3HARRIS TECHNOLOGIES, INC.



As Amended and Restated Effective April 2, 2020




BY-LAWS OF

L3HARRIS TECHNOLOGIES, INC.
ARTICLE I.
Offices.
The registered office of L3Harris Technologies, Inc. (the “Company”) shall be in the City of Wilmington, County of New Castle, State of Delaware.
The Company may also have offices at such other places as the Board of Directors from time to time may determine or the business of the Company may require.
ARTICLE II.
Meetings of Shareholders.
Section 1.    Place of Meeting. All meetings of shareholders for the election of directors or for any other purposes whatsoever shall be held at such place, either within or without the State of Delaware, or, in the case of virtual-only meetings, at no physical place but instead solely by means of remote communication, in each case, as may be decided upon from time to time by the Board of Directors and indicated in the notice of the meeting.
Section 2.    Annual Meeting. The annual meeting of the shareholders shall be held on such date as the Board of Directors may determine and at the time as shall be decided by the Board of Directors and indicated in the notice of the meeting. Directors shall be elected thereat and such other business transacted as may be specified in the notice of the meeting, or as may be properly brought before the meeting.
Section 3.    Special Meetings. (a) Special meetings of the shareholders may be called by, and only by, (i) the Board of Directors, or (ii) solely to the extent required by Section 3(b) hereof, the Secretary of the Company. Each special meeting shall be held at such date, time and place either within or without the State of Delaware, or, in the case of virtual-only meetings, at no physical place but instead solely by means of remote communication, in each case, as may be decided upon from time to time by the Board of Directors and indicated in the notice of the meeting.
(b)    A special meeting of the shareholders shall be called by the Secretary upon the written request of the holders Owning of record continuously for a period of at least one year prior to the date set forth on the Special Meeting Request (as defined below) not less than twenty-five percent of the voting power of all outstanding shares of common stock of the Company (the “Requisite Percent”), subject to the following:
(1)    In order for a special meeting upon shareholder request (a “Shareholder Requested Special Meeting”) to be called by the Secretary, one or more written requests for a special meeting (each, a “Special Meeting Request,” and collectively, the “Special Meeting Requests”) stating the purpose of the special meeting and the matters proposed to be acted upon thereat must be signed and dated by the Requisite Percent of record holders of
1


common stock of the Company (or their duly authorized agents), must be delivered to the Secretary at the principal executive offices of the Company and must set forth:
(i)    the information required by the second paragraph of Section 8(b) of this Article II; and
(ii)    an agreement by the requesting shareholder(s) to notify the Company immediately in the case of any disposition prior to the record date for the Shareholder Requested Special Meeting of shares of common stock of the Company owned of record and an acknowledgement that any such disposition shall be deemed a revocation of such Special Meeting Request to the extent of such disposition, such that the number of shares disposed of shall not be included in determining whether the Requisite Percent has been reached.
For purposes of this Section 3 and references to Shareholder Requested Special Meetings in these By-Laws, “Own”, “Owned” or “Owning” shall mean shares (a) with respect to which a person has title or to which a person’s nominee, custodian or other agent has title and which such nominee, custodian or other agent is holding on behalf of such person, or (b) with respect to which a person (1) has purchased, or has entered into an unconditional contract, binding on both parties thereto, to purchase such shares, but has not yet received such shares, (2) owns a security convertible into or exchangeable for such shares and has tendered such security for conversion or exchange, (3) has an option to purchase or acquire, or rights or warrants to subscribe to, such shares, and has exercised such option, rights or warrants or (4) holds a securities futures contract to purchase such shares and has received notice that the position will be physically settled and is irrevocably bound to receive the underlying shares; provided, that (I) a shareholder or beneficial owner shall be deemed to Own shares only to the extent that such shareholder or beneficial owner has a net long position in such shares, (II) the number of shares Owned, directly or indirectly, by any shareholder or beneficial owner shall not include the number of shares as to which such holder does not have the right to vote or direct the vote on the matter or matters to be brought before the special shareholders meeting, (III) a shareholder or beneficial owner shall not be deemed to Own shares as to which such holder has entered into any Derivative Transaction (as defined in Section 8 of this Article II) and (IV) whether shares constitute shares Owned shall be decided by the Board of Directors in its reasonable determination, which determination shall be conclusive and binding on the Company and its shareholders.
The Company will provide the requesting shareholder(s) with notice of the record date for the determination of shareholders entitled to vote at the Shareholder Requested Special Meeting. Each requesting shareholder is required to update the notice delivered pursuant to this Section 3 not later than ten business days after such record date to provide any material changes in the foregoing information as of such record date.
In determining whether a special meeting of shareholders has been requested by the record holders of shares representing in the aggregate at least the Requisite Percent, multiple Special Meeting Requests delivered to the Secretary will be considered together only if each such Special Meeting Request (x) identifies substantially the same purpose or purposes of the special meeting and substantially the same matters proposed to be acted on at the special meeting (in each case as determined in good faith by the Board of Directors), and (y) has been dated and
2


delivered to the Secretary within sixty days of the earliest dated of such Special Meeting Requests. If the record holder is not the signatory to the Special Meeting Request, such Special Meeting Request will not be valid unless documentary evidence is supplied to the Secretary at the time of delivery of such Special Meeting Request (or within ten business days thereafter) of such signatory’s authority to execute the Special Meeting Request on behalf of the record holder. Any requesting shareholder may revoke his, her or its Special Meeting Request at any time by written revocation delivered to the Secretary at the principal executive offices of the Company; provided, however, that if following such revocation (or any deemed revocation pursuant to clause (ii) above), the unrevoked valid Special Meeting Requests represent in the aggregate less than the Requisite Percent, there shall be no requirement to hold a special meeting. The first date on which unrevoked valid Special Meeting Requests constituting not less than the Requisite Percent shall have been delivered to the Company is referred to herein as the “Request Receipt Date”.
(2)    Special Meeting Request shall not be valid if:
(i)    the Special Meeting Request relates to an item of business that is not a proper subject for shareholder action under applicable law;
(ii)    the Request Receipt Date is during the period commencing ninety days prior to the first anniversary of the date of the immediately preceding annual meeting and ending on the date of the next annual meeting;
(iii)    the purpose specified in the Special Meeting Request is not the nomination, election or removal of directors and an identical or substantially similar item (as determined in good faith by the Board of Directors, a “Similar Item”) was presented at any meeting of shareholders held within the twelve months prior to the Request Receipt Date;
(iv)    the purpose specified in the Special Meeting Request is the nomination, election or removal of directors and a Similar Item was presented at any meeting of shareholders held within one hundred and twenty days prior to the Request Receipt Date; or
(v)    a Similar Item is included in the Company’s notice as an item of business to be brought before a shareholder meeting that has been called but not yet held or that is called for a date within ninety days of the Request Receipt Date.
(3)    A Shareholder Requested Special Meeting shall be held at such date and time as may be fixed by the Board of Directors; provided, however, that the Shareholder Requested Special Meeting shall be called for a date not more than ninety days after the Request Receipt Date.
(4)    Business transacted at any Shareholder Requested Special Meeting shall be limited to (i) the purpose(s) stated in the valid Special Meeting Request(s) received from the Requisite Percent of record holders and (ii) any additional matters that the Board of Directors determines to include in the Company’s notice of the meeting. If none of the shareholders who submitted the Special Meeting Request appears or sends a qualified representative to present the
3


matters to be presented for consideration that were specified in the Shareholder Meeting Request, the Company need not present such matters for a vote at such meeting, notwithstanding that proxies in respect of such matter may have been received by the Company.
(5)    For the avoidance of doubt, nothing herein shall be deemed to entitle any shareholder to the reimbursement of expenses for soliciting proxies or any other expenses incurred by such shareholder in connection with any shareholder meeting, which expenses shall be borne by such shareholder and not by the Company.
Section 4.    Notice of Meetings. A written or printed notice of every annual or special meeting of the shareholders stating the place, if any, date, time and the purposes of such meeting; the means of remote communications, if any, by which shareholders and proxy holders may be deemed to be present in person and vote at such meeting; and if such meeting is to be held solely by means of remote communication, the information required for shareholders to gain access to the shareholder list contemplated by Section 5 of this Article II shall be given to each shareholder entitled to vote thereat and to each shareholder entitled to notice as provided by law, which notice shall be given not less than ten (10) nor more than sixty (60) days prior to the date of the meeting. Such notice shall be deemed given: (i) if mailed, when deposited in the United States mail, postage prepaid, directed to each shareholder at such shareholder’s address as it appears on the records of the Company; (ii) if sent by electronic mail, when delivered to an electronic mail address at which the shareholder has consented to receive such notice; and (iii) if posted on an electronic network together with a separate notice to the shareholder of such specific posting, upon the later to occur of (A) such posting and (B) the giving of such separate notice of such posting. It shall be the duty of the Secretary to give written notice of the annual meeting, and of each special meeting when requested so to do by the Board of Directors or as provided in Section 3(b) of this Article II. Any shareholder may waive in writing any notice required to be given by law or under these By-Laws and by attendance or voting at any meeting without protesting the lack of proper notice shall be deemed to have waived notice thereof. Notice shall be deemed to have been given to all shareholders of record who share an address if notice is given in accordance with the “householding” rules set forth in Rule 14a-3(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 233 of the Delaware General Corporation Law.
Section 5.    Shareholder List. A complete list of the shareholders entitled to vote at each meeting of shareholders, arranged in alphabetical order, with the address of each and the number of voting shares held by each, shall be prepared by or at the instance of the Secretary. Such list shall be open to the examination of any shareholder for any purpose germane to the meeting for a period of at least ten (10) days prior to the meeting: (i) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting contemplated by Section 4 of this Article II; or (ii) during ordinary business hours, at the principal place of business of the Company. If the Company determines to make such list available on an electronic network, then the Company may take reasonable steps to ensure that such information is available only to shareholders of the Company. If the meeting is to be held at a place, then such list shall be produced and kept at the time and place of the meeting during the whole time thereof and may be examined by any shareholder who is present. If the meeting is to be held solely by means of remote communication, then such list shall also be
4


open to the examination of any shareholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of the meeting contemplated by Section 4 of this Article II.
Section 6.    Voting and Proxies. At all meetings of shareholders, only such shareholders shall be entitled to vote, in person or by proxy, who appear upon the records of the Company as the holders of shares at the time possessing voting power, or if a record date be fixed as hereinafter provided, those appearing as such on such record date. Each shareholder entitled to vote at a meeting of shareholders may authorize another person or persons to act for such shareholder by proxy, but no such proxy shall be voted or acted upon after three (3) years from its date, unless the proxy provides for a longer period. A shareholder may authorize another person or persons to act for such shareholder as proxy by executing a writing authorizing such person or persons to act for such shareholder as proxy or by transmitting or authorizing the transmission of a telegram, cablegram, or other means of electronic transmission to the person who will be the holder of the proxy or to a proxy solicitation firm, proxy support service organization or like agent duly authorized by the person who will be the holder of the proxy to receive such transmission, provided that any such telegram, cablegram, or other means of electronic transmission must either set forth or be submitted with information from which it can be determined that the telegram, cablegram or other means of electronic transmission was authorized by the shareholder.
Section 7.    Quorum and Adjournments. Except as may otherwise be required by law or by the Restated Certificate of Incorporation or by these By-Laws, the holders of a majority of the shares entitled to vote at a shareholders’ meeting shall constitute a quorum to hold such meeting; provided, however, that any meeting, whether or not a quorum is present or otherwise, may, by vote of the holders of a majority of the voting shares represented thereat, adjourn from time to time and from place to place or to no physical place without notice other than by announcement at such meeting of the place, if any, date and time of such adjourned meeting and the means of remote communications, if any, by which shareholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting.
Section 8.    Advance Notice of Shareholder Nominees for Director and Other Shareholder Proposals. (a) The matters to be considered and brought before any annual or special meeting of shareholders of the Company shall be limited to only such matters, including the nomination and election of directors, as shall be brought properly before such meeting in compliance with the procedures set forth in this Section 8 or in Section 3(b) of this Article II or Section 11 of this Article II.
(b)    For any matter to be brought properly before any annual meeting of shareholders, the matter must be (i) specified in the notice of the annual meeting given by or at the direction of the Board of Directors, (ii) otherwise brought before the annual meeting by or at the direction of the Board of Directors, (iii) brought before the annual meeting by a shareholder who is a shareholder of record of the Company on the date the notice provided for in this Section 8(b) is delivered to the Secretary of the Company, who is entitled to vote at the annual meeting of shareholders on such matter and who complies with the procedures set forth in this Section 8(b) or (iv) brought pursuant to Section 11 of this Article II. In addition to any other
5


requirements under applicable law and the Restated Certificate of Incorporation and these By-Laws, written notice (the “Shareholder Notice”) of any nomination or other proposal by a shareholder must be timely and any proposal, other than a nomination, must constitute a proper matter for shareholder action. To be timely, the Shareholder Notice must be delivered to the Secretary of the Company at the principal executive office of the Company not less than ninety (90) nor more than one hundred and twenty (120) days prior to the first anniversary date of the annual meeting for the preceding year; provided, however, that if (and only if) the annual meeting is not scheduled to be held within a period that commences thirty (30) days before such anniversary date and ends thirty (30) days after such anniversary date (an annual meeting date outside such period being referred to herein as an “Other Meeting Date”), the Shareholder Notice shall be given in the manner provided herein by the later of the close of business on (i) the date ninety (90) days prior to such Other Meeting Date or (ii) the tenth day following the date such Other Meeting Date is first publicly announced or disclosed.
A Shareholder Notice must contain the following information: (i) whether the shareholder is providing the notice at the request of a beneficial holder of shares, whether the shareholder, any such beneficial holder or any nominee has any agreement, arrangement or understanding with, or has received any financial assistance, funding or other consideration from any other person with respect to the investment by the shareholder or such beneficial holder in the Company or the matter the Shareholder Notice relates to, and the details thereof, including the name of such other person (the shareholder, any beneficial holder on whose behalf the notice is being delivered, any nominees listed in the notice and any persons with whom such agreement, arrangement or understanding exists or from whom such assistance has been obtained are hereinafter collectively referred to as “Interested Persons”), (ii) the name and address of all Interested Persons, (iii) a complete description of all equity securities and debt instruments, whether held in the form of loans or capital market instruments, of the Company or any of its subsidiaries beneficially owned by all Interested Persons, (iv) whether and the extent to which any hedging, derivative or other transaction (a “Derivative Transaction”) is in place or has been entered into within the six months preceding the date of delivery of the Shareholder Notice by or for the benefit of any Interested Person with respect to the Company or its subsidiaries, or any of their respective securities, debt instruments or credit ratings, the effect or intent of which transaction is to give rise to gain or loss as a result of changes in the trading price of such securities or debt instruments or changes in the credit ratings for the Company, its subsidiaries or any of their respective securities or debt instruments (or, more generally, changes in the perceived creditworthiness of the Company or its subsidiaries), or to increase or decrease the voting power of such Interested Person, and if so, a summary of the material terms thereof, and (v) a representation that the shareholder is a holder of record of stock of the Company that would be entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to propose the matter set forth in the Shareholder Notice. As used herein, “beneficially owned” with respect to securities shall mean all securities which such person is deemed to beneficially own pursuant to Rules 13d-3 and 13d-5 under the Exchange Act. The Shareholder Notice shall be updated not later than 10 days after the record date for the determination of shareholders entitled to vote at the meeting to provide any material changes in the foregoing information as of the record date. Any Shareholder Notice relating to the nomination of directors must also contain (i) the information regarding each nominee required by paragraphs (a), (e) and (f) of Item 401 of
6


Regulation S-K adopted by the Securities and Exchange Commission (or the corresponding provisions of any successor regulation), (ii) each nominee’s signed consent to serve as a director of the Company if elected, and (iii) information as to whether each nominee is eligible for consideration as an independent director under the relevant standards contemplated by Item 407(a) of Regulation S-K (or the corresponding provisions of any successor regulation). The Company may also require any proposed nominee to furnish such other information, including completion of the Company’s directors questionnaire, as it may reasonably require to determine whether the nominee would be considered “independent” as a director or as a member of the audit committee of the Board of Directors under the various rules and standards applicable to the Company. Any Shareholder Notice with respect to a matter other than the nomination of directors must contain (i) the text of the proposal to be presented, including the text of any resolutions to be proposed for consideration by shareholders and (ii) a brief written statement of the reasons such shareholder favors the proposal.
Notwithstanding anything in this Section 8(b) to the contrary, in the event that the number of directors to be elected to the Board of Directors of the Company at the next annual meeting is increased and either all of the nominees for director at the next annual meeting or the size of the increased Board of Directors is not publicly announced or disclosed by the Company at least one hundred (100) days prior to the first anniversary of the preceding year’s annual meeting, a Shareholder Notice shall also be considered timely hereunder, but only with respect to nominees for any new positions created by such increase, if it shall be delivered to the Secretary of the Company at the principal executive office of the Company not later than the close of business on the tenth day following the first date all of such nominees or the size of the increased Board of Directors shall have been publicly announced or disclosed.
(c)    For any matter to be brought properly before any special meeting of shareholders, the matter must be set forth in the Company’s notice of the meeting. In the event that the Company calls a special meeting of shareholders for the purpose of electing one or more persons to the Board of Directors, any shareholder may nominate a person or persons (as the case may be), for election to such position(s) as specified in the Company’s notice of the meeting, if the Shareholder Notice required by Section 8(b) hereof shall be delivered to the Secretary of the Company at the principal executive office of the Company not later than the close of business on the tenth day following the day on which the date of the special meeting and either the names of the nominees proposed by the Board of Directors to be elected at such meeting or the number of directors to be elected is publicly announced or disclosed.
(d)    For purposes of this Section 8, a matter shall be deemed to have been “publicly announced or disclosed” if such matter is disclosed in a press release reported by the Dow Jones News Service, Associated Press or a comparable national news or wire service or in a document publicly filed by the Company with the Securities and Exchange Commission.
(e)    In no event shall the adjournment of an annual meeting or special meeting or the postponement of any meeting that does not require a change in the record date for such meeting, or any announcement thereof, commence a new period for the giving of notice as provided in this Section 8. This Section 8 shall not (i) affect the rights of shareholders to request inclusion of proposals made pursuant to Rule 14a-8 under the Exchange Act or (ii) apply to the
7


election of directors selected by or pursuant to the provisions of Article FOURTH, Section 3 of the Restated Certificate of Incorporation relating to the rights of the holders of any class or series of stock of the Company having a preference over the Common Stock as to dividends or upon liquidation to elect directors under specified circumstances.
(f)    The person presiding at any meeting of shareholders, in addition to making any other determinations that may be appropriate to the conduct of the meeting, shall have the power and duty to determine whether notice of nominees and other matters proposed to be brought before a meeting has been duly given in the manner provided in this Section 8 and, if not so given, shall direct and declare at the meeting that such nominees and other matters are out of order and shall not be considered. Notwithstanding the foregoing provisions of this Section 8, if the shareholder or a qualified representative of the shareholder does not appear in person or, in the case of a virtual-only meeting solely by means of remote communication, by means of remote communication, at the annual or special meeting of shareholders of the Company to present any such nomination, or make any such proposal, such nomination or proposal shall be disregarded, notwithstanding that proxies in respect of such vote may have been received by the Company.
Section 9.    Conduct of Meetings. The Board of Directors of the Company may adopt by resolution such rules, regulations and procedures for the conduct of meetings of shareholders as it shall deem appropriate. Except to the extent inconsistent with applicable law and such rules and regulations adopted by the Board of Directors, the chairman of each meeting of shareholders shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts, including causing an adjournment of such meeting, as, in the judgment of such Chairman, are appropriate. Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed by the chairman of the meeting, may include, without limitation, the following: (a) the establishment of an agenda or order of business for the meeting, including fixing the time for opening and closing the polls for voting on each matter; (b) rules and procedures for maintaining order at the meeting and the safety of those present; (c) limitations on attendance at or participation in the meeting to shareholders of record of the Company, their duly authorized and constituted proxies or such other persons as the chairman shall permit; (d) restrictions on entry to the meeting after the time fixed for the commencement thereof; and (e) limitations on the time allotted to questions or comments by participants. Unless, and to the extent determined by the Board of Directors or the chairman of the meeting, meetings of shareholders shall not be required to be held in accordance with rules of parliamentary procedure.
Section 10.    Organization of Meetings. Meetings of shareholders shall be presided over by the Chairman of the Board of Directors, or in his or her absence by the Chief Executive Officer, or in the absence of the foregoing persons by a Chairman designated by the Board of Directors, or, in the absence of any such designation, by a Chairman chosen at the meeting. The Secretary, or in the absence of the Secretary, an Assistant Secretary, shall act as the secretary of the meeting, but in the absence of the Secretary or Assistant Secretary, the chairman of the meeting may appoint any person to act as secretary of the meeting.
8


Section 11.    Shareholder Nominations Included in the Company’s Proxy Materials. (a) Subject to the provisions of this Section 11, if expressly requested in the relevant Nomination Notice (as defined below), the Company shall include in its proxy statement for any annual meeting of shareholders:
(i)    the names of any person or persons nominated for election to the Board of Directors (each, a “Nominee”), which shall also be included on the Company’s form of proxy and ballot, by any Eligible Holder (as defined below) or group of up to 20 Eligible Holders that has (individually and collectively, in the case of a group) satisfied, as determined by the Board of Directors, all applicable conditions and complied with all applicable procedures set forth in this Section 11 (such Eligible Holder or group of Eligible Holders being a “Nominating Shareholder”);
(ii)    disclosure about each Nominee and the Nominating Shareholder required under Section 14 of the Exchange Act and the rules and regulations thereunder (the “Proxy Rules”) or other applicable law to be included in the proxy statement;
(iii)    any statement included by the Nominating Shareholder in the Nomination Notice and expressly designated therein for inclusion in the proxy statement in support of each Nominee’s election to the Board of Directors (subject, without limitation, to Section 11(e)(ii) hereof), if such statement does not exceed 500 words and fully complies with the Proxy Rules, including Rule 14a-9 (the “Supporting Statement”); and
(iv)    any other information that the Company or the Board of Directors determines, in their discretion, to include in the proxy statement relating to the nomination of each Nominee, including, without limitation, any statement in opposition to the nomination, any of the information provided pursuant to this Section 11 and any solicitation materials or related information with respect to a Nominee.
For purposes of this Section 11, any determination to be made by the Board of Directors may be made by the Board of Directors, a committee of the Board of Directors or any officer of the Company designated by the Board of Directors or a committee of the Board of Directors, and any such determination shall be final and binding on the Company, any Eligible Holder, any Nominating Shareholder, any Nominee and any other person so long as made in good faith (without any further requirements). The chairman of any annual meeting of shareholders, in addition to making any other determinations that may be appropriate to the conduct of the meeting, shall have the power and duty to determine whether a Nominee has been nominated in accordance with the requirements of this Section 11 and, if not so nominated, shall direct and declare at the meeting that such Nominee shall not be considered.
(b)    Maximum Number of Nominees.
(i)    The Company shall not be required to include in its proxy statement for an annual meeting of shareholders more Nominees than that number of individuals as is equal to the greater of (i) two or (ii) 20% of the total number of directors of the Company on the last day on which a Nomination Notice may be submitted
9


pursuant to this Section 11 (rounded down to the nearest whole number) (such greater number, the “Maximum Number”). The Maximum Number for a particular annual meeting shall be reduced by the number of: (1) Nominees whom the Board of Directors itself nominates for election at such annual meeting; (2) Nominees who cease to satisfy, or Nominees of Nominating Shareholders that cease to satisfy, the eligibility requirements in this Section 11, as determined by the Board of Directors; (3) Nominees whose nomination is withdrawn by the Nominating Shareholder or who become unwilling to serve on the Board of Directors; and (4) the number of incumbent directors who had been Nominees with respect to any of the preceding two annual meetings of shareholders and whose reelection at the upcoming annual meeting is being recommended by the Board of Directors. If one or more vacancies for any reason occurs on the Board of Directors after the deadline for submitting a Nomination Notice as set forth in Section 11(d) hereof but before the date of the annual meeting, and the Board of Directors resolves to reduce the size of the Board of Directors in connection therewith, then the Maximum Number shall be calculated based on the number of directors in office as so reduced.
(ii)    If the number of Nominees pursuant to this Section 11 for any annual meeting of shareholders exceeds the Maximum Number then, promptly upon notice from the Company, each Nominating Shareholder in turn will select one Nominee for inclusion in the proxy statement until the Maximum Number is reached, going in order of the amount (largest to smallest) of the ownership position as disclosed in each Nominating Shareholder’s Nomination Notice, with the process repeated if the Maximum Number is not reached after each Nominating Shareholder has selected one Nominee. If, after the deadline for submitting a Nomination Notice as set forth in Section 11(d) hereof, a Nominee or Nominating Shareholder ceases to satisfy the eligibility requirements in this Section 11, as determined by the Board of Directors, a Nominating Shareholder withdraws its nomination of a Nominee or a Nominee becomes unwilling to serve on the Board of Directors, whether before or after the mailing or other distribution of the definitive proxy statement, then the nomination of the applicable Nominee(s) shall be disregarded, and the Company: (1) shall not be required to include in its proxy statement or on any ballot or form of proxy the disregarded Nominee(s) or any successor or replacement nominee(s) proposed by the Nominating Shareholder or by any other Nominating Shareholder and (2) may otherwise communicate to its shareholders, including without limitation by amending or supplementing its proxy statement or ballot or form of proxy, that the disregarded Nominee(s) will not be included as a nominee in the proxy statement or on any ballot or form of proxy and will not be voted on at the annual meeting.

(c)    Eligibility of Nominating Shareholder.
(i)    An “Eligible Holder” is a person who has either (1) been a record holder of the shares of common stock used to satisfy the eligibility requirements in this Section 11(c) continuously for the three-year period specified in Section 11(c)(ii) hereof or (2) provides to the Secretary of the Company, within the time period referred to in
10


Section 11(d) hereof, evidence of continuous ownership of such shares for such three-year period from one or more securities intermediaries in a form that the Board of Directors determines would be deemed acceptable for purposes of a shareholder proposal under Rule 14a-8(b)(2) under the Exchange Act (or any successor rule).
(ii)    An Eligible Holder or group of up to 20 Eligible Holders may submit a nomination in accordance with this Section 11 only if the person or group (in the aggregate) has owned at least the Minimum Number (as defined below) of shares of the Company’s common stock continuously throughout the three-year period preceding and including the date of submission of the Nomination Notice, and continues to own at least the Minimum Number through the date of the annual meeting. Two or more funds that are (x) under common management and investment control, (y) under common management and funded primarily by a single employer or (z) a “group of investment companies,” as such term is defined in Section 12(d)(1)(G)(ii) of the Investment Company Act of 1940, as amended, shall be treated as one Eligible Holder if such Eligible Holder shall provide together with the Nomination Notice documentation reasonably satisfactory to the Board of Directors that demonstrates that the funds meet the criteria set forth in (x), (y) or (z) hereof. For the avoidance of doubt, in the event of a nomination by a group of Eligible Holders, any and all requirements and obligations for an individual Eligible Holder that are set forth in this Section 11, including the minimum holding period, shall apply to each member of such group; provided, however, that the Minimum Number shall apply to the ownership of the group in the aggregate. Should any shareholder cease to satisfy the eligibility requirements in this Section 11, as determined by the Board of Directors, or withdraw from a group of Eligible Holders at any time prior to the annual meeting of shareholders, the group of Eligible Holders shall be deemed only to own the shares held by the remaining members of the group.
(iii)    The “Minimum Number” of shares of the Company’s common stock means 3% of the number of outstanding shares of common stock as of the most recent date for which such amount is given in any filing by the Company with the Securities and Exchange Commission prior to the submission of the Nomination Notice.
(iv)    For purposes of this Section 11, an Eligible Holder “owns” only those outstanding shares of the Company as to which the Eligible Holder possesses both:
(A)    the full voting and investment rights pertaining to the shares; and
(B)    the full economic interest in (including the opportunity for profit and risk of loss on) such shares; provided that the number of shares calculated in accordance with clauses (A) and (B) of this Section 11(c)(iv) shall not include any shares: (1) purchased or sold by such Eligible Holder or any of its affiliates in any transaction that has not been settled or closed, (2) sold short by such Eligible Holder, (3) borrowed by such Eligible Holder or any of its affiliates for any purpose or purchased by such Eligible Holder or any of its affiliates pursuant to an agreement to resell or subject to any other obligation to resell to another person, or (4) subject to any option, warrant, forward contract, swap,
11


contract of sale, other derivative or similar agreement entered into by such Eligible Holder or any of its affiliates, whether any such instrument or agreement is to be settled with shares or with cash based on the notional amount or value of outstanding shares of the Company, in any such case which instrument or agreement has, or is intended to have, the purpose or effect of: (x) reducing in any manner, to any extent or at any time in the future, such Eligible Holder’s or any of its affiliates’ full right to vote or direct the voting of any such shares, and/or (y) hedging, offsetting, or altering to any degree, gain or loss arising from the full economic interest of such shares by such Eligible Holder or any of its affiliates.
An Eligible Holder “owns” shares held in the name of a nominee or other intermediary so long as the Eligible Holder retains the right to instruct how the shares are voted with respect to the election of directors and possesses the full economic interest in the shares. An Eligible Holder’s ownership of shares shall be deemed to continue during any period in which the Eligible Holder has delegated any voting power by means of a proxy, power of attorney, or other similar instrument or arrangement that is revocable at any time by the Eligible Holder. An Eligible Holder’s ownership of shares shall be deemed to continue during any period in which the Eligible Holder has loaned such shares provided that the Eligible Holder has the power to recall such loaned shares on five business days’ notice and continues to hold such shares through the date of the annual meeting. The terms “owned,” “owning” and other variations of the word “own” shall have correlative meanings. Whether outstanding shares of the Company are “owned” for these purposes shall be determined by the Board of Directors.
(v)    No Eligible Holder shall be permitted to be in more than one group constituting a Nominating Shareholder, and if any Eligible Holder appears as a member of more than one group, it shall be deemed to be a member of the group that has the largest ownership position as reflected in the Nomination Notice.
(d)    Nomination Notice. To nominate a Nominee, the Nominating Shareholder must, no earlier than 150 calendar days and no later than 120 calendar days before the anniversary of the date that the Company mailed its proxy statement for the prior year’s annual meeting of shareholders, submit to the Secretary of the Company at the principal executive office of the Company all of the following information and documents (collectively, the “Nomination Notice”); provided, however, that if (and only if) the annual meeting is not scheduled to be held within a period that commences 30 days before such anniversary date and ends 30 days after the anniversary of the prior year’s meeting date (an annual meeting date outside such period being referred to herein as an “Other Meeting Date”), the Nomination Notice shall be given in the manner provided herein by the later of the close of business on the date that is 180 days prior to such Other Meeting Date or the tenth day following the date such Other Meeting Date is first publicly announced or disclosed:
(i)    A Schedule 14N (or any successor form) relating to each Nominee, completed and filed with the Securities and Exchange Commission by the Nominating Shareholder as applicable, in accordance with rules promulgated under the Exchange Act;
(ii)    A written notice, in a form deemed satisfactory by the Board of Directors, of the nomination of each Nominee that includes the following additional information, agreements, representations and warranties by the Nominating Shareholder
12


(including, in the case of a Nominating Shareholder comprised of a group of Eligible Holders, by each Eligible Holder in such group):
(A)    the information required with respect to the nomination of directors pursuant to Section 8 of this Article II;
(B)    the details of any relationship that existed within the past three years and that would have been described pursuant to Item 6(e) of Schedule 14N (or any successor item) if it existed on the date of submission of the Schedule 14N;
(C)    a representation and warranty that the Nominating Shareholder acquired the securities of the Company in the ordinary course of business and did not acquire, and is not holding, securities of the Company for the purpose or with the effect of influencing or changing control of the Company;
(D)    a representation and warranty that each Nominee’s candidacy or, if elected, Board membership would not violate applicable state or federal law or the rules of any stock exchange on which the Company’s securities are traded;
(E)    a representation and warranty that each Nominee:
(1)    does not have any direct or indirect relationship with the Company that would cause the Nominee to be considered not independent pursuant to the Company’s Director Independence Standards as most recently published on its website and otherwise qualifies as independent under the rules of the primary stock exchange on which the Company’s shares of common stock are traded;
(2)    meets the audit committee and compensation committee independence requirements under the rules of the primary stock exchange on which the Company’s shares of common stock are traded;
(3)    is a “non-employee director” for the purposes of Rule 16b-3 under the Exchange Act (or any successor rule); and
(4)    is not and has not been subject to any event specified in Rule 506(d)(1) of Regulation D (or any successor rule) under the Securities Act of 1933 or Item 401(f) of Regulation S-K (or any successor rule) under the Exchange Act, without reference to whether the event is material to an evaluation of the ability or integrity of such Nominee;
(F)    a representation and warranty that the Nominating Shareholder satisfies the eligibility requirements set forth in Section 11(c) hereof and has provided evidence of ownership to the extent required by Section 11(c)(i) hereof;
(G)    a representation and warranty that the Nominating Shareholder intends to continue to satisfy the eligibility requirements described in Section 11(c) hereof through the date of the annual meeting;
(H)    details of any position of a Nominee as an officer or director of any competitor (that is, any entity that produces products, provides services or engages in business activities that compete with or are alternatives to the principal products produced, services provided or business activities engaged
13


in by the Company or its affiliates) of the Company, within the three years preceding the submission of the Nomination Notice;
(I)    a representation and warranty that the Nominating Shareholder will not engage in a “solicitation” within the meaning of Rule 14a-1(l) under the Exchange Act (without reference to the exception in Section 14a-1(l)(2)(iv)) (or any successor rules) with respect to the annual meeting, other than with respect to a Nominee or any nominee of the Board of Directors;
(J)    a representation and warranty that the Nominating Shareholder will not use any proxy card other than the Company’s proxy card in soliciting shareholders in connection with the election of a Nominee at the annual meeting;
(K)    if desired, a Supporting Statement; and
(L)    in the case of a Nominating Shareholder comprised of a group of Eligible Holders, the designation by all Eligible Holders in such group of one Eligible Holder in such group that is authorized to act on behalf of all Eligible Holders in such group with respect to matters relating to such Nominating Shareholders’ nomination, including withdrawal of the nomination;
(iii)    An executed agreement, in a form deemed satisfactory by the Board of Directors, pursuant to which the Nominating Shareholder (and, in the case of a Nominating Shareholder comprised of a group of Eligible Holders, each Eligible Holder in such group) agrees:
(A)    to comply with all applicable laws, rules and regulations in connection with the nomination, solicitation and election;
(B)    to file any written solicitation with the Company’s shareholders relating to one or more of the Company’s directors or director nominees or any Nominee with the Securities and Exchange Commission, regardless of whether any such filing is required under rule or regulation or whether any exemption from filing is available for such materials under any rule or regulation;
(C)    to assume all liability stemming from an action, suit or proceeding concerning any actual or alleged legal or regulatory violation arising out of any communication by the Nominating Shareholder or any of its Nominees with the Company, its shareholders or any other person in connection with the nomination or election of directors, including, without limitation, the Nomination Notice;
(D)    to indemnify and hold harmless (jointly with all other Eligible Holders in a group, in the case of an Eligible Holder in such group) the Company and each of its directors, officers and employees individually against any liability, loss, damages, expenses or other costs (including attorneys’ fees) incurred in connection with any threatened or pending action, suit or proceeding, whether legal, administrative or investigative, against the Company or any of its directors, officers or employees arising out of or relating to a failure or alleged failure of the Nominating Shareholder or any of its Nominees to comply with, or any breach or alleged breach of, its or their obligations, agreements or representations under this Section 11;
14


(E)    in the event that any information included in the Nomination Notice, or any other communication by the Nominating Shareholder (including, in the case of a Nominating Shareholder comprised of a group of Eligible Holders, with respect to any Eligible Holder in such group), with the Company, its shareholders or any other person in connection with the nomination or election ceases to be true and accurate in all material respects (or omits a material fact necessary to make the statements made not misleading), or that the Nominating Shareholder (including, in the case of a Nominating Shareholder comprised of a group of Eligible Holders, any Eligible Holder in such group) has failed to continue to satisfy the eligibility requirements described in Section 11(c) hereof, to promptly (and in any event within 48 hours of discovering such misstatement, omission or failure) notify the Company and any other recipient of such communication of (1) the misstatement or omission in such previously provided information and of the information that is required to correct the misstatement or omission or (2) such failure; and
(iv)    An executed agreement, in a form deemed satisfactory by the Board of Directors, from each Nominee pursuant to which such Nominee agrees:
(A)    to provide to the Company such other information and certifications, including completion of the Company’s directors questionnaire, as it may reasonably request;
(B)    at the reasonable request of the Nominating and Governance Committee (or any applicable successor committee), to meet with such Committee to discuss matters relating to the nomination of such Nominee to the Board of Directors, including the information provided by such Nominee to the Company in connection with his or her nomination and such Nominee’s eligibility to serve as a member of the Board of Directors;
(C)    that such Nominee has read and agrees, if elected, to serve as a member of the Board of Directors, to adhere to the Company’s Corporate Governance Guidelines, Code of Conduct, Policies and Procedures with Respect to Related Person Transactions and any other Company policies and guidelines applicable to directors; and
(D)    that such Nominee is not and will not become a party to (i) any compensatory, payment or other financial agreement, arrangement or understanding with any person or entity in connection with his or her nomination, service or action as a director of the Company that has not been disclosed to the Company, (ii) any agreement, arrangement or understanding with any person or entity as to how such Nominee would vote or act on any issue or question as a director (a “Voting Commitment”) that has not been disclosed to the Company or (iii) any Voting Commitment that could limit or interfere with such Nominee’s ability to comply, if elected as a director of the Company, with his or her fiduciary duties under applicable law.
The information and documents required by this Section 11(d) to be provided by the Nominating Shareholder shall be: (i) provided with respect to and executed by each group member, in the case of information applicable to group members; and (ii) provided with respect to the persons specified in Instruction 1 to Items 6(c) and (d) of Schedule 14N (or any successor item) in the case of a Nominating Shareholder or group member that is an entity. The Nomination Notice shall be deemed submitted on the date on which all the information and documents referred to in this Section 11(d) (other than such information and documents
15


contemplated to be provided after the date the Nomination Notice is provided) have been delivered to or, if sent by mail, received by the Secretary of the Company.
(e)    Exceptions.
(i)    Notwithstanding anything to the contrary contained in this Section 11, the Company may omit from its proxy statement any Nominee and any information concerning such Nominee (including a Nominating Shareholder’s Supporting Statement) and no vote on such Nominee will occur (notwithstanding that proxies in respect of such vote may have been received by the Company), and the Nominating Shareholder may not, after the last day on which a Nomination Notice would be timely, cure in any way any defect preventing the nomination of such Nominee, if:
(A)    the Company receives a notice pursuant to Section 8 of this Article II that a shareholder intends to nominate a candidate for director at the annual meeting, whether or not such notice is subsequently withdrawn or made the subject of a settlement with the Company;
(B)    the Nominating Shareholder or the designated lead group member, as applicable, or any qualified representative thereof, does not appear in person or, in the case of a virtual-only meeting solely by means of remote communication, by means of remote communication, at the meeting of shareholders to present the nomination submitted pursuant to this Section 11, the Nominating Shareholder withdraws its nomination or the chairman of the annual meeting declares that such nomination was not made in accordance with the procedures prescribed by this Section 11 and shall therefore be disregarded;
(C)    the Board of Directors determines that such Nominee’s nomination or election to the Board of Directors would result in the Company violating or failing to be in compliance with the Company’s By-Laws or certificate of incorporation or any applicable law, rule or regulation to which the Company is subject, including any rules or regulations of the primary stock exchange on which the Company’s shares of common stock are traded;
(D)    such Nominee was nominated for election to the Board of Directors pursuant to this Section 11 at one of the Company’s two preceding annual meetings of shareholders and either withdrew or became ineligible or received a vote of less than 25% of the shares of common stock cast for or against such Nominee;
(E)    such Nominee has been, within the past three years, an officer or director of a competitor, as defined for purposes of Section 8 of the Clayton Antitrust Act of 1914, as amended; or
(F)    the Company is notified, or the Board of Directors determines, that the Nominating Shareholder or the Nominee has failed to continue to satisfy the eligibility requirements described in Section 11(c) hereof, any of the representations and warranties made in the Nomination Notice ceases to be true and accurate in all material respects (or omits a material fact necessary to make the statements made not misleading), such Nominee becomes unwilling or unable to serve on the Board of Directors or any material violation or breach occurs of the obligations, agreements, representations or warranties of the Nominating Shareholder or such Nominee under this Section 11;
(ii)    Notwithstanding anything to the contrary contained in this Section 11, the Company may omit from its proxy statement, or may supplement or correct, any
16


information, including all or any portion of the Supporting Statement or any other statement in support of a Nominee included in the Nomination Notice, if the Board of Directors determines that:
(A)    such information is not true in all material respects or omits a material statement necessary to make the statements made not misleading;
(B)    such information directly or indirectly impugns the character, integrity or personal reputation of, or directly or indirectly makes charges concerning improper, illegal or immoral conduct or associations, without factual foundation, with respect to, any person; or
(C)    the inclusion of such information in the proxy statement would otherwise violate the Proxy Rules or any other applicable law, rule or regulation.
The Company may solicit against, and include in the proxy statement its own statement relating to, any Nominee.
ARTICLE III.
Board of Directors.
Section 1.    Number. Subject to the Restated Certificate of Incorporation, the Board of Directors shall consist of not less than eight nor more than thirteen members as may be determined by the Board of Directors. After any such determination, the number so determined shall continue as the authorized number of members of the Board until the same shall be changed as aforesaid. Directors need not be shareholders.
Section 2.    Manner of Election. Subject to the Restated Certificate of Incorporation, except as may be otherwise required by the Restated Certificate of Incorporation, each director shall be elected by the vote of the majority of the votes cast (meaning the number of shares voted “for” a nominee must exceed the number of shares voted “against” such nominee) at any meeting for the election of directors at which a quorum is present, provided that the directors shall be elected by a plurality of the votes cast (instead of by votes cast for or against a nominee) at any meeting at which a quorum is present for which (i) the Secretary of the Company receives a notice in compliance with the applicable requirements for shareholder nominations for director set forth in these By-Laws and (ii) such proposed nomination has not been withdrawn by such shareholder on or prior to the tenth day preceding the date the Company first mails its notice of meeting for such meeting to the shareholders.
Section 3.    Tenure; Vacancies. Subject to the Restated Certificate of Incorporation, each director shall hold office for the term set forth in Article ELEVENTH of the Restated Certificate of Incorporation and until his or her successor shall be elected and qualified; subject, however, to prior resignation, death or removal as provided by law. Any director may resign at any time by oral statement to that effect made at a meeting of the Board of Directors, to be effective upon its acceptance by the Board, or in writing to that effect delivered to the Secretary, to be effective upon its acceptance or at the time specified in such writing. Subject to the Restated Certificate of Incorporation, any vacancy on the Board of Directors that results from an increase in the number of directors shall be filled by a majority of the Board of Directors then in office, and any other vacancy occurring in the Board of Directors shall be filled by a majority of
17


the directors then in office, although less than a quorum, or by a sole remaining director. Any director elected to fill a vacancy not resulting from an increase in the number of directors shall have the same remaining term as that of his predecessor.
Section 4.    Organization Meeting. Immediately after each annual meeting of the shareholders or special meeting held in lieu thereof, the newly elected Board of Directors, if a quorum is present, shall hold an organization meeting for the purpose of electing officers and transacting any other business. Notice of such meeting need not be given. If, for any reason, said organization meeting is not held at such time, a special meeting for such purpose shall be held as soon thereafter as practicable.
Section 5.    Regular Meetings. Regular meetings of the Board of Directors for the transaction of any business may be held at such times and places as may be determined by the Board of Directors. The Secretary shall give to each director at least five (5) days written notice of each such meeting.
Section 6.    Special Meetings. Special meetings of the Board of Directors may be held at any time and place upon call by the Chairman of the Board, the Chief Executive Officer, or a majority of the Directors. Notice of each such meeting shall be given to each director by letter, telegram or telephone or in person not less than two (2) days prior to such meeting; provided, however, that such notice shall be deemed to have been waived by the directors attending or voting at any such meeting, without protesting the lack of proper notice, and may be waived in writing or by telegram by any director either before or after such meeting. Unless otherwise indicated in the notice thereof, any business may be transacted at such meeting.
Section 7.    Quorum. At all meetings of the Board of Directors a majority of the directors in office at the time shall constitute a quorum for the transaction of business, but in no case shall such quorum be less than one-third of the total authorized number of directors.
Section 8.    Compensation. If so determined by the Board of Directors, all or any members of the Board of Directors or of any committee of the Board who are not Company employees shall be compensated for their services in such capacities either a fixed sum for attendance at each meeting of the Board or of such committee or such other amount as may be determined from time to time by the Board of Directors. Compensation may be paid in cash and in the Company’s stock and stock equivalents. Directors may be reimbursed for expenses reasonably incurred by them in attending such meetings.

18


ARTICLE IV.
Committees.
Subject to the Restated Certificate of Incorporation, the Board of Directors may, by resolution or resolutions passed by a majority of the whole Board, designate or eliminate one or more committees, each committee to consist of one or more of the directors of the Company. Subject to the Restated Certificate of Incorporation, the Board of Directors may designate one or more members as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. Subject to the Restated Certificate of Incorporation, any such committee, to the extent provided in said resolution or resolutions of the Board of Directors and to the extent permitted by Delaware law shall have and may exercise the powers of the Board of Directors in the management of the business and affairs of the Company, and may have power to authorize the seal of the Company to be affixed to all papers which may require it. Subject to the Restated Certificate of Incorporation, such committee or committees shall have such name or names as may be determined from time to time by resolution adopted by the Board of Directors. Unless otherwise provided in the resolution of the Board of Directors designating the committees, a committee may create one or more subcommittees, each subcommittee to consist of one or more members of the committee, and delegate to a subcommittee any or all of the powers and authority of the committee.
ARTICLE V.
Officers.
Section 1.    Officers Designated. Subject to the Restated Certificate of Incorporation, the officers of the Company shall be elected by the Board of Directors at their organization meeting or any other meeting. Subject to the Restated Certificate of Incorporation, the Board of Directors shall elect the executive officers of the Company which may include a Chairman of the Board of Directors, President, and one or more Vice Presidents (any one or more of whom may be designated as Executive Vice Presidents, or as Senior Vice Presidents or by any other designations). In addition thereto, the officers shall include a Controller or Principal Accounting Officer, a General Counsel, a Secretary and a Treasurer. In their discretion the Board of Directors may elect one or more Assistant Secretaries and Assistant Treasurers and any other additional officers. Subject to the Restated Certificate of Incorporation, the Chairman of the Board shall be elected from among the directors. The other officers may but need not be elected from among the directors. Any two offices may be held by the same person, but in any case where the action of more than one officer is required no one person shall act in more than one capacity.
Section 2.    Tenure of Office. Subject to the Restated Certificate of Incorporation, the officers of the Company shall hold office until the next organization meeting of the Board of Directors and until their respective successors are chosen and qualified, except in case of resignation, death or removal. Subject to the Restated Certificate of Incorporation, the Board of Directors may remove any officer at any time with or without cause by the vote of the majority of the directors in office at the time. Subject to the Restated Certificate of Incorporation, a vacancy in any office may be filled by election by the Board of Directors.
19


Section 3.    Powers and Duties of Officers in General. Subject to the Restated Certificate of Incorporation, the powers and duties of the officers shall be exercised in all cases subject to such directions as the Board of Directors may see fit to give. Subject to the Restated Certificate of Incorporation, the respective powers and duties hereinafter set forth are subject to alteration by the Board of Directors. Subject to the Restated Certificate of Incorporation, the Board of Directors is also authorized to delegate the duties of any officer to any other officer, employee or committee and to require the performance of duties in addition to those provided for herein. Subject to the Restated Certificate of Incorporation and such directions, if any, as the Board of Directors may give from time to time, the chief executive officers of the Company are authorized to establish and to modify from time to time an organization plan defining the respective duties and functions of the officers of the Company.
Section 4.    Chairman of the Board; Vice Chairman of the Board. The Chairman of the Board or, in his or her absence, the Vice Chairman of the Board shall preside at meetings of the shareholders and of the Board of Directors.
Section 5.    Chief Executive Officer. Subject to the Restated Certificate of Incorporation, the Chief Executive Officer shall be either the Chairman of the Board and/or the President, as the Board of Directors so designates, and he or she shall have general responsibility for the major functions of the business of the Company and shall initiate and develop broad Company policies.
Section 6.    President; Vice Presidents. In the absence or disability of the Chief Executive Officer, the President shall perform the Chief Executive Officer’s duties. In the absence or disability of the Chief Executive Officer and the President, the Vice Presidents, in the order designated by the Board of Directors, shall perform the Chief Executive Officer’s duties. If so determined by the Board of Directors, one Vice President may be designated as manager of specific sectors, divisions, districts or such other unit or as being in charge of specific functions, another as Vice President in Charge of Sales, and other Vice Presidents as managers of specified divisions or sales districts of the Company or as being in charge of specified functions.
Section 7.    Controller or Principal Accounting Officer, General Counsel, Secretary, and Treasurer. The Controller or Principal Accounting Officer, General Counsel, the Secretary, and the Treasurer shall perform such duties as are indicated by their respective titles, subject to the provisions of Section 3 of this Article V. The Secretary shall have the custody of the corporate seal.
Section 8.    Other Officers. Subject to the Restated Certificate of Incorporation, all other officers shall have such powers and duties as may be prescribed by the Board of Directors, or, in the absence of their action, by the chief executive officers of the Company or by the respective officers having supervision over them.
Section 9.    Compensation. Subject to the Restated Certificate of Incorporation, the Board of Directors is authorized to determine, or to provide the method of determining, or to empower a committee of its members to determine, the compensation of all officers.
20


Section 10.    Bond. If so requested and authorized by the Board of Directors, the Company shall furnish a fidelity bond in such sum and with such security as the Board of Directors may require.
Section 11.    Signing Checks and Other Instruments. The Board of Directors is authorized to determine or provide the method of determining the manner in which deeds, contracts and other obligations and instruments of the Company shall be signed. However, persons doing business with the Company shall be entitled to rely upon the action of the Chairman of the Board, the President, any Vice President, the Secretary, the Treasurer, the Controller or Principal Accounting Officer or General Counsel in executing contracts and other obligations and instruments, of the Company as having been duly authorized. The Board of Directors of the Company is authorized to designate or provide the method of designating depositaries of the funds of the Company and to determine or provide the method of determining the manner in which checks, notes, bills of exchange and similar instruments shall be signed, countersigned or endorsed.
Section 12.    Specified Post-Merger Period. Article Fourteenth of the Restated Certificate of Incorporation prescribes certain terms regarding the appointment of the Chief Executive Officer of the Company and the President and Chief Operating Officer of the Company, and such terms are incorporated herein by reference.
ARTICLE VI.
Indemnification of Directors and Officers.
The Company shall indemnify to the full extent permitted by law any person made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person is or was a director or officer of the Company, is or was a director, officer, trustee, member, shareholder, partner, incorporator or liquidator of a Subsidiary of the Company, or serves or served at the request of the Company as a director, officer, trustee, member, shareholder, partner, incorporator or liquidator of or in any other capacity for any other enterprise. Expenses, including attorneys’ fees, incurred by any such person in defending any such action, suit or proceeding shall be paid or reimbursed by the Company promptly upon demand by such person and, if any such demand is made in advance of the final disposition of any such action, suit or proceeding, promptly upon receipt by the Company of an undertaking of such person to repay such expenses if it shall ultimately be determined that such person is not entitled to be indemnified by the Company. The rights provided to any person by this by-law shall be enforceable against the Company by such person, who shall be presumed to have relied upon it in serving or continuing to serve as a director or officer or in such other capacity as provided above. In addition, the rights provided to any person by this by-law shall survive the termination of such person as any such director, officer, trustee, member, shareholder, partner, incorporator or liquidator and, insofar as such person served at the request of the Company as a director, officer, trustee, member, shareholder, partner, incorporator or liquidator of or in any other capacity for any other enterprise, shall survive the termination of such request as to service prior to termination of such request. No amendment of this by-law shall impair the rights of any person arising at any time with respect to events occurring prior to such amendment.
21


Notwithstanding anything contained in this Article VI, except for proceedings to enforce rights provided in this Article VI, the Company shall not be obligated under this Article VI to provide any indemnification or any payment or reimbursement of expenses to any director, officer or other person in connection with a proceeding (or part thereof) initiated by such person (which shall not include counterclaims or crossclaims initiated by others) unless the Board of Directors has authorized or consented to such proceeding (or part thereof) in a resolution adopted by the Board.
For purposes of this by-law, the term “Subsidiary” shall mean any corporation, partnership, limited liability company or other entity in which the Company owns, directly or indirectly, a majority of the economic or voting ownership interest; the term “other enterprise” shall include any corporation, partnership, limited liability company, joint venture, trust, association or other unincorporated organization or other entity and any employee benefit plan; the term “officer,” when used with respect to the Company, shall refer to any officer elected by or appointed pursuant to authority granted by the Board of Directors of the Company pursuant to Article V of these By-Laws, when used with respect to a Subsidiary or other enterprise that is a corporation, shall refer to any person elected or appointed pursuant to the by-laws of such Subsidiary or other enterprise or chosen in such manner as is prescribed by the by-laws of such Subsidiary or other enterprise or determined by the Board of Directors of such Subsidiary or other enterprise, and when used with respect to a Subsidiary or other enterprise that is not a corporation or is organized in a foreign jurisdiction, the term “officer” shall include in addition to any officer of such entity, any person serving in a similar capacity or as the manager of such entity; service “at the request of the Company” shall include service as a director or officer of the Company which imposes duties on, or involves services by, such director or officer with respect to an employee benefit plan, its participants or beneficiaries; any excise taxes assessed on a person with respect to an employee benefit plan, its participants or beneficiaries shall be deemed to be indemnifiable expenses; and action by a person with respect to an employee benefit plan which such person reasonably believes to be in the interest of the participants and beneficiaries of such plan shall be deemed to be action not opposed to the best interests of the Company.
To the extent authorized from time to time by the Board of Directors, the Company may provide to (i) any one or more employees and other agents of the Company, (ii) any one or more officers, employees and other agents of any Subsidiary and (iii) any one or more directors, officers, employees and other agents of any other enterprise, rights of indemnification and to receive payment or reimbursement of expenses, including attorneys’ fees, that are similar to the rights conferred in this Article VI on directors and officers of the Company or any Subsidiary or other enterprise. Any such rights shall have the same force and effect as they would have if they were conferred in this Article VI.
Nothing in this Article VI shall limit the power of the Company or the Board of Directors to provide rights of indemnification and to make payment and reimbursement of expenses, including attorneys’ fees, to directors, officers, employees, agents and other persons otherwise than pursuant to this Article VI.

22


ARTICLE VII.
Corporate Seal.
The corporate seal, circular in form, shall have inscribed thereon the name of the Company and the words “Corporate Seal--Delaware.”
ARTICLE VIII.
Record Dates.
The Board of Directors may close the stock transfer books of the Company for a period not exceeding sixty (60) days preceding the date of any meeting of the shareholders, or the date for the payment of any dividend, or the date for the allotment of rights, or the date when any change or conversion or exchange of shares shall go into effect; provided, however, that in lieu of closing the stock transfer books as aforesaid, the Board of Directors may fix in advance a date, not exceeding sixty (60) days preceding the date of any meeting of shareholders, or the date for the payment of any dividend, or the date for the allotment of rights, or the date when any change or conversion or exchange of shares shall go into effect, as a record date for the determination of the shareholders entitled to notice of, and to vote at, any such meeting and any adjournment thereof, or entitled to receive payment of any such dividend, or to any such allotment of rights, or to exercise the rights in respect of any such change, conversion or exchange of shares, and in such case such shareholders, and only such shareholders as shall be shareholders of record on the date so fixed, shall be entitled to such notice of, and to vote at, such meeting and any adjournment thereof, or to receive payment of such dividend or to receive such allotment of rights or to exercise such rights as the case may be, notwithstanding any transfer of any shares on the books of the Company after any such record date fixed as aforesaid.
ARTICLE IX.
Stock.
Section 1.    Certificates; Uncertificated Shares. The shares of stock of the Company shall be represented by certificates in such form as the appropriate officers of the Company may from time to time prescribe; provided that the Board of Directors may provide by resolution or resolutions that some or all of any or all classes or series of stock of the Company shall be uncertificated shares. Notwithstanding the foregoing or the adoption of such a resolution or resolutions by the Board of Directors, each holder of uncertificated shares shall be entitled, upon request, to a certificate representing such shares. Any such resolution shall not apply to any share represented by a certificate theretofore issued until such certificate is surrendered to the Company. Share certificates shall be numbered and registered in a share register as they are issued. Share certificates shall exhibit the name of the registered holder and the number and class of shares and the series, if any, represented thereby and the par value of each such share or a statement that each such share is without par value, as the case may be. Except as otherwise provided by law, the rights and obligations of the holders of uncertificated shares and the rights and obligations of the holders of shares represented by certificates of the same class and series shall be identical.
Section 2.    Signatures on Certificates. Every share certificate shall be signed, in the name of the Company, by the Chairman of the Board, the Chief Executive Officer, the President
23


or a Vice President and countersigned, in the name of the Company, by the Corporate Secretary, an Assistant Secretary, the Treasurer or an Assistant Treasurer and shall be sealed with the Company’s corporate seal. Such signatures and seal may be facsimile, engraved or printed. The Board of Directors may appoint one or more transfer agents or transfer clerks and one or more registrars and may require any or all certificates representing shares of stock to bear the signature or signatures of any of them. Where a certificate is signed (a) by a transfer agent or an assistant or co-transfer agent, (b) by a transfer clerk or (c) by a registrar or co-registrar, the signature thereon of any authorized signatory may be facsimile. Where a certificate is signed by a registrar or co-registrar, the signature of any transfer agent or assistant or co-transfer agent thereon may be by facsimile signature of the authorized signatory of such transfer agent or assistant or co-transfer agent. In case any officer or officers of the Company who have signed, or whose facsimile, engraved or printed signature or signatures have been used on, any such certificate or certificates shall cease to be such officer or officers, whether because of death, resignation or otherwise, before such certificate or certificates have been delivered by the Company, such certificate or certificates may, nevertheless, be issued and delivered as though the person or persons who signed such certificate or certificates or whose facsimile, engraved or printed signature or signatures have been used thereon had not ceased to be such officer or officers of the Company.
Section 3.    Lost, Stolen or Destroyed Certificates; Issuance of New Certificates. In case of loss, theft or destruction of any certificate representing shares of stock or other securities of the Company, another may be issued, or uncertificated shares may be issued, in its place upon satisfactory proof of such loss, theft or destruction and upon the giving of a satisfactory bond of indemnity to the Company and to the transfer agents, transfer clerks and registrars, if any, of such stock or other securities, as the case may be.
Section 4.    Transfer of Shares. Subject to valid transfer restrictions and stop-transfer orders, upon surrender to the Company, or a transfer agent, transfer clerk or registrar of the Company, of a certificate representing shares duly endorsed or accompanied by proper evidence of succession, assignment or authority to transfer, the Company may issue a new certificate or new equivalent uncertificated shares, as the case may be, or in the case of uncertificated shares, upon request, a certificate representing, or other evidence of, such new equivalent uncertificated shares, to the person entitled thereto, cancel the old certificate and record the transaction upon its books. Upon receipt of proper transfer instructions from the holder of uncertificated shares, the Company shall cancel such uncertificated shares and issue new equivalent uncertificated shares, or, upon such holder’s request, a certificate representing, or other evidence of, such new equivalent uncertificated shares, to the person entitled thereto, and record the transaction upon its books. In no event shall a transfer of shares affect the right of the Company to pay any dividend upon the stock to the holder of record thereof for all purposes, and no transfer shall be valid, except between the parties thereto, until such transfer shall have been made upon the books of the Company.
Section 5.    Registered Shareholders. The Company and its transfer agents, transfer clerks and registrars, if any, shall be entitled to treat the holder of record of any share or shares as the holder in fact thereof and shall not be bound to recognize any equitable or other claims to, or interest in, such shares on the part of any other person and shall not be liable for any registration
24


or transfer of shares which are registered, or to be registered, in the name of a fiduciary or the nominee of a fiduciary unless made with actual knowledge that a fiduciary, or nominee of a fiduciary, is committing a breach of trust in requesting such registration or transfer, or with knowledge of such facts that its participation therein amounts to bad faith.
ARTICLE X.
Fiscal Year.
Unless and until the Board of Directors shall otherwise determine, (i) up to and including June 28, 2019, the fiscal year of the Company shall end on the Friday nearest June 30 and (ii) commencing June 29, 2019, the fiscal year of the Company shall end on the Friday nearest December 31 and the period commencing on June 29, 2019 shall be a fiscal transition period ending on January 3, 2020.
ARTICLE XI.
Amendments.
Subject to the Restated Certificate of Incorporation, these By-Laws may be made or altered in any respect in whole or in part by the affirmative vote of the holders of a majority of the shares entitled to vote thereon at any annual or special meeting of the shareholders, if notice of the proposed alteration or change to be made is properly brought before the meeting under these By-Laws. Subject to the Restated Certificate of Incorporation, these By-Laws may also be made or altered in any respect in whole or in part, by the affirmative vote of the majority of the directors then comprising the Board of Directors.
ARTICLE XII.
Exclusive Forum for Certain Actions.
Unless the Company consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of fiduciary duty owed by any director or officer or other employee of the Company to the Company or the Company’s shareholders, (iii) any action asserting a claim against the Company or any director or officer or other employee of the Company arising pursuant to any provision of the Delaware General Corporation Law or the Restated Certificate of Incorporation or these By-Laws (in each case, as they may be amended from time to time), or (iv) any action asserting a claim against the Company or any director or officer or other employee of the Company governed by the internal affairs doctrine shall be a state court located within the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal district court for the District of Delaware).



25




CERTIFICATE OF AMENDMENT

TO THE

BY-LAWS

OF

L3HARRIS TECHNOLOGIES, INC.


L3Harris Technologies, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, as amended, does hereby certify that Section 1 of ARTICLE III of the By-Laws of the Corporation shall hereby be amended and restated to read in its entirety as follows:

    “Section 1.    Number. Subject to the Restated Certificate of Incorporation, the Board of Directors shall consist of not less than eight nor more than fifteen members as may be determined by the Board of Directors. After any such determination, the number so determined shall continue as the authorized number of members of the Board until the same shall be changed as aforesaid. Directors need not be shareholders.”


IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be executed and acknowledged on its behalf by its duly authorized officer as of this 22nd day of April, 2022.
L3HARRIS TECHNOLOGIES, INC.

By:    /s/ Scott T. Mikuen    

Name:        Scott T. Mikuen
Title:        Senior Vice President,
        General Counsel and Secretary

    


1


L3Harris Proprietary Information

Exhibit 10.1


CONDITIONAL WAIVER, SEPARATION AGREEMENT AND RELEASE OF ALL CLAIMS
JESUS (JAY) MALAVE

This CONDITIONAL WAIVER, SEPARATION AGREEMENT AND RELEASE OF ALL CLAIMS (this “Agreement”) is between L3Harris Technologies, Inc. (“L3Harris”) and JESUS (JAY) MALAVE (“you,” “your” and similar words). The intent of this Agreement is to mutually and finally resolve all matters relating to your employment with and separation from L3Harris.

1.    Separation Date and Treatment. Your employment with L3Harris will end at close of business on January 21, 2022 (your “Separation Date”). You will be paid any accrued but unpaid base salary on the next regularly scheduled payroll date after the Separation Date. For purposes of any post-separation benefits applicable to you (other than equity awards), your separation from employment will be treated and designated as a voluntary resignation. Benefit accruals and contributions under the Retirement Savings Plan and Excess Retirement Savings Plan, including matching contributions, will end as of your Separation Date.

2.    Conditional Waiver of Non-Competition Provisions. You are currently subject to covenants prohibiting you from, directly or indirectly, as an employee or officer or investor or in other capacities, participating in any activities with, or providing services to, a competitive business for a period of not less than the twelve (12) month period following your employment termination date. Such covenants are referred to in this Agreement as the “Existing Non-Compete Agreements” (which are listed on Attachment A to this Agreement). You acknowledge and agree L3Harris has the right to enforce the Existing Non-Compete Agreements and to enjoin you from participating as an employee, officer or otherwise with a competitive business. You have requested that L3Harris waive and not enforce the Existing Non-Compete Agreements and provide consent for you to become the Chief Financial Officer of Lockheed Martin Corporation. Subject to the conditions set forth below in this Section 2, L3Harris agrees to waive the Existing Non-Compete Agreements and to consent to you becoming a full-time employee of Lockheed Martin Corporation (but no other competitive business). This waiver and consent is subject to your compliance with your obligations and agreements contained in this Agreement, including without limitation the condition that you at all times fully comply with and do not breach the following sections of this Agreement:

        (a)    Section 18 “Confidentiality”;
        (b)    Section 19 “Employee Non-Solicitation/Non-Engagement”;
        (c)    Section 20 “Non-Disparagement”;
        (d)    Section 21 “Non-Competition”; and
        (e)    Section 22 “Recusal and Other Protective Provisions.”

The waiver and consent is also conditional on your timely executing and delivering this Agreement to L3Harris and not revoking the Release of All Claims set forth herein. The waiver and consent provided in this Section is referred to in this Agreement as the “Conditional Waiver.”

You acknowledge and agree that if you do not fully satisfy and comply with the Conditional Waiver, the Conditional Waiver will be null and void and terminated as if it had never been granted. In such instance, you agree that L3Harris will be entitled to fully enforce the Existing Non-Compete Agreements (notwithstanding that you may have commenced employment at a competitive business) in addition to enforcement of this Agreement, including but not limited to, Sections 18, 19, 20, 21, and 22. Furthermore, in accordance with Section 7 of this Agreement, you agree that if you do not fully satisfy and comply with the Conditional Waiver and the Sections referenced therein, you will forfeit 3,092 vested Restricted Stock Units and/or the value associated with such units.



JM             JG
Employee                L3Harris


STM/bs/22-001    Page 1 of 12




L3Harris Proprietary Information

Exhibit 10.1
3.    Benefits. Effective as of the close of business on the Separation Date, you will cease to be eligible for the employee benefit plans, programs and arrangements maintained by L3Harris in accordance with the applicable terms thereof. For the purpose of the Consolidated Omnibus Budget Reconciliation Act (“COBRA”), 29 U.S.C. § 1161 et seq., your Separation Date shall serve as the “qualifying event” for the purpose of any rights you may have under COBRA. If you participate in the Medical, Dental, or Vision or a Health Care Flexible Spending Account, you will be offered the opportunity to elect continued coverage for yourself and your qualifying dependents in accordance with COBRA. L3Harris will not pay any premiums due under the Medical, Dental or Vision Plans. You may continue coverage for the COBRA period at the full monthly cost plus a 2% administrative fee. If you do not elect COBRA within the time period required under COBRA, your healthcare benefits and Health Care Flexible Spending Account participation will end on your Separation Date.

4.    Annual Incentive Plan. You acknowledge and agree that in consideration of this Agreement and other good and valuable consideration, including without limitation the Conditional Waiver, the receipt and sufficiency of which is hereby acknowledged and notwithstanding any terms of the L3Harris Annual Incentive Plan (“AIP”) to the contrary, L3Harris may in its sole and absolute discretion determine that you are not entitled to any payment under the AIP in respect of L3Harris’ completed fiscal year 2021, and you hereby waive any entitlement to an AIP payout for L3Harris’ completed fiscal year 2021.
5.    Stock Options. The stock options you hold as of the Separation Date (including Performance Stock Options) will be governed by the terms of the applicable L3Harris Equity Incentive Plan(s) and terms and conditions thereunder in effect at the time of the grant (as amended, if applicable). You agree that this Section supersedes any contrary provision in your award agreements and that all of your stock options (vested or unvested, exercised or unexercised) will, as of the Separation Date, immediately expire, and be cancelled, terminated and forfeited in their entirety and shall not be exercisable to any extent. For purposes of clarity, you agree that you have waived the right to exercise any vested stock options after the Separation Date.

6.    Performance Unit Awards. Your outstanding performance unit awards (including “Momentum” awards) which you hold as of the Separation Date will be governed by the terms of the L3Harris Equity Incentive Plan(s) and terms and conditions thereunder in effect at the time of grant (as amended, if applicable). You agree that this Section supersedes any contrary provision in your award agreements and that all of your performance unit awards (vested or unvested, exercised or unexercised) will, as of the Separation Date, immediately expire, and be cancelled, terminated and forfeited in their entirety.

7.    Restricted Unit Awards. (a) Your outstanding unvested restricted unit awards which you hold as of the Separation Date will be governed by the terms of the applicable L3Harris Equity Incentive Plan(s) and terms and conditions thereunder in effect at the time of the grant (as amended, if applicable). You agree that this Section supersedes any contrary provision in your award agreements and that all of your unvested restricted units will, as of the Separation Date, immediately expire, and be cancelled, terminated and forfeited in their entirety.




JM             JG
Employee                L3Harris


STM/bs/22-001    Page 2 of 12




L3Harris Proprietary Information

Exhibit 10.1
(b)    Prior to your Separation Date, 3,092 Restricted Stock Units granted on August 1, 2019 vested. You agree that if you breach any of the provisions of Sections 18, 19, 20, 21, and 22 of this Agreement, in addition to any and all other remedies available to L3Harris (including under Section 23), L3Harris shall have the right to reclaim and receive from you: (i) all shares of L3Harris stock and cash, as applicable, issued or paid to you in respect of restricted units that have vested prior to the Separation Date; or (ii) to the extent that you have transferred such shares, the fair market value thereof (as of the date such shares were transferred by you) in cash. Any such return of shares or payment of cash by you shall be made within five (5) business days following receipt of written demand therefore.

8.    No Outplacement Assistance. You will not be eligible for the outplacement program and you will not receive cash in lieu thereof.

9.    No Further Benefits. Unless otherwise expressly provided in this Agreement or pursuant to applicable L3Harris employee compensation or benefit arrangements, you will not be entitled to any pay, wages, paid time off, compensation, severance, insurance, or employment benefits from L3Harris after your Separation Date, and you expressly waive and disclaim such benefits or entitlement. Unless otherwise provided in this Agreement, any post-employment benefits will be governed by the terms and conditions of the applicable plan or program, which may be amended.

10.    Additional Representations and Warranties. You acknowledge that you have read and understand L3Harris’ Code of Conduct and that you do not have any information or knowledge as to non-compliance with, or violation of, the policies and standards set forth therein. You further represent and agree that: (a) you have not instituted, prosecuted, filed, or processed any litigation or other claims or charges against L3Harris that have not previously been communicated to L3Harris in writing; (b) you are not aware of any facts that would give rise to a personal or class action claim against L3Harris under the Family and Medical Leave Act, the Fair Labor Standards Act, any claim for sexual assault, sexual harassment, or any other federal or state statute; (c) you are not aware of any work-related injuries for which you do not already have a pending claim; and (d) you will not sue L3Harris, or join in any lawsuit, or bring or join in any other claim, charge, or proceeding against L3Harris, or any other Releasee (as defined below) concerning any of the claims released by this Agreement. Notwithstanding the foregoing, to the extent, if any, you have a non-waivable right to file or participate in a claim or charge against L3Harris, this Agreement shall not be intended to waive such a right.

11.    Indemnification Agreement; Resignation from Office. (a) The Indemnification Agreement between you and L3Harris (the “Indemnification Agreement”) will remain in full force or effect for claims, proceedings, liability, or loss you incur arising from that portion of any actual or alleged conduct or wrongful acts in your capacity as an employee and officer of L3Harris that occurred prior to your Separation Date. In no event shall this Agreement confer any indemnification or advancement rights or protection for claims, proceedings, liability, or loss you incur arising from that portion of any actual or alleged conduct or wrongful acts that occur after your Separation Date. This Agreement does not waive any rights you may have to indemnification under L3Harris Restated Certificate of Incorporation or By-Laws or to any third-party insurance, including but not limited to any directors and officer’s liability insurance policy(ies) issued to L3Harris.
(b)    You agree that no later than the Separation Date you will resign from any offices, directorships, trusteeships, committee memberships or other positions you hold with L3Harris or


JM             JG
Employee                L3Harris


STM/bs/22-001    Page 3 of 12




L3Harris Proprietary Information

Exhibit 10.1
any of its affiliates. You agree to execute any documents provided by L3Harris to effectuate your resignation from such offices, directorships, trusteeships, committee memberships or other positions.

12.    Releasees. For purposes of this Agreement, “Releasees” include L3Harris and its subsidiaries and affiliated companies and their officers, directors, shareholders, employees, agents, representatives, plans, trusts, administrators, fiduciaries, insurance companies, successors, and assigns.

13.    Release of All Claims. You, on behalf of yourself and your personal and legal representatives, heirs, executors, successors and assigns, hereby acknowledge full and complete satisfaction of, and fully and forever waive, release, and discharge Releasees from, any and all claims, causes of action, demands, liabilities, damages, obligations, and debts (collectively referenced as “Claims”), of every kind and nature, whether known or unknown, suspected or unsuspected, that you hold as of the date you sign this Agreement, or at any time previously held, against any Releasee, arising out of any matter whatsoever (except for breach of this Agreement). This release specifically includes, but is not limited to, any and all Claims:

a.    Arising out of or in any way related to your employment with or separation from L3Harris, or any contract or agreement between you and L3Harris;

b.    Arising under or based on the Equal Pay Act of 1963 (EPA); Title VII of the Civil Rights Act of 1964 (Title VII); Section 1981 of the Civil Rights Act of 1866 (42 U.S.C. §1981); the Civil Rights Act of 1991 (42 U.S.C. §1981a); the Americans with Disabilities Act of 1990 (ADA); the Family and Medical Leave Act of 1993 (FMLA); the Genetic Information Nondiscrimination Act of 2008 (GINA); the National Labor Relations Act (NLRA); the Worker Adjustment and Retraining Notification Act of 1988 (WARN); the Uniform Services Employment and Reemployment Rights Act (USERRA); the Rehabilitation Act of 1973; the Occupational Safety and Health Act (OSHA); the Employee Retirement Income Security Act of 1974 (ERISA) (except claims for vested benefits, if any, to which you are legally entitled); the False Claims Act; Title VIII of the Corporate and Criminal Fraud and Accountability Act (18 U.S.C. §1514A) (Sarbanes-Oxley Act); the federal Whistleblower Protection Act and any state whistleblower protection statute(s); the Florida Civil Rights Act or any other fair employment practice statute(s) of any state, in each case as amended from time to time;

c.    Arising under or based on any other federal, state, county or local law, statute, ordinance, decision, order, policy or regulation prohibiting employment discrimination; providing for the payment of wages or benefits (including overtime and workers’ compensation); or otherwise creating rights or claims for employees, including, but not limited to, any and all claims alleging breach of public policy; the implied obligation of good faith and fair dealing; or any express, implied, oral or written contract, handbook, manual, policy statement or employment practice; or alleging misrepresentation; defamation; libel; slander; interference with contractual relations; intentional or negligent infliction of emotional distress; invasion of privacy; assault; battery; retaliation; fraud; negligence; harassment; retaliation; or wrongful discharge; and

d.    Arising under or based on the Age Discrimination in Employment Act of 1967 (“ADEA”), as amended by the Older Workers Benefit Protection Act (“OWBPA”), and alleging a violation thereof by any Releasee, at any time on or prior to the date this Agreement is executed.

        Notwithstanding the foregoing, the release granted under Section 13 specifically excludes:



JM             JG
Employee                L3Harris


STM/bs/22-001    Page 4 of 12




L3Harris Proprietary Information

Exhibit 10.1
(a)    any violation of any federal, state or local statutory and/or public policy right or entitlement that, by applicable law, may not be waived;
(b)    any right to base salary accrued prior to the Separation Date; and
(c)    any Claim that is based on an act or omission that occurs after the revocation period in Section 25.
14.    Filing an Action Despite Release. You agree that you will not file a civil action, lawsuit or administrative proceeding against any Releasee with respect to any of the Claims released herein (this does not include claims which, by law, cannot be waived). This provision prohibits you from recovering monetary or other relief in any legal proceeding brought by you or on your behalf, but does not apply to or limit your right to initiate or participate in an EEOC or other administrative proceeding in which you do not seek personal relief. This provision also does not preclude you from bringing suit to challenge the validity or enforceability of this Agreement under the ADEA, as amended by the OWBPA.

This Agreement does not limit your ability: (a) to report possible violations of law or regulation to, or file a charge or complaint with, the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the National Labor Relations Board, or the Occupational Safety and Health Administration, or any other federal, state or local governmental agency or commission. This Agreement does not limit your ability under applicable U.S. federal law to: (a) disclose trade secrets in confidence to an attorney or to federal, state and local government officials for the sole purpose of reporting or investigating a suspected violation of law or (b) disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if such filing is made under seal and protected from public disclosure.

15.    Return of Property. You agree that, no later than your Separation Date, you will return to L3Harris all company information and property, in whatever form, including but not limited to laptop, phone, tablets, documents, records, reports, notebooks, drawings, photographs, technical data, credit cards, keys, equipment, computer software, supplies, or other information or property containing confidential or proprietary information of L3Harris or its subsidiaries and affiliates, and you agree that you will not retain copies of same. You further agree and certify that, no later than your Separation Date, you will permanently delete from your personal computers, tablets or storage devices any and all confidential or proprietary documents and/or information relating to L3Harris and its subsidiaries and affiliates.

16.    Trading Restrictions; Officer Questionnaire. (a) You agree and acknowledge that following your Separation Date you shall continue to be subject to the L3Harris securities insider trading policies. You also acknowledge that trading on the basis of material non-public information, or providing such information to others that may trade, is a violation of the federal securities laws. You also agree not to trade in any L3Harris securities until after the expiration of ninety (90) days after your Separation Date.

(b)    Upon reasonable request by L3Harris, you shall complete an officer questionnaire in the form provided to L3Harris senior executives, the responses to which may be used to enable L3Harris to comply with the disclosure obligations to the SEC.



JM             JG
Employee                L3Harris


STM/bs/22-001    Page 5 of 12




L3Harris Proprietary Information

Exhibit 10.1
17.    Legal Proceedings and Cooperation. You agree that you will, to the extent reasonably requested, cooperate with and serve in any capacity reasonably requested by L3Harris in any pending or future investigation (including internal investigation), litigation or proceedings in which L3Harris is or may be a party, and regarding which you, by virtue of your employment with L3Harris, may have knowledge or information which L3Harris deems relevant to said litigation, investigation or proceedings including, but not limited to, acting as L3Harris’ representative or on behalf of L3Harris in any said investigation, litigation, or proceedings. You further agree that you will, without the necessity for subpoena, provide in any jurisdiction in which L3Harris requests, truthful testimony relevant to said investigation, litigation or proceedings. In connection with the foregoing, L3Harris will attempt to accommodate your schedule, provide you with reasonable advance notice of the times at which your services are needed and reimburse you for reasonable out-of-pocket expenses. This provision shall survive termination of this Agreement.

18.    Confidentiality. In addition to your agreement to return all company information and property to L3Harris, you acknowledge that, while employed by L3Harris, you had access to, acquired and/or assisted in the development of confidential or proprietary information, inventions, and trade secrets relating to the present and anticipated business and operations of L3Harris or its subsidiaries and affiliates, whether or not marked or otherwise designated as confidential, whether in document, electronic or other form and includes, but is not limited to: financial projections, financial forecasts, performance results; research projects; manufacturing or operating processes; sales and marketing methods; business opportunities; marketing plans; sales forecasts and product plans; distributor and customer pricing information; personnel data regarding employees of L3Harris or its subsidiaries and affiliates, including salaries; and other information of a similar confidential nature not available to the public. You agree to keep confidential and not to disclose or use such confidential and proprietary information, inventions and trade secrets without the prior written consent of a senior executive of L3Harris or until such time as the information, inventions and trade secrets become public knowledge. You further agree not to use or disclose such confidential or proprietary information, inventions and trade secrets to solicit business directly or indirectly on behalf of any subsequent employer from any present or prospective customer(s) of L3Harris or its subsidiaries or affiliates. You understand that these obligations continue after your Separation Date. The provisions of this Section 18 are separate from and in addition to the confidentiality restrictions contained in the equity awards granted to you by L3Harris and accepted by you or in any other confidentiality agreement entered into between you and L3Harris or any subsidiary or affiliate thereof. Any breach of the above-described additional confidentiality provisions will also constitute a violation and breach of this Agreement.

    The Parties agree that this Agreement is not confidential nor proprietary information of L3Harris and you are permitted to disclose its terms to third parties, including but not limited to your spouse, professional advisors and Lockheed Martin Corporation. L3Harris agrees that your disclosure of this Agreement shall not be a breach of this Agreement, the confidentiality obligations contained in the equity awards granted to you by L3Harris or any other confidentiality agreement entered into between you and L3Harris or any subsidiary or affiliate thereof.

19.    Employee Non-Solicitation/Non-Engagement.  In consideration of the benefits and consideration to be made to you under this Agreement, including but not limited to the Conditional Waiver, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, commencing on the date hereof and continuing through January 21, 2024, you agree that you will not, directly or indirectly, individually or on behalf of any other employer or any other business, person or entity: (i) recruit, induce, Solicit, attempt to recruit, attempt to induce, or attempt to Solicit any Restricted Employee to terminate, abandon or otherwise leave or discontinue


JM             JG
Employee                L3Harris


STM/bs/22-001    Page 6 of 12




L3Harris Proprietary Information

Exhibit 10.1
employment with L3Harris or any of its subsidiaries for the purpose of joining or affiliating with Lockheed Martin Corporation or any other Competitive Business; or (ii) hire or cause or assist any Restricted Employee to become employed by or provide services to Lockheed Martin Corporation or any other Competitive Business, person or entity whether as an employee, consultant, contactor or otherwise. You also agree that this restriction is reasonable and necessary for the protection of L3Harris’ legitimate business interests, that it does not infringe on your ability to earn a living, and that a violation of this restriction will cause irreparable harm to L3Harris.  The provisions of this Section 19 are separate from and in addition to any other non-solicit agreement between you and L3Harris or its subsidiaries or affiliates, including but not limited to the terms and conditions of equity awards granted to you by L3Harris and accepted by you. Any breach of the above-described additional non-solicitation provisions will also constitute a violation and breach of this Agreement. For purposes of this Agreement “Solicit” or “Soliciting” means any direct or indirect communication of any kind, regardless of who initiates it, that in any way invites, advises, encourages, engages or requests any person to take or refrain from taking any actions. For purposes of this Agreement, “Restricted Employee” means any person who, as of the Separation Date, is a Corporate Officer of L3Harris or who holds a job classification level at L3Harris of XL3, XL2, XL1, or XL0 or any person with whom you dealt in the course of performing your job duties during the twelve (12) months prior to the Separation Date.

20.    Non-Disparagement. (a) In consideration of the benefits to be made to you under this Agreement, including but not limited to the Conditional Waiver, and for other good and valuable consideration, the receipt and sufficiency of which you hereby acknowledge, you agree that you will not, directly or indirectly, criticize, disparage, defame, or otherwise attempt to impugn the character, integrity or reputation of Releasees or the products or services of L3Harris and its subsidiaries or affiliates (verbally, in writing or otherwise), nor will you unlawfully interfere with any of the business relationships of L3Harris and its subsidiaries or affiliates.

(b)    L3Harris agrees to instruct its Corporate Officers not to criticize, disparage, defame, or otherwise attempt to impugn your character, integrity or reputation to Lockheed Martin Corporation.

(c)    The provisions of this Section 20 are separate from and in addition to any other non-disparagement agreement between you and L3Harris or its subsidiaries or affiliates, including but not limited to, the non-disparagement restrictions contained in the equity awards granted to you by L3Harris and accepted by you. Any breach of the above-described additional non-disparagement provisions will also constitute a violation and breach of this Agreement. Nothing in this Section 20 is intended or should be construed to prevent you or L3Harris or its designated representatives from providing truthful testimony or information to any person or entity as required by law or fiduciary duties.

21.    Non-Competition. (a) In consideration of the benefits and consideration to be made to you under this Agreement, including but not limited to the Conditional Waiver, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, you agree that from your Separation Date through January 21, 2023, you shall not, directly or indirectly, as an employee, independent contractor, consultant, officer, director, principal, lender or investor engage or otherwise participate in any activities with, or provide services to, a Competitive Business, without the prior written consent of the Vice President, Chief Human Resources or other designated executive officer of L3Harris (which consent shall be at such officer’s discretion to give or withhold). Nothing in this section shall preclude you from owning up to 1% of the equity in any publicly traded company. For purposes of this Agreement, “Competitive Business” means any


JM             JG
Employee                L3Harris


STM/bs/22-001    Page 7 of 12




L3Harris Proprietary Information

Exhibit 10.1
business, person or entity that is engaged, or planning or contemplating to engage within a period of twelve (12) months, in any business activity that is competitive with the business and business activities engaged in by a business unit of L3Harris at the Separation Date. The provisions of this Section 21 are separate from and in addition to any other non-competition agreement between you and L3Harris or its subsidiaries or affiliates, including but not limited to the Existing Non-Compete Agreements. Any breach of the Existing No-Compete Agreements will also constitute a violation and breach of this Agreement.

(b)    Provided you are in compliance with the Conditional Waiver and all other terms of this Agreement, Lockheed Martin Corporation will not be considered a Competitive Business for purposes of this Section 21.

22.    Recusal and Other Protective Provisions. You agree that from your Separation Date through July 21, 2023 you will recuse yourself from any discussions of or participation in : (1) bids and proposals or awards or other contracts or opportunities in which Lockheed Martin Corporation is in competition with L3Harris or its subsidiaries, and (2) any business opportunity in which L3Harris is a subcontractor to or a “teammate” or contracting party with Lockheed Martin Corporation, or vice versa. Notwithstanding the expiration of the recusal obligations set forth in this Section 22, you acknowledge and agree that you will remain subject to the confidentiality obligations you have to L3Harris following the expiration of such recusal period, including under Section 18 of this Agreement.

23.    Breach of Agreement; Clawback. If you file or permit to be filed any civil action, lawsuit, or administrative proceeding against any Releasee seeking personal legal or equitable relief in connection with any matter relating to your employment with or separation from L3Harris, breach the restrictive covenants applicable to you under this Agreement or otherwise breach a provision of this Agreement, in addition to any other rights, remedies, or defenses L3Harris or the other Releasees may have, L3Harris may: (1) immediately terminate this Agreement, if still in effect, without further obligation or liability to you of any kind; (2) recover from you the aggregate dollar value of all pay, insurance, and other benefits provided to you following the Separation Date; (3) recover and reclaim from you shares of L3Harris stock or cash, as the case may be, as set forth in Section 7(b); and (4) recover from you all damages, costs and expenses, including reasonable attorneys’ fees and costs, incurred by L3Harris or the other Releasee(s) in defending such civil action, lawsuit or administrative proceeding or in connection with such breach, including such reasonable attorneys’ fees and costs incurred in recovering such amounts. You further agree that any breach or threatened breach by you, intentional or otherwise, of the non-solicitation, non-competition or other provisions of this Agreement, including Sections 18, 19, 20, 21, and 22 will entitle L3Harris, in addition to other available remedies, to a temporary and permanent injunction or any other appropriate degree of specific performance in order to enjoin such breach or threatened breach.

24.    No Admission of Liability. By entering into this Agreement, L3Harris does not admit to, and expressly denies, any liability or wrongdoing. In addition, you acknowledge and agree that this Agreement may not be used as evidence to claim or prove any alleged wrongdoing by L3Harris, other than failure to comply with the terms of this Agreement.




JM             JG
Employee                L3Harris


STM/bs/22-001    Page 8 of 12




L3Harris Proprietary Information

Exhibit 10.1
25.    Acknowledgement of ADEA Rights and Informed Consent. You acknowledge as follows:

a.    You are advised to consult with an attorney or other representative of your choice prior to signing this Agreement;

b.    By executing this Agreement, you waive all rights or claims, if any, that you have or may have against any Releasee under the ADEA, as amended by the OWBPA, and under any state or local laws prohibiting age discrimination;

c.    You are waiving rights and claims that you may have under the ADEA in exchange for consideration that is additional to anything of value to which you are already entitled, including but not limited to, the Conditional Waiver;

d.    You are not waiving rights and claims that you may have under the ADEA that may arise after the date this Agreement is signed;

e.    You fully understand this Agreement and are signing it voluntarily and of your own free will;

f.    You received this Agreement on or prior to your Separation Date, and you have up to 21 calendar days from that date to consider whether to sign it, and such 21-day period will not re-start with changes to this Agreement whether material or immaterial;

g.    If you wish to sign this Agreement prior to the expiration of the 21-day period explained above, you may do so;

h.    You have seven (7) calendar days following the date you sign this Agreement to revoke your release of claims under the ADEA, and your release of such claims will not become effective until the revocation period has expired without your revoking it (at which time it will become fully enforceable and irrevocable); and

i.    To revoke your release of claims under the ADEA, you must deliver to L3Harris (via both U.S. mail and electronically), within the 7-day revocation period, a signed written statement that you revoke your release of claims under the ADEA. The revocation must be postmarked within the period stated above and addressed to:

James P. Girard
Vice President, Chief Human Resources Officer
L3Harris Technologies, Inc.
1025 W NASA Blvd
Melbourne, Florida 32919

If you revoke your release of claims under the ADEA, you understand that you will not be entitled to receive the benefits and consideration, including the Conditional Waiver, described herein.

26.    Entire Understanding. This Agreement constitutes the entire agreement between you and L3Harris with respect to the subjects addressed herein. However, except as specifically set forth in this Agreement, this Agreement is not intended to supersede the provisions of (1) the terms and conditions of equity grants set forth on Attachment A to this Agreement, or (2) any other


JM             JG
Employee                L3Harris


STM/bs/22-001    Page 9 of 12




L3Harris Proprietary Information

Exhibit 10.1
obligations you may have regarding confidentiality, non-disclosure, intellectual property, ownership of inventions, non-competition and/or non-solicitation pursuant to any agreement with L3Harris or its subsidiaries or affiliates.

27.    Withholding. Notwithstanding any other provision of this Agreement, L3Harris may withhold from amounts payable under this Agreement all amounts that are required or authorized to be withheld, including, but not limited to, federal, state, local and foreign taxes to be withheld by applicable laws or regulations.

28.    Successors and Assigns. This Agreement will be binding in all respects upon, and will inure to the benefit of, the parties’ representatives, heirs, executors, successors, and assigns.

29.    Governing Law. The parties agree that L3Harris is headquartered in Melbourne, Florida. The validity and interpretation of this Agreement will be governed exclusively by Florida law without giving effect to principles of conflicts of law. The parties stipulate that jurisdiction and venue will lie exclusively in Brevard County, Florida or the United States District Court for the Middle District of Florida for any action involving the validity, interpretation and enforcement of this Agreement, for any claim for breach of this Agreement, and for damages or any other relief sought under this Agreement.

30.    Severability and Intent for Court to Enforce Covenants to Maximum Extent. In the event that any provision of this Agreement is found to be partially or wholly invalid, illegal or unenforceable, the parties agree that such provision shall be modified or restricted as necessary to render it valid, legal and enforceable. It is expressly understood and agreed that such modification or restriction may be accomplished by mutual accord between the parties or, alternatively, by disposition of a court. The parties further agree that if such provision cannot under any circumstances be so modified or restricted, it shall be excised from this Agreement without affecting the validity, legality or enforceability of any of the remaining provisions. You acknowledge and agree that (i) the scope and duration of the restrictions in Sections 18, 19, 20, 21, and 22 are fair and reasonable; (ii) if any provisions of Sections 18, 19, 20, 21, or 22 or any part thereof are held to be unenforceable, the court making such determination shall have the power to revise or modify such provision to make it enforceable to the maximum extent permitted by applicable law and, in its revised or modified form, such provision shall then be enforceable, and if the provision is not capable of being modified or revised so that it is enforceable, it shall be excised from this Agreement without affecting the enforceability of the remaining provisions.
31.    Recovery of Previous Awards for Restatements, Etc. You agree that you will remain subject to Section 15 of the Annual Incentive Plan and Section 13.10 of the 2015 Equity Incentive Plan if any of the L3Harris’ financial restatements are restated as a result of errors, omissions or fraud and L3Harris seeks to recover all or a portion of prior payments or awards made to you under such plans.

32.    Preparation of Agreement. This Agreement will be interpreted in accordance with the plain meaning of its terms and not strictly for or against any of the parties hereto. Regardless of which party initially drafted this Agreement, it will not be construed against any one party, and will be construed and enforced as a mutually-prepared document.

33.    Headings. Section headings are for convenience only and shall not be used to interpret or construe this Agreement.



JM             JG
Employee                L3Harris


STM/bs/22-001    Page 10 of 12




L3Harris Proprietary Information

Exhibit 10.1
34.    Waiver of Jury Trial. The Parties expressly waive their right to a jury to decide any controversy or claim concerning or arising out of this Agreement. Any controversy or claim concerning or arising out of this Agreement shall be adjudicated by a judge sitting without a jury. THIS CONSTITUTES A WAIVER OF JURY RIGHTS.

35.    Counterparts. This Agreement may be executed in counterparts or by copies transmitted electronically, all of which have the same force and effect as the original.

PLEASE READ AND CAREFULLY CONSIDER THIS AGREEMENT BEFORE SIGNING IT. THIS AGREEMENT CONTAINS A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS, INCLUDING BUT NOT LIMITED TO THOSE MADE UNDER FEDERAL, STATE, AND/OR LOCAL LAWS PROHIBITING DISCRIMINATION IN EMPLOYMENT, TO THE EXTENT PERMITTED BY LAW.

YOU AFFIRM AND ACKNOWLEDGE THAT, EXCEPT AS OTHERWISE PROVIDED HEREIN, L3HARRIS HAS PAID YOU ANY AND ALL WAGES, BONUSES, COMMISSIONS, INCENTIVES, SEVERANCE PAY, VACATION PAY AND/OR OTHER PAY OWED TO YOU AS A RESULT OF YOUR EMPLOYMENT BY L3HARRIS, AND YOU AGREE THAT NO SUCH FURTHER PAYMENTS OR AMOUNTS ARE OR WILL BE OWED.

YOU ACKNOWLEDGE THAT THIS AGREEMENT CONTAINS A WAIVER OF JURY RIGHTS.

Agreed to:


Employee:    L3Harris Technologies, Inc.


/s/ Jesus Malave            By: /s/ James P. Girard         
Signature    Name:    James P. Girard
        Title:    Vice President,
            Chief Human Resources Officer

Jesus Malave            Date:    January 21, 2022
Print Name        

    
Date: January 21, 2022




JM             JG
Employee                L3Harris


STM/bs/22-001    Page 11 of 12




L3Harris Proprietary Information

Exhibit 10.1
Attachment A

EQUITY AWARDS AND EXISTING NON-COMPETE AGREEMENTS



Grant Date / Type*

# Granted
Vested Prior to
January 21, 2022
8-1-19    Stock Options34,7070
8-1-19    Performance Share Units3,2220
8-1-19    Restricted Units4,6383,092
2-28-20    Stock Options15,2225,074    **
2-28-20    Performance Share Units5,3110
2-28-20    Restricted Share Units2,6560
2-26-21    Stock Options14,2320
2-26-21    Performance Share Units6,5970
2-26-21    Restricted Share Units3,2990
* All listed equity grants include non-compete provisions which were accepted.
** Such stock options were terminated, cancelled and forfeited on the Separation Date.
For avoidance of doubt, any and all other options, restricted units and performance share units are forfeited.



JM             JG
Employee                L3Harris


STM/bs/22-001    Page 12 of 12

l3harrislogopra33a.jpg                            Exhibit 10.2
PERSONAL & CONFIDENTIAL
January 9, 2022
Michelle Turner
17 Elm Lane
Princeton, NJ 08540

Re: Offer of Employment
Dear Michelle:
Congratulations! I am pleased to offer you the position of Senior Vice President & Chief Financial Officer reporting to Christopher Kubasik, Vice Chair and Chief Executive Officer. This is an Executive Officer position based in Melbourne, FL commencing January 24, 2022, and your responsibilities will be as discussed.
Michelle, we believe you will make an outstanding contribution to the L3Harris organization, and as such, we have crafted a total rewards package for you, consistent with L3Harris’ executive compensation program design. The elements of this package include:
1)    An annual base salary of $750,000 payable bi-weekly. Base salaries are reviewed annually, with adjustments made subject to both business and personal performance.
2)    As an L3Harris executive, you will participate in the L3Harris Annual Incentive Plan (“AIP”) with a target opportunity equal to 100% of your base salary. Incentive awards are paid based on the achievement of pre-established, annual business operating metrics and the successful completion of personal performance objectives set during the annual performance management cycle. Incentive awards may range from 0% to 200% of target based on business and personal performance. Your participation in AIP will begin retroactively to the start of the 2022 performance year. To the extent earned, payouts are made by March 15th following prior year end, less applicable withholdings and deductions.
3)    Eligibility to receive annual equity awards granted by L3Harris under its 2015 Equity Incentive Plan (the “Plan”), with a target value of $2,500,000. The awards are granted in late February following the Board of Directors approval of annual equity awards to L3Harris executives. Once approved and accepted by you, the awards are subject to the applicable terms and conditions in effect at the time of the grant. Annual equity



grants are performance-based and the award amount may vary from year-to-year. You will be eligible for annual equity grants beginning in 2022.
4)    A one-time cash sign-on bonus of $750,000 to offset foregone annual incentive, and to partially offset foregone equity compensation scheduled to vest on February 11, 2022 at your current employer. The sign-on bonus will be made less applicable deductions and withholdings, and payable within thirty (30) days from your start date.
5)    A one-time grant of 3-year cliff vest equity with an approximate grant date value of $2,700,000 USD to offset foregone equity compensation at your current employer. The grant will be comprised of 50% Restricted Stock Units (“RSUs”) and 50% Non-Qualified Stock Options. This award is subject to the applicable terms and conditions in effect at the time of the grant, and the award will be granted on the first New York Stock Exchange trading day during the month following your start date (if that trading day occurs within a Quiet Period as defined by L3Harris’ equity grant policy, the grant date will be the first trading day following the end of the Quiet Period).
6)    Eligibility to participate in the L3Harris Retirement Plan 401(k) with a company match equivalent to 100% of the first 6% of employee contributions. While you will be immediately eligible to participate in the plan up to individual plan contribution limits, company match contributions will only be made after one year of service.
7)    Eligibility to participate in the L3Harris Excess Retirement Savings Plan (“ERSP”) upon the next annual open enrollment period. This IRS non-qualified retirement plan preserves your ability to make pre-tax contributions, and receive employer match contributions (after one year of service) above the qualified IRS limits in accordance with the plan terms.
8)    Participation in health and welfare benefit plans, including qualified dependents as applicable. These plans include medical, prescription, dental, vision, life and short and long-term disability benefits. Coverage under these programs is effective, should you choose to participate, as soon as day one of employment with L3Harris.
9)    Relocation benefits to assist with your move from Princeton, NJ to the Melbourne, FL area. Benefits will include, but not be limited to home sale assistance; home purchase assistance; six months of temporary living accommodations; the packing and shipment of household goods; and a miscellaneous expense allowance payment of $10,000, less applicable taxes and other withholdings. Additional details regarding your relocation benefits will be provided under separate cover. In order to receive relocation benefits you must execute a Relocation Assistance Repayment Agreement.
Page: 2 of 4    Initials: ____


10)    This offer of employment is subject to the following conditions:
    Successful completion of L3Harris’ pre-employment drug and background screening, where permitted by law.
    Submission of all required documents and fully disclose, and provide copies where applicable, of any written or other agreements or understandings to which you are a party that relate to the protection of confidential, trade secret or proprietary information; non-competition restrictions; non-solicitation or no-hire prohibitions (employees or customers); and/or ownership of invention provisions. You affirm that your employment with L3Harris will not violate any such agreements or understandings.
    You provide proof of identity and employment eligibility, through completion of Form I-9, and demonstrate that you are lawfully able to work for L3Harris.
    Approval by the L3Harris Compensation Committee.
Step forward and join L3Harris as we build the future. I look forward to you joining the L3Harris team and am confident that you will make many significant contributions to the organization. Should you accept the terms of this offer, please sign and date below, and email a copy of this letter to me directly at the address below. We ask that you bring the original signed version with you on your first day of work.
Sincerely,
/s/ James P. Girard
James P. Girard
Vice President and Chief Human Resources Officer
L3Harris Technologies

Page: 3 of 4    Initials: ____


ACKNOWLEDGEMENT & ACCEPTANCE
By accepting this offer of employment, I acknowledge that I: (1) accept the terms and conditions of the offer; (2) understand that the offer constitutes the full, complete, and final agreement between you and L3Harris regarding the initial terms of my employment; and (3) understand that my employment with L3Harris is at-will and that the offer does not constitute a contract of employment or a guarantee of continued employment for any period.
Accepted and Agreed,
/s/ Michelle Turner        Date: January 9, 2022
Signature: Michelle Turner

Page: 4 of 4    Initials: ____




Exhibit 10.3
AMENDMENT NUMBER TEN
TO THE
L3HARRIS RETIREMENT SAVINGS PLAN

WHEREAS, L3Harris Technologies, Inc., a Delaware corporation (“L3Harris”), heretofore has adopted and maintains the L3Harris Retirement Savings Plan, as amended and restated effective January 1, 2021 (the "Plan");

WHEREAS, pursuant to Section 17.1 of the Plan, the Employee Benefits Committee of L3Harris (the “Committee”) has the authority to amend the Plan;

WHEREAS, pursuant to Section 13.3 of the Plan, the Committee has delegated certain of such amendment authority to the head of global benefits of L3Harris (currently, the Senior Director, Global Benefits) (the “Head of Global Benefits”);

WHEREAS, L3Harris has entered into a Sale Agreement with EMCORE Corporation and its wholly-owned subsidiary, Ringo Acquisition Sub, Inc. (collectively, “Purchaser”) dated as of February 14, 2022 pursuant to which L3Harris and its subsidiary will sell to Purchaser L3Harris’ Space & Navigation business operated previously within the Precision Engagement Systems sector of its Aviation Systems segment and currently within the Defense Electronics Systems Division of its Advanced Development Group Sector of the Integrated Mission Systems segment (such agreement, as it may be amended from time to time, the “Sale Agreement”);

WHEREAS, as a result of such sale all “Transferred Employees” (for all purposes of this Amendment, as such term is defined in the Sale Agreement) will cease to participate in the Plan;

WHEREAS, the Sale Agreement provides that effective as of the “Closing Date” (for all purposes of this Amendment, as such term is defined in the Sale Agreement), each Transferred Employee shall become fully vested in his or her account balance in the Plan; and

WHEREAS, the Head of Global Benefits desires to amend the Plan to reflect the above-described term of the Sale Agreement.

NOW, THEREFORE, BE IT RESOLVED, that Schedule B of the Plan, Special Rules Applying to Divestiture Accounts and Divestiture Participants, is hereby amended, contingent upon the occurrence of the “Closing” (as such term is defined in the Sale Agreement) and effective as of the Closing Date, to add a new paragraph at the end thereof as follows:

14.    Divestiture of Space & Navigation Business

(a) In General. The Company has entered into a Sale Agreement with EMCORE Corporation and its wholly-owned subsidiary, Ringo Acquisition Sub, Inc., dated as of February 14, 2022 pursuant to which the Company and its subsidiary will sell the Company’s Space & Navigation business operated previously within the Precision Engagement Systems sector of its Aviation Systems segment and at the time of sale within the Defense Electronics Systems Division of its Advanced Development Group








Exhibit 10.3
Sector of the Integrated Mission Systems segment (such agreement, as it may be amended from time to time, the “Space & Navigation Sale Agreement”).
(b) Vesting. Notwithstanding any other provision in the Plan, effective as of the “Closing Date” (as such term is defined in the Space & Navigation Sale Agreement), the “Transferred Employees” (as such term is defined in the Space & Navigation Sale Agreement) shall be 100% vested in their Accounts under the Plan.
APPROVED by the HEAD OF GLOBAL BENEFITS on this 28th day of March, 2022.

                            /s/ Allison Oncel        
Allison Oncel
Senior Director, Global Benefits




Exhibit 15
Acknowledgment of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors of L3Harris Technologies, Inc.:

We are aware of the incorporation by reference of our report dated April 29, 2022, relating to the unaudited condensed consolidated interim financial statements of L3Harris Technologies, Inc. that is included in its Form 10-Q for the quarter ended April 1, 2022, in the following Registration Statements of L3Harris Technologies, Inc.:    
Form S-4No. 333-236885L3Harris Technologies, Inc. Offer to Exchange
Form S-3No. 333-233827L3Harris Technologies, Inc. Debt and Equity Securities
Form S-4/ANo. 333-228829Harris Corporation Shares of Common Stock
Form S-8No. 333-232482L3 Technologies, Inc. Amended and Restated 2008 Long Term Performance Plan; L3 Technologies, Inc. Master Savings Plan; and Aviations Communications & Surveillance Systems 401(k) Plan
Form S-8No. 333-222821Harris Corporation Retirement Plan
Form S-8  No. 333-192735  Harris Corporation Retirement Plan
Form S-8No. 333-163647Harris Corporation Retirement Plan
Form S-8No. 333-75114Harris Corporation Retirement Plan
Form S-8  No. 333-130124  Harris Corporation 2005 Equity Incentive Plan
Form S-8  No. 333-207774  L3Harris Technologies, Inc. 2015 Equity Incentive Plan

/s/ Ernst & Young LLP
Orlando, Florida
April 29, 2022


Exhibit 31.1
CERTIFICATION
I, Christopher E. Kubasik, Vice Chair and Chief Executive Officer of L3Harris Technologies, Inc., certify that:
1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended April 1, 2022 of L3Harris Technologies, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: April 29, 2022  /s/ Christopher E. Kubasik
  Name:Christopher E. Kubasik
  Title:Vice Chair and Chief Executive Officer


Exhibit 31.2
CERTIFICATION
I, Michelle L. Turner, Senior Vice President and Chief Financial Officer of L3Harris Technologies, Inc., certify that:
1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended April 1, 2022 of L3Harris Technologies, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: April 29, 2022  /s/ Michelle L. Turner
  Name: Michelle L. Turner
  Title: Senior Vice President and Chief Financial Officer


Exhibit 32.1
Certification
Pursuant to Section 1350 of Chapter 63 of Title 18 of the
United States Code as Adopted Pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
In connection with the filing of the Quarterly Report on Form 10-Q of L3Harris Technologies, Inc. (“L3Harris”) for the fiscal year ended April 1, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Christopher E. Kubasik, Vice Chair and Chief Executive Officer of L3Harris, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of L3Harris as of the dates and for the periods expressed in the Report.
Date: April 29, 2022  /s/ Christopher E. Kubasik
  Name:Christopher E. Kubasik
  Title:Vice Chair and Chief Executive Officer


Exhibit 32.2
Certification
Pursuant to Section 1350 of Chapter 63 of Title 18 of the
United States Code as Adopted Pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
In connection with the filing of the Quarterly Report on Form 10-Q of L3Harris Technologies, Inc. (“L3Harris”) for the fiscal year ended April 1, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Michelle L. Turner, Senior Vice President and Chief Financial Officer of L3Harris, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of L3Harris as of the dates and for the periods expressed in the Report.
Date: April 29, 2022  /s/ Michelle L. Turner
  Name: Michelle L. Turner
  Title: Senior Vice President and Chief Financial Officer